0001493152-22-019396.txt : 20220715 0001493152-22-019396.hdr.sgml : 20220715 20220715083038 ACCESSION NUMBER: 0001493152-22-019396 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 43 CONFORMED PERIOD OF REPORT: 20220531 FILED AS OF DATE: 20220715 DATE AS OF CHANGE: 20220715 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Biopower Operations Corp CENTRAL INDEX KEY: 0001510832 STANDARD INDUSTRIAL CLASSIFICATION: CONSTRUCTION SPECIAL TRADE CONTRACTORS [1700] IRS NUMBER: 274460232 STATE OF INCORPORATION: NV FISCAL YEAR END: 1130 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 333-172139 FILM NUMBER: 221084326 BUSINESS ADDRESS: STREET 1: 5379 LYONS RD. STREET 2: SUITE 301 CITY: COCONUT CREEK STATE: FL ZIP: 33073 BUSINESS PHONE: 954-509-9830 MAIL ADDRESS: STREET 1: 5379 LYONS RD. STREET 2: SUITE 301 CITY: COCONUT CREEK STATE: FL ZIP: 33073 10-Q 1 form10-q.htm
0001510832 false Q2 --11-30 0001510832 2021-12-01 2022-05-31 0001510832 2022-07-15 0001510832 2022-05-31 0001510832 2021-11-30 0001510832 us-gaap:SeriesAPreferredStockMember 2022-05-31 0001510832 us-gaap:SeriesAPreferredStockMember 2021-11-30 0001510832 us-gaap:SeriesCPreferredStockMember 2022-05-31 0001510832 us-gaap:SeriesCPreferredStockMember 2021-11-30 0001510832 2022-03-01 2022-05-31 0001510832 2021-03-01 2021-05-31 0001510832 2020-12-01 2021-05-31 0001510832 BOPO:SaleOfTokensMember 2022-03-01 2022-05-31 0001510832 BOPO:SaleOfTokensMember 2021-03-01 2021-05-31 0001510832 BOPO:SaleOfTokensMember 2021-12-01 2022-05-31 0001510832 BOPO:SaleOfTokensMember 2020-12-01 2021-05-31 0001510832 BOPO:SaleOfTokensRelatedPartyMember 2022-03-01 2022-05-31 0001510832 BOPO:SaleOfTokensRelatedPartyMember 2021-03-01 2021-05-31 0001510832 BOPO:SaleOfTokensRelatedPartyMember 2021-12-01 2022-05-31 0001510832 BOPO:SaleOfTokensRelatedPartyMember 2020-12-01 2021-05-31 0001510832 2020-11-30 0001510832 2021-05-31 0001510832 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2021-02-28 0001510832 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2021-02-28 0001510832 us-gaap:PreferredStockMember 2021-02-28 0001510832 us-gaap:CommonStockMember 2021-02-28 0001510832 us-gaap:AdditionalPaidInCapitalMember 2021-02-28 0001510832 us-gaap:RetainedEarningsMember 2021-02-28 0001510832 2021-02-28 0001510832 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2022-02-28 0001510832 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2022-02-28 0001510832 us-gaap:PreferredStockMember 2022-02-28 0001510832 us-gaap:CommonStockMember 2022-02-28 0001510832 us-gaap:AdditionalPaidInCapitalMember 2022-02-28 0001510832 us-gaap:RetainedEarningsMember 2022-02-28 0001510832 2022-02-28 0001510832 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2020-11-30 0001510832 us-gaap:PreferredStockMember 2020-11-30 0001510832 us-gaap:CommonStockMember 2020-11-30 0001510832 us-gaap:AdditionalPaidInCapitalMember 2020-11-30 0001510832 us-gaap:RetainedEarningsMember 2020-11-30 0001510832 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2021-11-30 0001510832 us-gaap:PreferredStockMember 2021-11-30 0001510832 us-gaap:CommonStockMember 2021-11-30 0001510832 us-gaap:AdditionalPaidInCapitalMember 2021-11-30 0001510832 us-gaap:RetainedEarningsMember 2021-11-30 0001510832 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2021-03-01 2021-05-31 0001510832 us-gaap:PreferredStockMember 2021-03-01 2021-05-31 0001510832 us-gaap:CommonStockMember 2021-03-01 2021-05-31 0001510832 us-gaap:AdditionalPaidInCapitalMember 2021-03-01 2021-05-31 0001510832 us-gaap:RetainedEarningsMember 2021-03-01 2021-05-31 0001510832 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2022-03-01 2022-05-31 0001510832 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2022-03-01 2022-05-31 0001510832 us-gaap:PreferredStockMember 2022-03-01 2022-05-31 0001510832 us-gaap:CommonStockMember 2022-03-01 2022-05-31 0001510832 us-gaap:AdditionalPaidInCapitalMember 2022-03-01 2022-05-31 0001510832 us-gaap:RetainedEarningsMember 2022-03-01 2022-05-31 0001510832 us-gaap:CommonStockMember 2020-12-01 2021-05-31 0001510832 us-gaap:AdditionalPaidInCapitalMember 2020-12-01 2021-05-31 0001510832 us-gaap:RetainedEarningsMember 2020-12-01 2021-05-31 0001510832 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2021-12-01 2022-05-31 0001510832 us-gaap:PreferredStockMember 2021-12-01 2022-05-31 0001510832 us-gaap:CommonStockMember 2021-12-01 2022-05-31 0001510832 us-gaap:AdditionalPaidInCapitalMember 2021-12-01 2022-05-31 0001510832 us-gaap:RetainedEarningsMember 2021-12-01 2022-05-31 0001510832 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2021-05-31 0001510832 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2021-05-31 0001510832 us-gaap:PreferredStockMember 2021-05-31 0001510832 us-gaap:CommonStockMember 2021-05-31 0001510832 us-gaap:AdditionalPaidInCapitalMember 2021-05-31 0001510832 us-gaap:RetainedEarningsMember 2021-05-31 0001510832 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2022-05-31 0001510832 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2022-05-31 0001510832 us-gaap:PreferredStockMember 2022-05-31 0001510832 us-gaap:CommonStockMember 2022-05-31 0001510832 us-gaap:AdditionalPaidInCapitalMember 2022-05-31 0001510832 us-gaap:RetainedEarningsMember 2022-05-31 0001510832 BOPO:BioPowerCorporationMember 2011-01-06 0001510832 BOPO:ChiefExecutiveOfficerAndDirectorMember 2010-09-12 2010-09-13 0001510832 srt:ChiefExecutiveOfficerMember BOPO:FTZExchangeLLCMember 2012-06-06 2012-06-07 0001510832 BOPO:HyFiMember 2021-06-28 2021-06-29 0001510832 BOPO:HyFiTokensMember 2021-06-28 2021-06-29 0001510832 us-gaap:SeriesCPreferredStockMember 2021-06-29 0001510832 us-gaap:SeriesCPreferredStockMember 2021-06-28 2021-06-29 0001510832 BOPO:ChinaEnergyPartnersLLCMember BOPO:RedemptionAgreementMember us-gaap:SeriesAPreferredStockMember 2021-06-29 0001510832 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember BOPO:TwoCustomerMember 2022-03-01 2022-05-31 0001510832 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember BOPO:FiveCustomerMember 2021-12-01 2022-05-31 0001510832 2021-07-28 0001510832 BOPO:CanadianInvestorMember 2022-03-03 2022-03-04 0001510832 BOPO:CanadianInvestorMember 2022-03-04 0001510832 BOPO:DemandLoansMember 2022-05-31 0001510832 BOPO:DemandLoansMember srt:MinimumMember 2022-05-31 0001510832 srt:MaximumMember BOPO:DemandLoansMember 2022-05-31 0001510832 BOPO:DemandLoansMember 2021-12-01 2022-05-31 0001510832 BOPO:ReclassificationOfAccruedCompensationToNotesPayableMember 2022-05-31 0001510832 BOPO:ReclassificationOfAccruedCompensationToNotesPayableMember 2021-12-01 2022-05-31 0001510832 BOPO:DemandLoanAgreementsMember BOPO:ThirdPartyInvestorMember 2016-07-27 0001510832 BOPO:DemandLoanAgreementsMember BOPO:LenderMember 2012-01-07 0001510832 BOPO:DemandLoanAgreementsMember BOPO:LenderMember 2011-10-28 2012-01-07 0001510832 BOPO:ConvertibleDebtAgreementMember BOPO:ThirdPartyInvestorMember 2013-12-03 0001510832 BOPO:ConvertibleDebtAgreementMember BOPO:ThirdPartyInvestorMember 2015-07-30 0001510832 BOPO:ConvertibleDebtAgreementMember BOPO:ThirdPartyInvestorMember 2015-07-29 2015-07-30 0001510832 BOPO:ConvertibleDebtAgreementMember BOPO:ThirdPartyInvestorMember 2016-05-23 0001510832 BOPO:ConvertibleDebtAgreementMember BOPO:ThirdPartyInvestorMember 2016-05-22 2016-05-23 0001510832 BOPO:ConvertibleDebtAgreementMember BOPO:ThirdPartyInvestorOneMember 2015-07-30 0001510832 BOPO:ConvertibleDebtAgreementMember BOPO:ThirdPartyInvestorOneMember 2015-07-29 2015-07-30 0001510832 BOPO:ConvertibleDebtAgreementMember BOPO:ThirdPartyInvestorTwoMember 2015-07-30 0001510832 BOPO:ConvertibleDebtAgreementMember BOPO:ThirdPartyInvestorTwoMember 2015-07-29 2015-07-30 0001510832 2015-07-28 0001510832 2014-12-03 2015-07-28 0001510832 BOPO:ThirdPartiesMember 2022-03-01 2022-05-31 0001510832 BOPO:ThirdPartiesMember 2021-03-01 2021-05-31 0001510832 BOPO:ThirdPartiesMember 2021-12-01 2022-05-31 0001510832 BOPO:ThirdPartiesMember 2020-12-01 2021-05-31 0001510832 srt:ChiefExecutiveOfficerMember 2016-05-26 2016-05-27 0001510832 srt:ChiefExecutiveOfficerMember 2016-05-27 0001510832 srt:ChiefExecutiveOfficerMember 2016-06-01 2016-06-02 0001510832 srt:ChiefFinancialOfficerMember 2021-12-01 2022-05-31 0001510832 srt:ChiefFinancialOfficerMember 2020-12-01 2021-11-30 0001510832 srt:ChiefFinancialOfficerMember 2022-05-31 0001510832 srt:ChiefFinancialOfficerMember 2020-11-30 0001510832 BOPO:DirectorOfBusinessStrategyMember 2016-05-26 2016-05-27 0001510832 BOPO:DirectorOfBusinessStrategyMember 2016-05-27 0001510832 BOPO:DirectorOfBusinessStrategyMember BOPO:ThreeNotesMember 2016-05-27 0001510832 BOPO:DirectorOfBusinessStrategyMember 2016-06-01 2016-06-02 0001510832 BOPO:DirectorOfBusinessStrategyMember 2021-12-01 2022-05-31 0001510832 BOPO:DirectorOfBusinessStrategyMember 2020-12-01 2021-11-30 0001510832 BOPO:DirectorOfBusinessStrategyMember 2022-05-31 0001510832 BOPO:DirectorOfBusinessStrategyMember 2021-11-30 0001510832 us-gaap:InvestorMember 2016-11-30 0001510832 us-gaap:InvestorMember 2016-11-29 2016-11-30 0001510832 srt:ChiefOperatingOfficerMember 2016-03-31 0001510832 srt:ChiefOperatingOfficerMember 2016-03-01 2016-03-31 0001510832 srt:ChiefOperatingOfficerMember 2016-03-02 0001510832 srt:ChiefOperatingOfficerMember 2016-05-18 0001510832 BOPO:ThirdPartyInvestorMember 2016-05-23 0001510832 srt:ChiefOperatingOfficerMember 2016-05-23 0001510832 srt:ChiefOperatingOfficerMember 2016-05-31 0001510832 srt:ChiefOperatingOfficerMember 2016-05-01 2016-05-31 0001510832 srt:ChiefOperatingOfficerMember 2016-07-31 0001510832 srt:ChiefOperatingOfficerMember 2016-07-01 2016-07-31 0001510832 BOPO:RobertKohnMember 2021-06-29 0001510832 BOPO:RobertKohnMember 2022-05-31 0001510832 BOPO:RobertKohnMember 2021-11-30 0001510832 BOPO:HyFiTokensMember BOPO:TechnologyMember BOPO:RelatedPartiesMember 2020-12-01 2021-11-30 0001510832 BOPO:TechnologyMember BOPO:RelatedPartiesMember 2021-11-30 0001510832 BOPO:HyFiTokensMember BOPO:TechnologyMember BOPO:TroyMacDonaldMember 2020-12-01 2021-11-30 0001510832 BOPO:TechnologyMember BOPO:RelatedPartiesMember 2020-12-01 2021-11-30 0001510832 BOPO:NotesPayableAndConvertibleDebtMember 2022-03-01 2022-05-31 0001510832 BOPO:NotesPayableAndConvertibleDebtMember 2021-03-01 2021-05-31 0001510832 BOPO:NotesPayableAndConvertibleDebtMember 2021-12-01 2022-05-31 0001510832 BOPO:NotesPayableAndConvertibleDebtMember 2020-12-01 2021-05-31 0001510832 BOPO:ChinaEnergyPartnersLLCMember 2022-05-31 0001510832 BOPO:ChinaEnergyPartnersLLCMember 2021-11-30 0001510832 BOPO:ChinaEnergyPartnersLLCMember 2022-03-01 2022-05-31 0001510832 BOPO:ChinaEnergyPartnersLLCMember 2021-12-01 2022-05-31 0001510832 BOPO:ConsultantMember 2021-08-04 2021-08-05 0001510832 BOPO:ConsultantMember 2021-08-05 0001510832 BOPO:BaruchHalpernMember 2021-08-04 2021-08-05 0001510832 BOPO:BaruchHalpernMember 2021-08-05 0001510832 BOPO:RobertKohnMember 2021-08-04 2021-08-05 0001510832 BOPO:RobertKohnMember 2021-08-05 0001510832 BOPO:BonnieNelsonMember 2021-08-04 2021-08-05 0001510832 BOPO:BonnieNelsonMember 2021-08-05 0001510832 BOPO:StockPurchaseAgreementMember 2022-03-05 2022-03-05 0001510832 BOPO:DigitalArtMember BOPO:SanctumAgreementMember 2022-04-05 2022-04-06 0001510832 BOPO:DigitalArtMember BOPO:SanctumAgreementMember 2022-04-03 2022-04-04 0001510832 BOPO:DigitalArtMember BOPO:SanctumAgreementMember 2022-05-18 2022-05-19 0001510832 BOPO:DigitalArtMember BOPO:SanctumAgreementMember us-gaap:SubsequentEventMember 2022-06-30 2022-07-01 0001510832 BOPO:SecuritiesPurchaseAgreementMember us-gaap:ConvertibleDebtMember 2022-05-31 0001510832 BOPO:SecuritiesPurchaseAgreementMember us-gaap:ConvertibleDebtMember 2022-05-31 2022-05-31 0001510832 BOPO:ChinaEnergyPartnersNoteAmendmentMember us-gaap:SubsequentEventMember 2022-07-28 0001510832 BOPO:ChinaEnergyPartnersNoteAmendmentMember us-gaap:SubsequentEventMember 2022-07-29 0001510832 BOPO:ExclusiveLicenseOptionsYearOneMember BOPO:PIPAgreementMember us-gaap:SubsequentEventMember 2022-06-26 0001510832 BOPO:ExclusiveLicenseOptionsYearFiveMember us-gaap:SubsequentEventMember BOPO:PIPAgreementMember 2022-06-26 0001510832 us-gaap:SubsequentEventMember BOPO:PIPAgreementMember 2022-06-26 0001510832 BOPO:PIPAgreementMember us-gaap:SubsequentEventMember BOPO:RestrictedCommonStockMember 2022-06-25 2022-06-26 0001510832 BOPO:PIPAgreementMember us-gaap:SubsequentEventMember BOPO:RestrictedCommonStockMember 2022-06-26 0001510832 BOPO:PrepaymentPeriodOneMember 2022-05-31 0001510832 BOPO:PrepaymentPeriodTwoMember 2022-05-31 0001510832 BOPO:PrepaymentPeriodThreeMember 2022-05-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure BOPO:Integer

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended May 31, 2022

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from _____________ to ______________

 

Commission file number: 000-53274

 

BioPower Operations Corporation

(Exact name of registrant as specified in its charter)

 

Nevada   27-4460232
(State or other jurisdiction of   (I.R.S. Employer
incorporation or organization)   Identification No.)

 

 

20801 Biscayne Blvd., Suite 403

Aventura, FL. 33180

 
  (Address of principal executive offices) (Zip Code)  

 

Registrant’s telephone number, including area code: (786) 923-0272

 

N/A

(Former name, former address and former fiscal year, if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
N/A   N/A   N/A

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer Accelerated filer
Non-accelerated filer Smaller reporting company
Emerging growth company    

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No

 

As of July 15, 2022, the registrant had 45,625,000 shares of common stock outstanding.

 

 

 

 
 

 

BIOPOWER OPERATIONS CORPORATION

FORM 10-Q

 

TABLE OF CONTENTS

 

      PAGE
NO.
PART I FINANCIAL INFORMATION
       
  Item 1. Financial Statements
    Consolidated Balance Sheets as of May 31, 2022 and November 30, 2021 (Unaudited) F-1
    Consolidated Statements of Operations for the Three and Six Months ended May 31, 2022 and 2021 (Unaudited) F-2
    Consolidated Statements of Cash Flows for the Six Months ended May 31, 2022 and 2021 (Unaudited) F-3
    Consolidated Statements of Changes in Stockholders’ Deficit for the Three and Six Months ended May 31, 2022 and 2021 (Unaudited) F-4
    Consolidated Notes to the Unaudited Financial Statements F-5
       
  Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 3
       
  Item 3. Quantitative and Qualitative Disclosures About Market Risk 12
       
  Item 4. Controls and Procedures 12
       
PART II OTHER INFORMATION 13
       
  Item 1. Legal Proceedings 13
       
  Item 1A. Risk Factors 13
       
  Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 13
       
  Item 3. Defaults Upon Senior Securities 13
       
  Item 4. Mine Safety Disclosures 13
       
  Item 5. Other Information 13
       
  Item 6. Exhibits 13
       
  SIGNATURES 14

 

2
 

 

BioPower Operations Corporation and Subsidiaries

Consolidated Balance Sheets

 

   May 31,   November 30 
   2022   2021 
         
Assets          
Current assets          
Cash and cash equivalents  $522,356   $95,973 
Accounts receivable   331      
Inventory   12,893    -  
Prepaid expenses   77,593    - 
Total assets  $613,173   $95,973 
           
Liabilities and Stockholders’ Deficit          
Current liabilities          
Accounts payable and accrued expenses  $372,897   $563,967 
Accounts payable and accrued expenses - related party   2,000,905    1,530,668 
Notes payable   130,671    130,671 
Convertible debt   368,031    368,031 
Convertible debt - related parties,   399,447    399,447 
Notes payable Senior secured - related party   1,000,000    1,000,000 
Notes payable   193,667    193,667 
Notes payable - related parties   1,320,700    1,320,700 
Total current liabilities   5,786,318    5,507,151 
           
Commitments and Contingencies (Note 9)   -    - 
           
Stockholders’ deficit          
Preferred stock - Series A, $1.00 par value: 10,000 authorized, 0 and 1 shares issued and outstanding on May 31, 2022 and November 30, 2021, respectively   -    - 

Preferred stock - Series C, $.001 par value: 5,000,000 authorized, 900,000 and 0 shares issued and outstanding on May 31, 2022 and November 30, 2021, respectively

 

   900    900 
Common stock, $.0001 par value: 500,000,000 authorized; 45,625,000 and 45,000,000 issued and outstanding on May 31, 2022 and November 30, 2021, respectively   4,564    4,501 
Additional paid-in capital   4,390,339    4,140,411 
Accumulated deficit   (9,568,948)   (9,556,990)
Total stockholders’ deficit   (5,173,145)   (5,411,178)
Total liabilities and stockholders’ deficit  $613,173    95,973 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-1
 

 

BioPower Operations Corporation and Subsidiaries

Consolidated Statements of Operations

 

   2022   2021   2022   2021 
   For the three Months Ended May 31,   For the six months ended May 31, 
   2022   2021   2022   2021 
Revenue:                    
Sale of Tokens   136,000    -    336,000    - 
Sale of Tokens - related party   110,700    -    110,700    - 
Total Revenue  $246,700   $-   $446,700   $- 
                     
Operating expenses                    
Selling, general and administrative expenses   212,443    8,081    363,868    8,081 
Total operating expenses   212,443    8,081    363,868    8,081 
                     
Income / (Loss) from operations   34,257    (8,081)   82,832    (8,081)
                     
Other expenses                    
Interest expense   (11,248)   (11,247)   (22,495)   (22,494)
Interest expense -related party   (36,147)   (21,189)   (72,295)   (42,378)
Total other expenses   (47,395)   (32,436)   (94,790)   (64,872)
                     
Net loss  $(13,138)  $(40,517)  $(11,958)  $(72,953)
                     
Net loss per common share: basic and diluted  $(0.00)  $(0.00)  $(0.00)  $(0.00)
                     
Weighted average common shares outstanding: basic and diluted   45,597,826    43,107,680    45,302,198    43,107,680 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-2
 

 

BioPower Operations Corporation and Subsidiaries

Consolidated Statements of Cash Flows

 

   2022   2021 
   For the six months ended May 31, 
   2022   2021 
Cash flows from operating activities          
Net loss  $(11,958)  $(72,953)
Adjustments to reconcile net loss to net          
Changes in operating assets and liabilities          
Increase in accounts receivable   (331)   - 
Increase in prepaid expenses   (77,593)   - 
increase in inventory   (12,893)     
Accounts payable and accrued expenses   (191,071)   30,575 
Accounts payable and accrued expenses - related party   470,238    42,378 
Net cash used in operating activities   176,392    - 
           
Cash flow from financing activities          
Proceeds from issuance of common stock   249,991    - 
Net cash provided by financing activities   249,991    - 
           
Net increase in cash and cash equivalents   426,383    - 
Cash and cash equivalents at beginning of period   95,973      
Cash and cash equivalents at end of period  $522,356   $- 
           
Supplemental disclosure of cash flow information:          
Cash paid for interest  $-   $- 
Cash paid for income taxes  $-   $- 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-3
 

 

BioPower Operations Corporation and Subsidiaries

Consolidated Statements of Changes in Stockholders’ Deficit

For the Three and Six Months Ended May 31, 2022 and May 31, 2021

(Unaudited)

 

   Shares   Par   Shares   Par   Shares   Par   Paid-in   Accumulated     
   Preferred Series C   Preferred Stock   Common Stock   Additional         
   Shares   Par   Shares   Par   Shares   Par   Paid-in   Accumulated     
   Outstanding   Amount   Outstanding   Amount   Outstanding   Amount   Capital   Deficit   Total 
Balance February 29, 2021   -    -  -  -    -    43,107,680   $4,312   $4,746,884   $(9,148,101)  $(4,396,905)
Net loss, for the three months ended May 31,2021           -              -  -  -    -    -    -    -    (40,517)   (40,517)
Balance May 31, 2021   -   $-  1  -   $-    43,107,680   $4,312   $4,746,884   $(9,188,619)  $(4,437,422)

 

   Preferred Series C   Preferred Stock   Common Stock   Additional         
   Shares   Par   Shares   Par   Shares   Par   Paid-in   Accumulated     
   Outstanding   Amount   Outstanding   Amount   Outstanding   Amount   Capital   Deficit   Total 
Balance February 29, 2022   -   $- -   900,000   $900    45,000,000   $4,500   $4,140,411   $(9,555,809)  $(5,409,998)
Sale of common stock   -    -    -    -    625,000    63    249,928    -    249,991 
Net loss, for the three months ended May 31,2022   -    -  -  -    -    -    -    -    (13,138)   (13,138)
Balance May 31, 2022   -   $-  1  900,000   $900    45,625,000   $4,563   $4,390,339   $(9,568,948)  $(5,173,145)

 

   Shares   Par   Shares   Par   Shares   Par   Paid-in   Accumulated     
   Preferred Stock - Series A   Preferred Stock   Common Stock   Additional         
   Shares   Par   Shares   Par   Shares   Par   Paid-in   Accumulated     
   Outstanding   Amount   Outstanding   Amount   Outstanding   Amount   Capital   Deficit   Total 
Balance November 30, 2020   1    1    -    -    43,107,680   $4,312   $4,746,884   $(9,115,666)  $(4,364,469)
 Net income loss           -              -     -               -    -    -    -    (72,953)   (72,953)
Balance May 31, 2021   1   $1    -   $-    43,107,680   $4,312   $4,746,884   $(9,188,619)  $(4,437,422)
                                              
Balance November 30, 2021   1   $1    900,000   $900    45,000,000   $4,500   $4,140,411   $(9,556,990)  $(5,411,178)
Sale of common stock   -    -    -    -    625,000    63    249,928    -    249,991 
Net loss, for six months ended May 31, 2022   -    -    -    -    -    -    -    (11,958)   (11,958)
Balance May 31, 2022   1   $1    900,000   $900    45,625,000   $4,563   $4,390,339   $(9,568,948)  $(5,173,145)

 

F-4
 

 

BioPower Operations Corporation and Subsidiaries

Notes to Unaudited Consolidated Financial Statements

May 31, 2022

 

Note 1. Organization:

 

BioPower Corporation (“BioPower” or the “Company”) was incorporated in the State of Florida on September 13, 2010. On January 5, 2011, the Company re-domiciled to Nevada and formed BioPower Operations Corporation, a Nevada corporation. On January 6, 2011, the shareholders of BioPower Corporation contributed their shares of BioPower Corporation to BioPower Operations Corporation and BioPower Corporation became a wholly owned subsidiary.

 

On October 24, 2014, the Company executed a Share Exchange Agreement (“SEA”) with Green3Power Holdings Company (“G3P”) to acquire G3P and its wholly owned subsidiaries Green3Power Operations Inc., a Delaware corporation (“G3P OPS”), and Green3Power International Company, a Nevis corporation (“G3PI”). This transaction was a stock for stock exchange (the “Exchange”), which was accounted for as an acquisition and recorded as an expense based on the fair value of the Company’s common stock as of the date of the exchange. Also exchanged was one share of the Company’s Series B preferred stock, which is convertible into common shares two years from the date of the SEA, if certain milestones are met as required by the SEA. No value was attributed to the preferred share. We conduct all of our operations through G3P and its subsidiaries which are primarily engaged in the development of waste-to-energy projects and services including design, permitting, equipment procurement, construction management and operations and maintenance of the intended facilities. We intend to hold equity interests in the waste-to-energy facilities on a global basis and operate and maintain the facilities. A second business unit is focused on providing waste remediation services globally.

 

The Company’s fiscal year end is November 30.

 

On January 6, 2011, we acquired 100% of BioPower Corporation (“BC”), a Florida corporation incorporated on September 13, 2010, by our then-CEO and Director contributing 100% of the outstanding shares to the Company. As a result, BC became a wholly owned subsidiary of the Company.

 

On May 12, 2012, the Company formed FTZ Energy Exchange Inc., a wholly owned subsidiary, for the future development of an energy exchange. On June 7, 2012, the Company’s then-Chief Executive Officer contributed 100% of his member interest in FTZ Exchange, LLC (“FTZ”), a wholly owned subsidiary, to the Company for no consideration. FTZ is a licensing company that licenses business know-how and technology to build transaction fee-based exchanges for the sale of products and services in vertical markets.

 

On August 2, 2012, the Company formed Agribopo, Inc., a wholly owned subsidiary, for the development of biomass related projects. On November 27, 2012, the Company entered into a non-exclusive global license with Advanced Green Technologies, LLC to convert biomass wastes from animals, humans and cellulosic biomass to cellulosic ethanol, fertilizer and other derivative products.

 

On October 24, 2014, the Company entered into the SEA with G3P to acquire G3P and its wholly owned subsidiaries, G3P OPS and G3PI through the Exchange.

 

By October 24, 2016, G3P had failed to meet the provisions of the SEA that would allow G3P to take over control of the Company. As a result, the Company’s Board of Directors tried to come to an arrangement to separate BioPower from its subsidiaries, but in the end, decided that it would be in the best interests of the Company’s shareholders to move forward looking for a new acquisition. From October 24, 2016 until February 2017, the Company continued project development of waste-to-energy projects with extremely limited funds. In February 2017, the Company ceased all operations. At that time, we became a shell company.

 

In 2019, we entered into a memorandum of understanding with WPP Energy GmbH and China Energy Partners, LLC (“CEP”), but after exhausting all efforts we were unable to negotiate a definitive agreement or close the transaction.

 

F-5

 

 

On June 29, 2021, we entered into an Asset Purchase Agreement (the “APA”) with Rafael Ben Shaya, Troy MacDonald, Adam Benchaya, Thomas Perez, Tom Saban and Edouard Pouchoy (collectively, Messrs. Ben Shaya, MacDonald, Benchaya, Perez, Saban and Pouchoy are referred to herein as the “Sellers”).

 

Pursuant to the terms of the APA, the Company agreed to acquire from the Sellers, and the Sellers agreed to sell to the Company, certain assets comprised of the goodwill, intellectual property, business proprietary know-how and trade secrets, intangible property and other assets of Sellers’ business with respect to HyFi, and any and all rights of Sellers in and to the foregoing (the “Assets”), and certain governance/utility virtual tokens (collectively, the “HyFi Tokens”) expected to be used as a means of payment on the HyFi Platform, as hereinafter defined (the “Acquisition”). The “HyFi Platform” refers to the HyFi Decentralized Finance (“DeFi”) exchange marketplace using blockchain platform technology. The DeFi principles are based on an ecosystem of financial services utilizing tokenization and non-fungible tokens (“NFTs”) in connection with qualifying products, licenses and projects.

 

In addition, the Sellers agreed to (i) pay to the Company, on the closing date of the Acquisition, $300,000 (the “Cash Consideration”), and (ii) transfer to the Company, on the closing date of the Acquisition, 400,000,000 HyFi Tokens (the “HyFi Token Consideration”). The Company used the Cash Consideration to bring the Company into a fully reporting status with the Securities and Exchange Commission (the “SEC”) and for public company operating expenses.

 

Pursuant to the terms of the APA, the Company agreed to file with the State of Nevada the certificate of designation for the Series C preferred stock on or before the date that is 60 calendar days after the closing of the Acquisition. In exchange for the sale of the Assets and the Cash Consideration, the Company agreed to issue to the Sellers an aggregate of 900,000 Series C preferred shares within 30 calendar days after the State of Nevada provides written confirmation of filing of the certificate of designation for the Series C preferred stock.

 

Pursuant to the terms of the APA, the parties agreed that the Series C preferred stock will have the following terms, among others:

 

1. Authorized Shares of Series C Preferred Stock. The number of authorized shares of Series C preferred stock will be 900,000.

 

2. Conversion. Subject to the other terms and conditions in the certificate of designation, a Series C preferred stock holder will have the right from time to time and at any time following the date that is one year after the date on the signature page of the certificate of designations to convert each outstanding share of Series C preferred stock into 450 shares of Company common stock. Based on the number of shares of common stock issued and outstanding as of June 29, 2021, if all of the 900,000 shares of Series C preferred stock are issued and subsequently converted, the holders of the converted stock will hold 90% of the issued and outstanding shares of common stock.

 

3. Voting. Except as otherwise set forth in the certificate of designation, each share of Series C preferred stock will, on any matter submitted to the holders of Company common stock, or any class thereof, for a vote, vote together with the common stock, or any class thereof, as applicable, as one class on such matter, and each share of Series C preferred stock will have 450 votes.

 

4. Dividends. The Series C preferred stock is not entitled to receive dividends or distributions.

 

The Acquisition closed on June 29, 2021 (the “Closing Date”). On the Closing Date, the Sellers delivered the Cash Consideration and the HyFi Token Consideration.

 

On August 27, 2021, the Company filed with the State of Nevada a certificate of designations for the Series C preferred stock.

 

Series A Preferred Stock Redemption Agreement & Senior Promissory Note

 

F-6

 

 

Also on the Closing Date, the Company and CEP entered into a share redemption agreement (the “Redemption Agreement”), dated as of June 29, 2021, pursuant to which the Company redeemed one share of the Company’s Series A preferred stock from CEP (the “Series A Share”). On the Closing Date, as provided in the Redemption Agreement, the Company issued to CEP a senior promissory note (the “Note”) in the principal amount of $1,000,000. The Series A Share will be held in escrow. If an Event of Default (as defined in the Note) occurs under the Note, then the Company will direct the escrow agent to release the Series A Share to CEP; provided, however, that CEP will also retain all rights and privileges under the Note (and the Company will remain bound to all obligations under Note) even if the Series A Share is required to be released by the escrow agent to CEP as provided in the Redemption Agreement. For the avoidance of doubt, CEP will regain all rights, title, and interest in and to the Series A Share upon the occurrence of an Event of Default under the Note, regardless of the amount of the outstanding balance owed under the Note at the time of the occurrence of an Event of Default under the Note.

 

On October 7, 2021, the Company filed a certificate of amendment (the “Certificate of Amendment”) to its amended and restated articles in the State of Nevada and with FINRA, in order to change its corporate name from BioPower Operations Corporation. to HyFi Corp (the “Name Change”). The State of Nevada has officially changed the name of the Company to HYFI Corp. The Name Change and stock symbol change will be effective for Securities and Exchange Commission or trading purposes until it is cleared by the Financial Industry Regulatory Authority (FINRA).

 

Note 2. Summary of Significant Accounting Policies

 

Management’s Representation of Interim Financial Statements

 

The accompanying unaudited consolidated financial statements have been prepared by the Company without audit pursuant to the rules and regulations of the SEC. Certain information and disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) have been condensed or omitted as allowed by such rules and regulations, and management believes that the disclosures are adequate to make the information presented not misleading. These consolidated financial statements include all of the adjustments, which in the opinion of management are necessary to a fair presentation of financial position and results of operations. All such adjustments are of a normal and recurring nature. Interim results are not necessarily indicative of results for a full year. These unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements at filed as part of the Company’s Annual Report on Form 10-K with the SEC on February 17, 2022.

 

Principles of Consolidation

 

All inter-company accounts and transactions have been eliminated in consolidation.

 

Basis of Presentation

 

The accompanying financial statements have been prepared in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standard Codification (the “ASC”) which is the source of authoritative accounting principles recognized by the FASB to be applied by nongovernmental entities in the preparation of financial statements in conformity with GAAP.

 

Going Concern

 

The accompanying unaudited consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business for the twelve-month period following the date of these financial statements. The Company has incurred significant operating losses since inception. As of May 31, 2022, the Company had an accumulated deficit of $9,568,948 and stockholders’ deficit of $5,173,145.

 

Because the Company does not expect that existing operational cash flow will be sufficient to fund presently anticipated operations, this raises substantial doubt about the Company’s ability to continue as a going concern. Therefore, the Company will need to raise additional funds and is currently exploring alternative sources of financing. Historically, the Company has raised capital through private placements, as an interim measure to finance working capital needs and may continue to raise additional capital through the sale of common stock or other securities and obtaining some short-term loans. The Company will be required to continue to so until its operations become profitable. Also, the Company has, in the past, paid for consulting services with its common stock to maximize working capital, and intends to continue this practice where feasible.

 

F-7

 

 

Use of Estimates

 

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The most significant estimates relate to income taxes and contingencies. The Company bases its estimates on historical experience, known or expected trends and various other assumptions that are believed to be reasonable given the quality of information available as of the date of these financial statements. The results of these assumptions provide the basis for making estimates about the carrying amounts of assets and liabilities that are not readily apparent from other sources. Actual results could differ from these estimates.

 

Accounts Receivable

 

Accounts receivable are recorded at fair value on the date revenue is recognized. The Company provides allowances for doubtful accounts for estimated losses resulting from the inability of its customers to repay their obligation. If the financial condition of the Company’s customers were to deteriorate, resulting in an impairment of their ability to repay, additional allowances may be required. The Company provides for potential uncollectible accounts receivable based on specific customer identification and historical collection experience adjusted for existing market conditions. If market conditions decline, actual collection experience may not meet expectations and may result in decreased cash flows and increased bad debt expense.

 

The policy for determining past due status is based on the contractual payment terms of each customer, which are generally net 30 or net 60 days. Once collection efforts by the Company and its collection agency are exhausted, the determination for charging off uncollectible receivables is made.

 

Inventory

 

Inventories are stated at the lower of cost or net realizable value. Cost is determined by the first-in, first-out basis and net realizable value. Net realizable value is defined as sales price less cost of completion, disposition and transportation and a normal profit margin. As of May 31, 2022 and November 30, 2021, inventory amounted to $12,893 and $0, respectively, which consisted of finished goods.

 

Revenue Recognition

 

On July 1, 2018, the Company adopted ASC Topic 606, Revenue from Contracts with Customers (“ASC 606”). Results for reporting periods beginning after January 1, 2018, are presented under ASC 606.

 

On June 29, 2021, the Sellers agreed to (i) pay to the Company, on the closing date of the Acquisition, $300,000 (the “Cash Consideration”), and (ii) transfer to the Company, on the closing date of the Acquisition, 400,000,000 HyFi Tokens (the “HyFi Token Consideration”). The Company used the Cash Consideration to bring the Company into a fully reporting status with the SEC and for public company operating expenses.

Concentration

 

Two customers, including one related party, account for 100% of sales during the three months ended May 31, 2022.

 

Five customers, including two related parties, account for 100% of sales during the six months ended May 31, 2022.

 

Cash and cash equivalents

 

The Company considers all highly liquid temporary cash investments with an original maturity of three months or less to be cash equivalents. On May 31, 2022, and November 30, 2021, the Company’s cash equivalents totaled $522,356 and $95,973, respectively.

 

Income taxes

 

The Company accounts for income taxes under FASB ASC 740, “Accounting for Income Taxes”. Under FASB ASC 740, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Under FASB ASC 740, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. FASB ASC 740-10-05, “Accounting for Uncertainty in Income Taxes,” prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities.

 

F-8

 

 

The amount recognized is measured as the largest amount of benefit that is greater than 50% likely of being realized upon ultimate settlement. The Company assesses the validity of its conclusions regarding uncertain tax positions quarterly to determine if facts or circumstances have arisen that might cause it to change its judgment regarding the likelihood of a tax position’s sustainability under audit.

 

Stock-based Compensation

 

The Company accounts for stock-based compensation using the fair value method following the guidance outlined in Section 718-10 of the ASC for disclosure about stock-based compensation. This section requires a public entity to measure the cost of employee services received in exchange for an award of equity instruments based on the grant-date fair value of the award (with limited exceptions). That cost will be recognized over the period during which an employee is required to provide service in exchange for the award- the requisite service period (usually the vesting period). No compensation cost is recognized for equity instruments for which employees do not render the requisite service.

 

Net Loss per Share

 

Net loss per common share is computed by dividing net loss by the weighted average common shares outstanding during the period as defined by ASC Topic 260, “Earnings per Share.” Basic earnings per common share calculations are determined by dividing net income by the weighted average number of shares of common stock outstanding during the year. Diluted earnings per common share calculations are determined by dividing net income by the weighted average number of common shares and dilutive common share equivalents outstanding.

 

Recent Accounting Pronouncements

 

In February 2016, the FASB issued Accounting Standards Update (“ASU”) No. 2016-02, Leases (Topic 842), which establishes a new lease accounting model for lessees. The updated guidance requires an entity to recognize assets and liabilities arising from financing and operating leases, along with additional qualitative and quantitative disclosures. The amended guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018, with early adoption permitted. In March 2019, the FASB issued ASU 2019-01, Codification Improvements, which clarifies certain aspects of the new lease standard. The FASB issued ASU 2018-10, Codification Improvements to Topic 842, Leases in July 2018. Also in 2018, the FASB issued ASU 2018-11, Leases (Topic 842) Targeted Improvements, which provides an optional transition method whereby the new lease standard is applied at the adoption date and recognized as an adjustment to retained earnings. The amendments have the same effective date and transition requirements as the new lease standard.

 

We adopted ASC 842 on July 1, 2021. The adoption of ASC 842 did not have any impact on our financial statements.

 

Stockholders’ Equity

 

On July 28, 2021, the Company amended and restated its articles of incorporation, as amended, in order to, among other things, (i) increase the number of authorized shares of common stock from 100,000,000 to 500,000,000, (ii) increase the number of authorized shares of preferred stock from 10,000 to 5,000,000, and (iii) change the par value of the preferred stock from $1.00 par value per share to $0.0001 par value per share. As of November 30, 2021, the Company had authorized 500,000,000 shares of common stock, $0.0001 par value per share, and 5,000,000 shares of preferred stock, $0.0001 par value per share.

 

On March 4, 2022, the Company issued 625,000 shares of restricted common stock to a Canadian investor for $0.40 per share for a total purchase price of $250,000.

 

As of May 31, 2022, and November 30, 2021, respectively, there were 45,625,000 and 45,000,000 shares of common stock issued and outstanding, respectively, and 900,000 and 1 shares of preferred stock issued and outstanding, respectively.

 

F-9

 

 

Note 3. Notes Payable and Convertible Debt

 

Notes payable consists of the following:

 

   Balance   Interest Rate   Maturity 
Demand loans  $551,167    4% to 8 %   Various    
Reclassification of accrued compensation to notes payable   143,031    8%   December 1, 2017   
Balance –May 31, 2022 and November 30, 2021  $694,198           

 

As of May 31, 2022 and November 30, 2021, all loans are past due and in default.

 

On July 27, 2016, the Company entered into demand loan agreements with a third-party investor totaling $193,667 at 4% interest, payable upon demand.

 

Between October 28, 2011 and January 7, 2012, the Company issued a total of $70,000 in notes payable, due May 31, 2012. Interest on the notes is payable at 4%. The lender may elect to convert the loan before maturity at a conversion price of $0.25 per share. The loans are currently past due.

 

On December 3, 2013, the Company entered into convertible debt agreements with a third-party investor totaling $62,500 at 8% interest, payable upon demand. The debt is convertible into shares of common stock at a conversion price of $0.10 per share, for any amount up to 50% of the original amount of the notes. As of May 31, 2022 and November 30, 2021, the note was in default.

 

On July 30, 2015, the Company entered into convertible debt agreements with a third-party investor totaling $200,000 at 8% interest, due on December 31, 2015. The debt is convertible into shares of common stock at a conversion price of $0.15 per share. As of May 31, 2022 and November 30, 2021, the note was in default.

 

On May 23, 2016, the Company entered into convertible debt agreements with a third-party investor totaling $25,000 at 8% interest, due on May 23, 2018. The debt is convertible into shares of common stock at a conversion price of $0.10 per share. As of May 31, 2022 and November 30, 2021, the note was in default.

 

On July 30, 2015, the Company entered into convertible debt agreements with a third-party investor totaling $15,000 at 8% interest, due on May 23, 2018. The debt is convertible into shares of common stock at a conversion price of $0.15 per share. As of May 31, 2022 and November 30, 2021, the note was in default.

 

On July 30, 2015, the Company entered into convertible debt agreements with a third-party investor totaling $15,000 at 8% interest, due on May 23, 2018. The debt is convertible into shares of common stock at a conversion price of $0.15 per share. As of May 31, 2022 and November 30, 2021, the note was in default.

 

Between December 3, 2014 and July 28, 2015, the Company issued a total of $113,031 in notes payable. Interest on the notes is payable at 8%. The loans were due prior to December 31, 2015 and are past due.

 

Accrued interest on notes payable and convertible debt at May 31, 2022 and November 30, 2021 amounted to $297,565 and $275,071, respectively, which is included as a component of accounts payable and accrued expenses.

 

Interest expense on notes payable and convertible debt with third parties amounted to $11,247 and $11,247 for the three months ended May 31, 2022 and May 31, 2021 respectively. Interest expense on notes payable and convertible debt with third parties amounted to $22,494 and $22,494 for the six months ended May 31, 2022 and May 31, 2021 respectively.

 

Note 4. Related Party Transactions

 

On May 27, 2016, the former Chief Executive Officer, now our Chief Financial Officer, agreed to reduce his accrued compensation by $206,250 as a contribution to additional paid in capital. He also agreed to reclassify $874,000 in accrued compensation to long term debt upon the issuance of a non-convertible 4% interest bearing note with a maturity date of December 1, 2017. The compensation included was accrued during the period from January 2, 2011 to February 29, 2016. This compensation will be paid as bonuses out of future income only and is further subject to a cap of 20% of operating net cash flow in any given period. If bonuses are paid, accrued compensation will be paid with an amount decided by the Board. On June 1, 2016, he agreed to reduce his accrued compensation by $25,000 as a contribution to additional paid in capital. He also agreed to reduce his long term note by $214,000 as a contribution to additional paid in capital. As the Company was not funded prior to December 1, 2016, the Board of Directors reversed the contribution of accrued salaries. As of May 31, 2022 and November 30, 2021, the Chief Financial Officer was owed $445,250 and $445,250, respectively, of accrued compensation and accrued salary was reduced by $15,722.47. As of May 31, 2022 and November 30, 2020, the Chief Financial Officer was owed $805,637 and $805,637, respectively, of notes payable and accrued interest.

 

F-10

 

 

On May 27, 2016, the Director of Strategy agreed to reduce her accrued compensation by $206,250 as a contribution to additional paid in capital. She also agreed to reclassify $660,000 in accrued compensation to long term debt upon the issuance of a non-convertible 4% interest bearing note with a maturity date of December 1, 2017. The total principal amount of $710,000 included three different notes totaling $50,000@ 8% interest. The compensation included was accrued during the period from January 2, 2011 to February 29, 2016. This compensation will be paid as bonuses out of future income only and is further subject to a cap of 20% of operating net cash flow in any given period. If bonuses are paid, accrued compensation will be paid with an amount decided by the Board. On June 1, 2016, she agreed to reduce her accrued compensation by $225,000 as a contribution to additional paid in capital. She also agreed to reduce her long term note by $9,583 as a contribution to additional paid in capital. As the Company was not funded prior to December 1, 2016, the Board of Directors reversed the contribution of accrued salaries. As of May 31, 2022 and November 30, 2021, the Director was owed a total of $440,833 and $440,833, respectively, of accrued compensation. As of May 31, 2022 and November 30, 2021, the Director was owed a total of $883,791 and $883,791, respectively, of notes payable and accrued interest. There was a reduction in the liability by share issuance of $27,308.

 

As of November 30, 2016, a related party investor advanced a total of $99,448 due on or before June 15, 2016. Pursuant to the agreement, the investor is allowed to convert 100% of the debt at a share price of $0.15. As of May 31, 2022 and November 30, 2021, the note was in default.

 

In March 2016, the Chief Operating Officer loaned to the Company $100,000. The loan bears interest at 8% and is due on or before March 2, 2018. Pursuant to the agreement, the investor is allowed to convert 100% of the debt on the maturity date at a share price of $0.15. The Company accounted for the conversion of loan in accordance with ASC 470, “Debt with Conversion and Other Options”. The fair market value of the shares on March 2, 2016 was $0.10 per share and, accordingly, there was deemed to be no Beneficial Conversion Factor. On May 18, 2016, the Chief Operating Officer loaned the Company an additional $50,000 with conversion rights at $0.10 per share. Therefore, effective May 18, 2016, $50,000 of the Chief Operating Officer’s note payable had conversion rights of $0.10 per share. The Company accounted for the conversion of loan in accordance with ASC 470, “Debt with Conversion and Other Options”. The fair market value of the shares on May 18, 2016 was $0.10 per share and accordingly there was deemed to be no Beneficial Conversion Factor. On May 23, 2016, a third-party investor loaned the Company $25,000 with conversion rights at $0.10 per share. Therefore, effective May 23, 2016, an additional $25,000 of the Chief Operating Officer’s $100,000 note payable had conversion rights of $0.10 per share. The Company accounted for the conversion of loan in accordance with ASC 470, “Debt with Conversion and Other Options”. The fair market value of the shares on May 18, 2016 was $0.10 per share and accordingly, was deemed to have no Beneficial Conversion Factor. As of May 31, 2022 and November 30, 2021, the note was in default.

 

In May 2016, the Chief Operating Officer made a loan of $50,000, bearing interest at 8% and due on or before May 18, 2018. The debt is convertible into shares of common stock at a conversion price of $0.10 per share. As of May 31, 2022 and November 30, 2021, the note was in default.

 

In July 2016, the Chief Operating Officer made a loan of $50,000 as collateral, bearing interest at 8% and due on or before July 31, 2018. The debt is convertible into shares of common stock at a conversion price of $0.10 per share. As of May 31, 2022 and November 30, 2021, the note was in default.

 

On June 29, 2021 the Company entered into an employment agreement with Robert Kohn. The Company agreed to an annual salary of $150,000 beginning on September 30, 2021. As of May 31, 2022 and November 30, 2021 the Company accrued $100,000 and $25,000, respectively.

 

F-11

 

 

During the year ended November 30, 2021 the Company issued 17,500,000 HyFi Tokens to related parties for the purchase of technology. The Technology has a historical value of $0. In addition, the Company issued Troy MacDonald 175,000 HyFi Tokens as consideration for his sale of HyFi tokens at 5% of the related token sales.

 

Accrued interest on related party notes payable and convertible debt at May 31, 2022 and November 30, 2021, amounted to $526,534 and $484,156, respectively, and is a component of accounts payable and accrued expenses – related parties.

 

Interest expense on notes payable and convertible debt with related parties amounted to $21,189 and $21,189 for the three months ended May 31, 2022 and May 31, 2021, respectively. Interest expense on notes payable and convertible debt with related parties amounted to $42,378 and $42,378 for the six months ended May 31, 2022 and May 31, 2021, respectively.

 

The Company has separated accounts payable and accrued expenses on the balance sheet to reflect amounts due to related parties primarily consisting of officer compensation, health insurance, interest on notes and reimbursable expenses to officers for travel, meals and entertainment, vehicle and other related business expenses.

 

Note 5. Senior Promissory Note – related party

 

On June 29, 2021, the Closing Date, the Company and CEP entered into the Redemption Agreement, dated as of June 29, 2021, pursuant to which the Company redeemed the Series A Share. On the Closing Date, as provided in the Redemption Agreement, the Company issued to CEP the Note in the principal amount of $1,000,000 with an interest rate of 6% per annum. The Series A Share will be held in escrow. If an Event of Default (as defined in the Note) occurs under the Note, then the Company will direct the escrow agent to release the Series A Share to CEP; provided, however, that CEP will also retain all rights and privileges under the Note (and the Company will remain bound to all obligations under Note) even if the Series A Share is required to be released by the escrow agent to CEP as provided in the Redemption Agreement. For the avoidance of doubt, CEP will regain all rights, title, and interest in and to the Series A Share upon the occurrence of an Event of Default under the Note, regardless of the amount of the outstanding balance owed under the Note at the time of the occurrence of an Event of Default under the Note. Accrued interest parties amounted to $55,234 and $25,315 as of May 31, 2022 and November 30, 2021, respectively. Interest expense for the three and six months ended May 31, 2022 amounted to $15,123 and 29,918, respectively.

 

Note 6. Stockholders’ deficit

 

On August 5, 2021, Company effected the following share issuances:

 

The Company issued 50,000 shares of common stock valued at $2,500 ($0.05 per share) to a consultant.

 

The Company issued 750,000 shares of common stock valued at $37,500 ($0.05 per share) to Baruch Halpern for severance compensation.

 

The Company issued 546,160 shares of common stock valued at $27,307 ($0.05 per share) to Robert Kohn for partial conversion of accrued compensation.

 

The Company issued 546,160 shares of common stock valued at $27,307 ($0.05 per share) to Bonnie Nelson for partial conversion of accrued compensation.

 

On the Closing Date, the Company and CEP entered into the Redemption Agreement, dated as of June 29, 2021, pursuant to which the Company redeemed the Series A Share. On the Closing Date, as provided in the Redemption Agreement, the Company issued to CEP the Note in the principal amount of $1,000,000 with an interest rate of 6% per annum. The Series A Share will be held in escrow. If an Event of Default (as defined in the Note) occurs under the Note, then the Company will direct the escrow agent to release the Series A Share to CEP; provided, however, that CEP will also retain all rights and privileges under the Note (and the Company will remain bound to all obligations under Note) even if the Series A Share is required to be released by the escrow agent to CEP as provided in the Redemption Agreement. For the avoidance of doubt, CEP will regain all rights, title, and interest in and to the Series A Share upon the occurrence of an Event of Default under the Note, regardless of the amount of the outstanding balance owed under the Note at the time of the occurrence of an Event of Default under the Note.

 

F-12

 

 

On June 29, 2021, the Sellers agreed to (i) pay to the Company, on the closing date of the Acquisition, $300,000 (the “Cash Consideration”), and (ii) transfer to the Company, on the closing date of the Acquisition, 400,000,000 HyFi Tokens (the “HyFi Token Consideration”). The Company used the Cash Consideration to bring the Company into a fully reporting status with the SEC and for public company operating expenses.

 

In exchange for the sale of the Assets and the Cash Consideration, the Company agreed to issue to the Sellers an aggregate of 900,000 Series C preferred shares within 30 calendar days after the State of Nevada provides written confirmation of filing of the certificate of designation for the Series C preferred stock.

 

Pursuant to the terms of the APA, the parties agreed that the Series C preferred stock will have the following terms, among others:

 

1. Authorized Shares of Series C Preferred Stock. The number of authorized shares of Series C preferred stock will be 900,000.

 

2. Conversion. Subject to the other terms and conditions in the certificate of designation, a Series C preferred stock holder will have the right from time to time and at any time following the date that is one year after the date on the signature page of the certificate of designations to convert each outstanding share of Series C preferred stock into 450 shares of Company common stock. Based on the number of shares of common stock issued and outstanding as of November 30, 2021, if all of the 900,000 shares of Series C preferred stock are issued and subsequently converted, the holders of the converted stock will hold 90% of the issued and outstanding shares of common stock.

 

3. Voting. Except as otherwise set forth in the certificate of designation, each share of Series C preferred stock will, on any matter submitted to the holders of Company common stock, or any class thereof, for a vote, vote together with the common stock, or any class thereof, as applicable, as one class on such matter, and each share of Series C preferred stock will have 450 votes.

 

4. Dividends. The Series C preferred stock is not entitled to receive dividends or distributions.

 

On August 27, 2021, the Company filed with the State of Nevada a certificate of designations for the Series C preferred stock.

 

On July 28, 2021, the Company amended and restated its articles of incorporation, as amended, in order to, among other things, (i) increase the number of authorized shares of common stock from 100,000,000 to 500,000,000, (ii) increase the number of authorized shares of preferred stock from 10,000 to 5,000,000, and (iii) change the par value of the preferred stock from $1.00 par value per share to $0.0001 par value per share. As of November 30, 2021, the Company had authorized 500,000,000 shares of common stock, $0.0001 par value per share, and 5,000,000 shares of preferred stock, $0.0001 par value per share. As of May 31, 2022, and November 30, 2021, respectively, there were 45,625,000 and 45,000,000 shares of common stock issued and outstanding, and 900,000 and 1 shares of preferred stock issued and outstanding, respectively.

 

On March 5, 2022, the Company entered into a Stock Purchase Agreement (the “Compton SPA”) by and between the Company and Clarke Compton. Pursuant to the terms of the Compton SPA, the Company agreed to sell, and Mr. Compton agreed to purchase, 625,000 shares of the Company’s common stock for a total purchase price of $250,000.

 

Note 7. Commitments and Contingencies

 

Commitments

 

On April 6, 2022, the Company entered into an agreement (the “Sanctum Agreement”) with Sanctum Studios (“Sanctum”) relating to The Athena Project. Pursuant to the terms of the Sanctum Agreement, Sanctum agreed to conceptualize, create and produce a collection of 20,000 digital art assets based on the Greek Goddess Athena, in exchange for payment by the Company of $121,000 and certain variable rate payments depending on the number of vaults sold by the Company. The $121,000 is payable by the Company in three equal installments of $40,333.33 due on April 4, 2022, May 19, 2022 and July 1, 2022. The Company paid all installments due through May 31, 2022. The Sanctum deliverables are due by July 1, 2022 or earlier, as set forth in the Sanctum Agreement. The Company announced this material definitive agreement and associated Press Release, incorporated by reference, on a Current Report on Form 8-K which was filed with the SEC on April 7, 2022.

 

Contingencies

 

From time to time, the Company may be involved in legal matters arising in the ordinary course of business. While the Company believes that such matters are currently not material, there can be no assurance that matters arising in the ordinary course of business for which the Company is, or could be, involved in litigation, will not have a material adverse effect on its business, financial condition or results of operations.

 

F-13

 

 

Note 8. Subsequent Events

 

Diagonal Lending Securities Purchase Agreement & Convertible Note

 

On May 31, 2022, the Company entered into a Securities Purchase Agreement (the “Diagonal Lending SPA”) by and between the Company and 1800 Diagonal Lending LLC (“Diagonal Lending”). Pursuant to the terms of the Diagonal Lending SPA, the Company agreed to sell, and Diagonal Lending agreed to purchase, a convertible note of the Company in the aggregate principal amount of $90,000.

 

On May 31, 2022, pursuant to the terms of the Diagonal Lending SPA, the Company issued to Diagonal Lending a convertible promissory note (the “Diagonal Lending Note”) in the principal amount of $90,000. The Diagonal Lending Note was funded on June 23, 2022. The Diagonal Lending Note bears interest at a rate of 10% per annum and matures on May 31, 2023. The Diagonal Lending Note may not be prepaid in whole or in part except as otherwise explicitly set forth in the Diagonal Lending Note. Any amount of principal or interest which is not paid when due will bear interest at a rate of 22% per annum.

 

Diagonal Lending has the right from time to time, and at any time following November 27, 2022 and ending on the earlier of (i) payment of all amounts due under the Diagonal Lending Note, (ii) May 31, 2023, if all amounts are repaid in full at such time, or (iii) the date full repayment of all indebtedness to convert all or any part of the indebtedness into common stock subject to the terms of the Digital Lending Note at the Conversion Price (as hereinafter defined). The “Conversion Price” means 65% multiplied by the lowest trading price for the Company’s common stock during the 10 trading day period ending on the latest complete trading day prior to the conversion date, subject to a 4.99% equity blocker and subject to the terms of the Diagonal Lending Note.

 

The Diagonal Lending Note may be prepaid; provided, however, that if the Company exercises its right to prepay, the Company will make payment to Diagonal Lending of an amount in cash equal to the percentage as set forth in the table below, multiplied by the sum of: (w) the then outstanding principal amount of the Diagonal Lending Note, plus (x) accrued and unpaid interest on the unpaid principal amount of the Diagonal Lending Note, plus (y) default interest, if any, on the amounts referred to in clauses (w) and (x) plus (z) certain other amounts owed to Diagonal Lending pursuant to the terms of the Diagonal Lending Note.

 

Prepayment Period   Prepayment Percentage
May 31, 2022 to July 30, 2022   120%
July 31, 2022 to October 28, 2022   125%
October 29, 2022 to November 27, 2022   130%

 

After November 27, 2022, prepayment will be subject to agreement of the parties with respect to the applicable prepayment percentage.

 

China Energy Partners Note Amendment

 

On June 22, 2022, the Company entered into the Addendum and Amendment of Promissory Note (the “Note Amendment”) by and between the Company and China Energy Partners, LLC (“China Energy”). Pursuant to the terms of the Note Amendment, the Company and China Energy agreed to amend the Senior Promissory Note issued by the Company to China Energy on June 29, 2021 (the “China Energy Note”) such that (i) the principal amount and accrued interest under the China Energy Note will be repaid in full on or before June 28, 2022, with $800,000 to be paid in cash and $200,000 to be paid via the transfer to China Energy of tokens to an electronic wallet; and (ii) the parties agree that $60,000 in interest previously accrued under the China Energy Note was satisfied via the transfer by the Company to China Energy of 53 HyFi NFT Athena vaults.

 

On June 28, 2022, the China Energy Note, as amended by the Note Amendment, was paid in full.

 

PIP North America ILO and Multi-Agreement 

 

On June 26, 2022 , the Company entered into an ILO and Multi-Agreement (the “PIP Agreement”) with PIP North America Inc. (“PIP”). Pursuant to the terms of the PIP Agreement, the parties agreed as follows:

 

1.The Company agreed to provide PIP the exclusivity to list the first initial license offering (“ILO”) for a minimum of 90 days. PIP can mutually agree to allow the Company to list another ILO during this period and PIP will receive 50% of gross revenues.
2.PIP will not pay any listing fee for its first three ILOs, and the Company will provide free consulting services to help structure the ILOs.
3.The Company agreed to provide services necessary from Super How for the customization of the HyFi technology for the first three PIP ILOs, including smart contracts for each listing.
4.The Company agreed to provide, at the Company’s cost, Prime Trust for anti-money laundering (AML) and know your customer (KYC) services, including processing of the payments, conversion of tokens to fiat currency for the use by the ILO issuer and all other services necessary for any ILOs, projects or bridge loans that PIP agrees to list on HyFi marketplaces to raise capital.
5.The Company agreed to provide PIP with Exclusive License options for one-year $1 million and five-year $10 million exclusives for the agriculture category on the HyFi DeFi marketplaces. Whoever brings the issuer will receive 75% of the gross revenues and whoever does not bring the issuer will receive 25% of the gross revenues. The option for the one-year exclusive must be exercised while the first PIP ILO is listed on the HyFi ILO marketplace and, once exercised, will last for one year. Within 90 days of the expiration of the one-year exclusive license, PIP must exercise the 5-year license.
6.PIP agreed to pay the Company 5% of gross sales of PIP vaults plus usual and customary percentages charged by third party vendors for the vault program.
7.PIP agreed to purchase, and the Company agreed to sell, 500,000 shares of restricted common stock at a purchase price of $0.25 per share.
8.PIP agreed to purchase, and the Company agreed to sell, 3,125,000 HyFi tokens at a purchase price of $0.04 per token for $125,000. The HyFi tokens can be used as utility tokens in conjunction with HyFi DeFi marketplace fees and services, HyFi vaults, HyFi memberships and any other HyFi fees and services.
9.The Company agreed to grant PIP an option to purchase up to 50 HyFi vaults for $1,000. The option will expire on August 30, 2022.
10.The Company agreed to provide a license for the HyFi Vault Program, a blockchain promotional and marketing program, and services necessary from third party vendors, including Super How and Sanctum Studios.
11.In exchange for the above, PIP agreed to pay to the Company $500,000. The Company agreed to use this payment as part of the payments to retire the China Energy Note, as amended.

 

As indicated above, on June 28, 2022, the China Energy Note, as amended by the Note Amendment, was paid in full.

 

F-14

 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

 

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our unaudited financial statements and related notes included in this Quarterly Report on Form 10-Q and the audited financial statements and notes thereto as of and for the fiscal year ended November 30, 2021 and the related Management’s Discussion and Analysis of Financial Condition and Results of Operations, both of which are contained in the Company’s Annual Report on Form 10-K for the fiscal year ended November 30, 2021, filed with the Securities and Exchange Commission (the “SEC”) on February 17, 2022.

 

Forward-Looking Statements

 

The information in this discussion contains forward-looking statements and information. The words “anticipates,” “believes,” “estimates,” “expects,” “intends,” “may,” “plans,” “projects,” “will,” “should,” “could,” “predicts,” “potential,” “continue,” “would” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. We may not actually achieve the plans, intentions or expectations disclosed in our forward-looking statements and you should not place undue reliance on our forward-looking statements. Actual results or events could differ materially from the plans, intentions and expectations disclosed in the forward-looking statements that we make. The forward-looking statements are applicable only as of the date on which they are made, and we do not assume any obligation to update any forward-looking statements. All forward-looking statements in this Quarterly Report on Form 10-Q are made based on our current expectations, forecasts, estimates and assumptions, and involve risks, uncertainties and other factors that could cause results or events to differ materially from those expressed in the forward-looking statements. In evaluating these statements, you should specifically consider various factors, uncertainties and risks that could affect our future results or operations. These factors, uncertainties and risks may cause our actual results to differ materially from any forward-looking statement set forth in this Quarterly Report on Form 10-Q. You should carefully consider these risk and uncertainties described and other information contained in the reports we file with or furnish to the SEC before making any investment decision with respect to our securities. All forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by this cautionary statement.

 

Overview

 

BioPower Operations Corporation (“we,” “our,” “BioPower”, or the “Company”) was organized in Nevada on January 5, 2011. From February 2017 to February 17, 2022, the Company was a shell company. On October 7, 2021, the Company filed a certificate of amendment to its amended and restated articles in order to change its corporate name from BioPower Operations Corporation. to HyFi Corp (the “Name Change”). Although the Name Change has been approved by the State of Nevada, our new name and stock symbol will only become effective following clearance by the Financial Industry Regulatory Authority (FINRA), which is currently still pending.

 

HyFi Asset Purchase Agreement

 

On June 29, 2021, we entered into an Asset Purchase Agreement (the “APA”) with Rafael Ben Shaya, Troy MacDonald, Adam Benchaya, Thomas Perez, Tom Saban and Edouard Pouchoy (collectively, Messrs. Ben Shaya, MacDonald, Benchaya, Perez, Saban and Pouchoy are referred to herein as the “Sellers”).

 

Pursuant to the terms of the APA, the Company agreed to acquire from the Sellers, and the Sellers agreed to sell to the Company, certain assets comprised of the goodwill, intellectual property, business proprietary know-how and trade secrets, intangible property and other assets of Sellers’ business with respect to HyFi, and any and all rights of Sellers in and to the foregoing (the “Assets”), and certain governance/utility virtual tokens (collectively, the “HyFi Tokens”) expected to be used as a means of payment on the HyFi Platform, as hereinafter defined (the “Acquisition”). The “HyFi Platform” means a decentralized finances (“DeFi”) exchange marketplace using blockchain platform technology. The DeFi principles are based on an ecosystem of financial services utilizing tokenization and non-fungible tokens (“NFTs”) for production, licenses, projects and commodities across vertical and horizontal markets.

 

In addition, the Sellers agreed to (i) pay to the Company, on the closing date of the Acquisition, $300,000 (the “Cash Consideration”), and (ii) transfer to the Company, on the closing date of the Acquisition, 400,000,000  HyFi Tokens (the “HyFi Token Consideration”). The Company intends to use the Cash Consideration to bring the Company into a fully reporting status with the Securities and Exchange Commission and for public company operating expenses.

 

3
 

 

Pursuant to the terms of the APA, the Company agreed to file with the State of Nevada the certificate of designation for the Series C preferred stock on or before the date that is 60 calendar days after the closing of the Acquisition. In exchange for the sale of the Assets and the Cash Consideration, the Company agreed to issue to the Sellers an aggregate of 900,000 Series C preferred shares within 30 calendar days after the State of Nevada provides written confirmation of filing of the certificate of designation for the Series C preferred stock.

 

Pursuant to the terms of the APA, the parties agreed that the Series C preferred stock will have the following terms, among others:

 

  1. Authorized Shares of Series C Preferred Stock. The number of authorized shares of Series C preferred stock will be 900,000.
     
  2. Conversion. Subject to the other terms and conditions in the certificate of designation, a Series C preferred stock holder will have the right from time to time and at any time following the date that is one year after the date on the signature page of the certificate of designations to convert each outstanding share of Series C preferred stock into 450 shares of Company common stock. Based on the number of shares of common stock issued and outstanding as of June 29, 2021, if all of the 900,000 shares of Series C preferred stock are issued and subsequently converted, the holders of the converted stock will hold 90% of the issued and outstanding shares of common stock.
     
  3. Voting. Except as otherwise set forth in the certificate of designation, each share of Series C preferred stock will, on any matter submitted to the holders of Company common stock, or any class thereof, for a vote, vote together with the common stock, or any class thereof, as applicable, as one class on such matter, and each share of Series C preferred stock will have 450 votes.
     
  4. Dividends. The Series C preferred stock is not entitled to receive dividends or distributions.

 

The Acquisition closed on June 29, 2021 (the “Closing Date”). On the Closing Date, the Sellers delivered the Cash Consideration and the HyFi Token Consideration.

 

On August 27, 2021, the Company filed with the State of Nevada a certificate of designations for the Series C preferred stock. 

 

Series A Preferred Stock Redemption Agreement & Senior Promissory Note

 

Also on the Closing Date, the Company and China Energy Partners, LLC (“CEP”) entered into a share redemption agreement (the “Redemption Agreement”), dated as of June 29, 2021, pursuant to which the Company redeemed one share of the Company’s Series A preferred stock from CEP (the “Series A Share”). On the Closing Date, as provided in the Redemption Agreement, the Company issued to CEP a senior promissory note (the “Note”) in the principal amount of $1,000,000. The Series A Share will be held in escrow by an attorney designated by CEP (the “Escrow Agent”), and the CEP will designate such Escrow Agent within 30 calendar days after the Closing Date. If an Event of Default (as defined in the Note) occurs under the Note, then the Company will direct the Escrow Agent to release the Series A Share to CEP; provided, however, that CEP will also retain all rights and privileges under the Note (and the Company will remain bound to all obligations under Note) even if the Series A Share is required to be released by the Escrow Agent to CEP as provided in the Redemption Agreement. For the avoidance of doubt, CEP will regain all rights, title, and interest in and to the Series A Share upon the occurrence of an Event of Default under the Note, regardless of the amount of the outstanding balance owed under the Note at the time of the occurrence of an Event of Default under the Note.

 

As provided in the APA, on June 29, 2021, Robert Kohn resigned as the Company’s Chief Executive Officer. Mr. Kohn remained as a member of the Board of Directors, however. Also on June 29, 2021, the Company appointed the following individuals to serve as members of the Board of Directors: Troy MacDonald (Chairman), Adam Benchaya, and Thomas Perez. As a result, following the closing of the Acquisition, the Company’s Board of Directors consists of the following:

 

Troy MacDonald (Chairman)

Adam Benchaya

Robert Kohn

Thomas Perez

 

4
 

 

Also on June 29, 2021, the following individuals were appointed to serve as officers of the Company:

 

Troy MacDonald, Chief Executive Officer

Robert Kohn, Chief Financial Officer

Adam Benchaya, President and Chief Marketing Officer

 

The HyFi Platform

 

We are a U.S.-based fintech company that has developed and owns an innovative blockchain technology called “HyFi”. We license, operate and enable tokenized economies for various DeFi marketplaces and intend to utilize HyFi technology with our membership programs. We intend that the HyFi DeFi Marketplace shall be used by client issuers who register offerings with the SEC or comparable regulators located overseas, to offer NFT initial license offerings (“ILOs”), bridge loan offerings (“BLOs”), and pre-initial public offerings (“IPOs”). 

 

Any “fractionalized interest” – as described hereinafter – in any NFT, licensing fee or loan would be subject to a registered or exempt securities offering, in that such “fractionalized interest” would qualify as an investment contract similar to a security, consistent with the prevailing interpretation at issue in the U.S. Supreme Court decision found in Securities and Exchange Commission v. W. J. Howey Co., 328 U.S. 293 (1946), also known as the Howey Test.

 

The HyFi technology is also a candidate infrastructure for use in the metaverse and play-to-earn GameFi industry. HyFi technology allows users to securely own assets or items and move them across different platforms without the need for a central party’s permission. The HyFi technology is expected to allow for transparent trading of decentralized assets like NFTs and other digital assets. The DeFi principles are based on the creation of an innovative ecosystem of financial services accessible to anyone with internet access.

 

The HyFi token is featured on the HyFi DeFi Marketplace used as a utility payment token for transaction fees, for membership as well as for purchase of the proposed Vault offerings, which are expected to be bundles of digital and non-digital assets described later in this Quarterly Report on Form 10-Q. The HyFi DeFi Marketplace ecosystem is built on a combination of issuer tokens to support its economy. 

 

Proposed HyFi DeFi and CeDeFi Marketplace Types

 

Utilizing our HyFi blockchain technology, we are developing the following proposed DeFi marketplaces:

 

1. NFT Marketplace for Initial License Offerings (ILOs). Project developers and technology companies including renewable energy, environmental, agri-food and other important markets (“Issuers”) can raise money by incentivizing investors with SEC or other financial authorities registered offerings such as: (1) part of licensing fee related income or (2) project profits or (3) any other Issuer offering through tokenized technology licenses and project offerings enabled by NFTs. Investors can purchase the whole offering or fractional interests.

 

2. Bridge Loan Offerings (BLOs) for Businesses. Investors will also be able to purchase a fractionalized interest in an expected income return for the BLOs.

 

3. Pre-IPO Market Offerings. We expect that investors will be able to purchase a fractionalized interest in an expected income return, as well as option for shares of common stock from IPO pre-public offerings.

 

4. Traditional NFT Marketplace. We expect to provide a traditional NFT marketplace for offerings focused on appreciating one-of-a-kind assets, including but not limited to artwork, collectibles, memorabilia, jewelry and gemstones. 

 

5. CeDeFi Exchanges. Our initial CeDeFi exchange will focus on membership. We intend, in the future, to trade commodities and other tokens using the HyFi blockchain technology and ecosystem, which will require registration with the SEC as an Alternative Trading System (ATS) or as a Broker-Dealer. 

 

6. Metaverse & GameFi. We intend to enable our DeFi infrastructure for use with the Metaverse and GameFi.

 

5
 

 

NFT Marketplace

 

NFTs are collectible digital assets in which various objects are digitized. Each NFT represents ownership of something inherently distinct and unique, whether it be a physical or a digital item. NFTs cannot be mutually exchanged for one another because each NFT has a specific value based on its unique traits and attributes. When NFTs are sold, the digital version of the object is sold as a unique, blockchain-authenticated collectible.

 

NFT marketplaces are platforms where NFTs can be stored, displayed, traded and in some cases, created or “minted”. NFTs cannot be purchased on centralized or decentralized cryptocurrency or other exchanges. Instead, they are listed and traded on online marketplaces that are specially built for NFTs. We launched our demo NFT marketplace in October 2021.

 

We intend that cash flow technology license NFTs will be created that will represent up to a 49% ownership interest of a technology license for a geographic vertical market (e.g., India) or a horizontal market (e.g., energy-solar power.) We expect that there will be a subclass of NFTs that represents an opportunity for many participants to have fractional ownership and participation in the unique exclusive license NFT. The HyFi cash flow NFT marketplace is expected to initially list companies in the agriculture, environmental, and other related sectors that will provide license fees from unique license fee contracts for various territories. As an example, we are currently in discussions with an agriculture related company that expressed a possible willingness pay licensing fees of 5% annually with a potential bonus based on income for its agri production facility could list on the HyFi Platform. For illustration purposes only, we’ll assume that said company might be willing to sell up to 49% of its ownership in that license for a speculative value of between $5,000,000 and $10,000,000, with a minimum investment of $50,000 from accredited investors. In such a case, HyFi may receive fixed cash fees associated with this transaction.  The latter example is for illustration purposes only, as there can be no assurance that the parties will reach an agreement which would generate a revenue for the Company, if there ever reach an agreement, as well as what the terms of that agreement would be. 

 

6
 

 

NFT ILO Marketplace

 

ILO tokens are sub-class of tokens which are created to allow for fractional ownership of an NFT from an owner issuer that seeks to raise money for the development of new projects, technologies, intellectual property, licenses, brands, etc. A key distinguishing element of the HyFi marketplace is the fractionalization of the NFT that aggregates the investor contribution capability of many. On the HyFi Platform, the issuer is able to sell a percentage interest in its license in order to raise capital.

 

HyFi intends to introduce the ILO to investors and to a global network of brokers who are incentivized to introduce investors (institutional investors, corporations, family offices, private wealth and individuals) who may buy fractional interests (ILO Tokens) of the license offering or a total interest.

 

Traditional NFT Marketplace

 

We intend to establish an NFT marketplace for speculative  one-of-a-kind asset NFTs via tokenized NFT offerings, including but not limited to the following:

 

  Artwork
     
  Collectibles
     
  Memorabilia
     
  Music libraries
     
  Intellectual property rights
     
  Collectibles
     
  Precious metals/gems

 

We intend to offer cash flow generating NFTs, on full or fractional ownership basis, in the following major areas as conceptualized below:

 

  We anticipate that NFTs may be created, representing up to a 49% ownership interest of a license to a particular geographic market (example: India). There would also be a subclass of tokens that represent an opportunity for numerous participants to have fractional ownership of, and participation in, the unique one-of-a-kind exclusive license NFTs. We expect that those NFTs would be tradeable on the commodities section of the HyFi Platform once certain conditions have been met.
     
  We also expect that there may be NFTs issued for qualified projects related to renewable energy, waste to energy, agricultural and other approved projects showing potential and promise in their respective industry sectors.
     
  Ownership of technology licenses: We expect that NFTs may represent part or full ownership of technology licenses across many markets. Each such market is expected to include horizontal and vertical markets. For example, let’s assume that a given energy market could include the horizontal energy markets of green hydrogen and its many uses, electric generation, biofuels for marine, aviation and transportation and hydrogen fueling station networks. NFTs could also represent part or full ownership of a technology license in a specific geographic territory or vertical market.
     
  Physical projects related to renewable energy, environmental, agricultural and humanitarian causes. NFTs could be issued to represent an opportunity to invest in projects in any of the aforementioned categories.
     
  Other approved cases. In the future we may consider NFTs in the areas of medicine, space, internet & computing, artificial intelligence, robotics and nanotechnology, for example.

 

There can be no assurance that any of the above market segments will materialize, produce customers or revenue, or that the Company will achieve profitability.

 

7
 

 

Bridge Loan Offerings (BLO) Marketplace

 

We intend to establish a NFT marketplace for bridge loans via tokenized NFT offerings, including the following:

 

  Fractional ownership of loan contracts, expected to be typically high yielding
     
  Funds to be used for construction projects related to renewable energy, environment, agriculture, new technology, medical, humanitarian projects and pre-IPO companies
     
  Other licenses and projects qualified by the Company

 

“BLO Tokens” are a sub-class of tokens created to allow for fractional ownership of a unique NFT loan contract offered by an issuer that seeks to borrow money for typically a short period of time for a number of critical business reasons while it is awaiting the arrival of expected income or capital which would be used to pay back the loan, with interest owed. It is the fractionalization of the BLO NFT into BLO Tokens that aggregates the funding capability.

 

There can be no assurance that any of the above market segments will materialize, produce any customers or revenue whatsoever, or that the Company will achieve profitability.

 

In addition, we expect that commodities can be traded in the future on a to-be-formed HyFi Commodities Platform which would be registered with applicable regulatory authorities as an ATS and/or commodity exchange.

 

  We expect to have an initial emphasis on agri-foods , renewable energy and waste-to-energy via tokenized futures blockchain based smart contracts.
     
  The trading of certain commodities (e.g., green hydrogen production) would occur in most cases without any physical delivery obligation, and with electronic settlement only. Traders would purchase tokens to participate in the trading of those commodities. In some cases, commodities could be offered with a physical delivery option.
     
  Commodity future supply contracts: A futures contract is a legal agreement to buy or sell a particular commodity asset at a predetermined price at a specified time in the future. The seller of the futures contract is taking on the obligation to provide and deliver the underlying commodity at the contract’s expiration date. Futures contracts are available for every category of commodity. Some manufacturers and service providers use futures contracts as part of their budgeting process to normalize expenses and reduce cash flow-related headaches. Manufacturers and service providers that rely on commodities for their production process may take a position in the commodities markets as a way of reducing their risk of financial loss due to a change in price. There are many advantages to futures contracts as a method of participating in the commodities market. We believe that analysis can be easier because of the underlying commodity.

 

Proposed NFT Vault Programs

 

The HyFi NFT Vault Program has been developed for two main purposes: (1) to create an immediate and sustainable path to revenue for the Company by creating a unique NFT, to be coupled with other opportunities associated with an Art collectible(s); and (2) accelerate user participation by providing a main entry point to become a member and begin interacting with the HyFi DeFi Marketplaces.

 

The HyFi NFT Vault Program is the “Front Door” to HyFi and its DeFi marketplaces positioned as a well-rounded tool-kit for all that is needed to interact with HyFi DeFi Marketplace, plus a bonus of an Art asset(s) collectible.

 

8
 

 

When a user purchases a HyFi NFT Vault it contains an assortment of items such as:

 

1) An Art Collectible(s) with 1 in 5 chances of getting a Premier Art Collectible*;

 

2) A Pro or Ultimate Lifetime HyFi Membership - 1 in 5 chances of getting an Ultimate Lifetime Membership and 4 in 5 chances of getting a 2-year Pro Membership;

 

3) Gift Vouchers, to be used in the marketplaces or subsequent HyFi NFT Vault purchases;

 

4) HyFi Tokens to be used for further purchases of HyFi NFT Vaults, membership items and in the marketplaces; and

 

5) In 200 out of 100,000 Vaults a real physical .9999 Gold 5 oz. Athena Coin or a real physical gemstone (in 100 vaults each)

 

*Art Assets/ Collectibles/ Art Items. (The inclusion of the Art assets should qualify the Vault to be listed on various Art focused NFT marketplaces such as OpenSea)

 

We intend to sell the HyFi NFT Vaults to individuals and businesses. Various businesses have approached the Company to use our HyFi Vaults and put some of their gaming, collectibles and promotional items in the HyFi NFT Vault.

 

We expect variances in the types of assets/ items being offered in the potential various HyFi NFT Vault Programs. There can be no assurance any further Vault programs will be launched after the first HyFi NFT Vault.

 

HyFi also intends to license its Vault Program technology to companies for promoting their own brands, products and services.

 

Proposed Membership Plan

 

We have finalized a Membership Program which will enable members to earn money from referrals of companies and individuals to our DeFi Marketplace, as well as referral fee income for introducing other members. Members may also receive discounts for HyFi packaged financial products and tokens. HyFi tokens will be able to be used for any payments defined by each product or service.

 

On July 28, 2021, the Company amended and restated its articles of incorporation, as amended, in order to (i) increase the number of authorized shares of common stock from 100,000,000 to 500,000,000, (ii) increase the number of authorized shares of preferred stock from 10,000 to 5,000,000, (iii) change the par value of the preferred stock from $1.00 par value per share to $0.0001 par value per share; and (iv) increase the number of directors from one to four. As of August 31, 2021, the Company had authorized 500,000,000 shares of common stock, $0.0001 par value per share, and 5,000,000 shares of preferred stock, $0.0001 par value per share. As of August 31, 2021, there were 45,000,000 shares of common stock issued and outstanding, and 900,000 and 1 shares of preferred stock issued and outstanding.

 

On October 7, 2021, the Company filed a certificate of amendment (the “Certificate of Amendment”) to its amended and restated articles in order to change its corporate name from BioPower Operations Corporation. to HyFi Corp (the “Name Change”). Although the Name has been changed by the State of Nevada, the Name and Stock Symbol Change will only be effective following clearance by the Financial Industry Regulatory Authority (FINRA).

 

Going Concern

 

Our unaudited financial statements have been prepared assuming that we will continue as a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. The unaudited financial statements do not include any adjustments that might result from the outcome of this uncertainty. We have a minimal operating history and minimal revenues or earnings from operations. We have no significant assets or financial resources. We will, in all likelihood, sustain operating expenses without corresponding revenues for the immediate future.

 

There is substantial doubt that we can continue as an ongoing business for the next 12 months unless we obtain additional capital to pay our expenses. We must raise cash from sources other than revenues generated, such as from the proceeds of loans, public or private equity sales, and/or advances from related parties. There is no guarantee that any loans will be received, any equity sales will be made, and/or any related parties will advance funds to us or that such funds will be available on favorable terms.

 

9
 

 

Plan of Operation

 

We were dormant from February 2017 to June 29, 2021.

 

We have initiated our HyFi Vault Program and launched our Pre-Sale phase on June 20, 2022. We are focused on completing the full launch of our first Vault Program and deliverables of the Athena artwork from Sanctum Studios by July 1, 2022. We also intend to license our vault technology program  to other companies seeking to promote their own brand, products and services.

 

We continue to work on the regulatory and technology needs for our full launch of the DeFi Marketplaces. These include multiple Attorney Opinion Letters, which have now been accepted for U.S. approval by a major trust company.

 

The Company has been in discussions with various companies in energy and agriculture who are interested in listing their NFTs on the ILO, BLO and NFT enabled HyFi DeFi Marketplace.  At the same time, we are working with our vendors to build out the DeFi Marketplace. We are also in licensing discussions for our vault technology program  and DeFi marketplaces.

 

There can be no assurance that any of the above market segments will materialize, produce customers or revenue, or that the Company will achieve profitability.

 

Limited Operating History; Need for Additional Capital

 

We cannot guarantee we will be successful in our business operations. We have generated limited revenue since inception. Our business is subject to risks inherent in the establishment of a new business enterprise, including limited capital resources and possible cost overruns due to the price and cost increases in supplies and services.

 

If we are unable to meet our needs for cash from either our operations, or possible alternative sources, then we may be unable to continue, develop, or expand our operations.

 

Liquidity and Capital Resources

 

For the three months ended May 31, 2022, we had $246,700 in revenue from the sale of HyFi Tokens, which includes a related party transaction of $110,700, which represents an increase of $246,700 over $0 revenue for the three months ended May 31, 2021 when we were not in operation. Our net loss from operations at May 31, 2022, was $13,138, resulting from $246,700 in revenue, $212,443 in selling, general and administrative expenses and $47,395 in interest expenses which resulted in an increase of $27,379 versus a net loss of $40,517 for the three months ended May 31, 2021 when we had $40,517 in interest expenses against $0 revenues.

 

   For the three months ended May 31, 
   2022   2021 
Revenue  $246,700   $- 
           
Operating expenses          
Selling, general and administrative expenses   212,443    8,081 
Total operating expenses   212,443    8,081 
           
Income (loss) from operations   34,257    (8,081)
           
Other expenses          
Interest expense   (11,248)   (11,247)
Interest expense -related party   (36,147)   (21,189)
Total other expenses   (47,395)   (32,436)
           
Net loss  $(13,138)  $(40,517)

 

For the six months  ended May 31, 2022, we had $446,700 in revenue from the sale of HyFi Tokens, which amount includes a related party transaction of $110,700, which is an increase of $446,700 over $0 revenue for the six months ended May 31, 2021 when we were not in operation. Our net loss from operations at May 31, 2022, was $11,958, resulting from $446,700 in revenue, $362,868 in selling, general and administrative expenses and $97,790 in interest expenses which resulted in an increase of $60,995 versus a net loss of $72,953 for the six months ended May 31, 2021 when we had $72,953 in interest expenses against $0 revenues.

 

   For the six months ended May 31, 
   2022   2021 
Revenue  $446,700   $- 
           
Operating expenses          
Selling, general and administrative expenses   363,868    8,081 
Total operating expenses   363,858    8,081 
           
Loss from operations   (82,832)   (8,081)
           
Other expenses          
Interest expense   (22,495)   (11,247)
Interest expense -related party   (72,295)   (21,189)
Total other expenses   (94,790)   (32,436)
           
Net loss  $(11,958)  $(32,436)

 

On June 29, 2021 (“Closing Date”), the Company entered into an Asset Purchase Agreement (the “APA”) with Rafael Ben Shaya, Troy MacDonald, Adam Benchaya, Thomas Perez, Tom Saban and Edouard Pouchoy (collectively, Messrs. Ben Shaya, MacDonald, Benchaya, Perez, Saban and Pouchoy are referred to herein as the “Sellers”).

 

Pursuant to the terms of the APA, the Company agreed to acquire from the Sellers, and the Sellers agreed to sell to the Company, certain assets comprised of the goodwill, intellectual property, business proprietary know-how and trade secrets, intangible property and other assets of Sellers’ business with respect to HyFi, and any and all rights of Sellers in and to the foregoing (the “Assets”), and certain governance/utility virtual tokens (collectively, the “HyFi Tokens”) expected to be used as a means of payment on the HyFi Platform, as hereinafter defined (the “Acquisition”). The “HyFi Platform” refers to the HyFi Decentralized Finance (“DeFi”) exchange marketplace using blockchain platform technology. The DeFi principles are based on an ecosystem of financial services utilizing tokenization and non-fungible tokens (“NFTs”) in connection with qualifying products, licenses and projects.

 

10
 

 

In addition, on the Closing Date, the Company acquired 400,000,000 HyFi Tokens and a cash consideration of $300,000 in exchange for an aggregate of 900,000 of the Company’s Series C preferred shares (“Series C Preferred Stock”) within 30 calendar days after the State of Nevada provides written confirmation of filing of the certificate of designation for the Series C preferred stock. On August 27, 2021, the Company filed with the State of Nevada a certificate of designations for the Series C preferred stock. The shares of Series C Preferred Stock issuable upon exercise thereof have not been registered under the Securities Act, nor qualified under applicable state securities laws.  The Company used the Cash Consideration to ensure the Company reaches full reporting status with the SEC and for public company operating expenses.

 

Also, on the Closing Date, the Company and China Energy Partners, LLC (“CEP”) entered into a share redemption agreement (the “Redemption Agreement”), dated as of the Closing Date, pursuant to which the Company redeemed one share of the Company’s Series A preferred stock from CEP (the “Series A Preferred Stock”). On the Closing Date, as provided in the Redemption Agreement, the Company issued to CEP a senior promissory note (the “Note”) in the principal amount of $1,000,000. The Series A Preferred Stock will be held in escrow. If an Event of Default (as defined in the Note) occurs under the Note, then the Company will direct the escrow agent to release the Series A Preferred Stock to CEP; provided, however, that CEP will also retain all rights and privileges under the Note (and the Company will remain bound to all obligations under Note) even if the Series A Preferred Stock is required to be released by the escrow agent to CEP as provided in the Redemption Agreement. For the avoidance of doubt, CEP will regain all rights, title, and interest in and to the Series A Preferred Stock upon the occurrence of an Event of Default under the Note, regardless of the amount of the outstanding balance owed under the Note at the time of the occurrence of an Event of Default under the Note. The shares of Series A Preferred Stock redeemable in accordance with the Redemption Agreement thereof have not been registered under the Securities Act, nor qualified under applicable state securities laws.

 

Two customers, including one related party, account for 100% of sales during the three months ended May 31, 2022. Five customers, including two related parties, account for 100% of sales during the six months ended May 31, 2022.

 

For accounting purposes and for purposes of the financial statements reported herein, the Company considers all highly liquid temporary cash investments with an original maturity of three months or less to be cash equivalents. On May 31, 2022 and November 30, 2021, the Company’s cash equivalents totaled $522,356 and $95,973, respectively.

 

There is no historical financial information about us upon which to base an evaluation of our performance. We have generated revenues from operations of $175,000 for the year ending November 30, 2021, $446,700 through May 31, 2022. We cannot guarantee we will be successful in our business operations. Our business is subject to risks inherent in the establishment of a new business enterprise, including limited capital resources, possible delays in the launching of our games and market or wider economic downturns. We do not believe we have sufficient funds to operate our business for the next 12 months.

 

We have no assurance that future financing will be available to us on acceptable terms, or at all. If financing is not available on satisfactory terms, we may be unable to continue, develop or expand our operations. Equity financing could result in additional dilution to existing shareholders. If we are unable to raise additional capital to maintain our operations in the future, we may be unable to carry out our full business plan or we may be forced to cease operations. 

 

Critical Accounting Policies

 

The discussion and analysis of our financial condition and results of operations are based upon our financial statements, which have been prepared in accordance with the accounting principles generally accepted  in the United States of America. Preparing financial statements requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, and expenses. These estimates and assumptions are affected by management’s application of accounting policies. We believe that understanding the basis and nature of the estimates and assumptions involved with the following aspects of our financial statements is critical to an understanding of our financial statements.

 

Use of Estimates

 

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

11
 

 

Recent Accounting Pronouncements

 

Our company has implemented all new accounting pronouncements that are in effect and that may impact its financial statements and does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.

 

Off-Balance Sheet Arrangements

 

We do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to investors.

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

 

Not required for smaller reporting companies.

 

ITEM 4. CONTROLS AND PROCEDURES.

 

Evaluation of disclosure controls and procedures

 

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in company reports filed or submitted under the Exchange Act is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure.

 

As required by Rules 13a-15 and 15d-15 under the Exchange Act, our Chief Executive Officer and Chief Financial Officer carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of May 31, 2022. Based upon their evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) were not effective as of May 31, 2022.

 

We do not expect that our disclosure controls and procedures will prevent all errors and all instances of fraud. Disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and the benefits must be considered relative to their costs. Because of the inherent limitations in all disclosure controls and procedures, no evaluation of disclosure controls and procedures can provide absolute assurance that we have detected all our control deficiencies and instances of fraud, if any. The design of disclosure controls and procedures also is based partly on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

 

Change in internal control over financial reporting

 

There has been no change in our internal control over financial reporting that occurred during the quarterly period ended May 31, 2022 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

12
 

 

PART II: OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

We are not involved in any pending legal proceeding nor are we aware of any pending or threatened litigation against us.

 

ITEM 1A. RISK FACTORS

 

Not required for smaller reporting companies.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

None.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

None.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

Not applicable.

 

ITEM 5. OTHER INFORMATION

 

  (a) None
     
  (b) There have been no material changes to the procedures by which security holders may recommend nominees to the Company’s Board of Directors since the filing with the SEC of the Company’s Annual Report on Form 10-K for the year ended November 30, 2021.

 

ITEM 6. EXHIBITS

 

Exhibit
No.
  Exhibit Description
     
31.1   Certification of Principal Executive Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
     
31.2   Certification of Principal Financial Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
     
32.1   Certification of the Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
     
101.INS   Inline XBRL Instance Document
     
101.SCH   Inline XBRL Taxonomy Extension Schema Document
     
101.CAL   Inline XBRL Taxonomy Extension Calculation Document
     
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document
     
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document
     
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document
     
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

13
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  BioPower Operations Corporation
   
Date: July 15, 2022 By:  /s/ Troy MacDonald
    Troy MacDonald
    Chief Executive Officer
    (principal executive officer)
     
  By: /s/ Robert D. Kohn
    Robert D. Kohn
    Chief Financial Officer
    (principal financial officer and principal accounting officer)

 

14

 

EX-31.1 2 ex31-1.htm

 

Exhibit 31.1

 

CERTIFICATIONS

 

I, Troy MacDonald, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q for the quarterly period ended May 31, 2022 of BioPower Operations Corporation;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: July 15, 2022 /s/ Troy MacDonald
  Troy MacDonald
  Chief Executive Officer (principal executive officer)

 

 

 

EX-31.2 3 ex31-2.htm

 

Exhibit 31.2

 

CERTIFICATIONS

 

I, Robert D. Kohn, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q for the quarterly period ended May 31, 2022 of BioPower Operations Corporation;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: July 15, 2022 /s/ Robert D. Kohn
  Robert D. Kohn
  Chief Financial Officer (principal financial officer)

 

 

 

EX-32.1 4 ex32-1.htm

 

Exhibit 32.1

 

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the quarterly report on Form 10-Q of BioPower Operations Corporation (the “Company”) for the quarter ended May 31, 2022 as filed with the Securities and Exchange Commission (the “Report”), each of the undersigned, Troy MacDonald, Chief Executive Officer of the Company, and Robert D. Kohn, Chief Financial Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

 

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

2. The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

Date: July 15, 2022 /s/ Troy MacDonald
  Troy MacDonald, Chief Executive Officer (principal executive officer)
   
Date: July 15, 2022 /s/ Robert D. Kohn
  Robert D. Kohn, Chief Financial Officer (principal financial officer)

 

 

 

 

EX-101.SCH 5 bopo-20220531.xsd INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Consolidated Statements of Operations link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Consolidated Statements of Changes in Stockholders' Deficit (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - Organization link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Notes Payable and Convertible Debt link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Senior Promissory Note – related party link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Stockholders’ deficit link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Notes Payable and Convertible Debt (Tables) link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Subsequent Events (Tables) link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Organization (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Schedule of Notes Payable (Details) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Notes Payable and Convertible Debt (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Related Party Transactions (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Senior Promissory Note – related party (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Stockholders’ deficit (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Commitments and Contingencies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - Schedule of Amount Owed on Prepayment of Diagonal Lending Note (Details) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - Subsequent Events (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 6 bopo-20220531_cal.xml INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 7 bopo-20220531_def.xml INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 8 bopo-20220531_lab.xml INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Class of Stock [Axis] Series A Preferred Stock [Member] Series C Preferred Stock [Member] Product and Service [Axis] Sale of Tokens [Member] Sale of Tokens - Related Party [Member] Equity Components [Axis] Preferred Stock [Member] Common Stock [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] Investment, Name [Axis] BioPower Corporation [Member] Title of Individual [Axis] Chief Executive Officer and Director [Member] Chief Executive Officer [Member] Legal Entity [Axis] FTZ Exchange LLC [Member] Business Acquisition [Axis] HyFi [Member] HyFi Tokens [Member] China Energy Partners LLC [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Redemption Agreement [Member] Concentration Risk Type [Axis] Customer Concentration Risk [Member] Concentration Risk Benchmark [Axis] Revenue Benchmark [Member] Customer [Axis] Two Customer [Member] Five Customer [Member] Canadian Investor [Member] Debt Instrument [Axis] Demand Loans [Member] Statistical Measurement [Axis] Minimum [Member] Maximum [Member] Reclassification of Accrued Compensation To Notes Payable [Member] Demand Loan Agreements [Member] Related Party [Axis] Third Party Investor [Member] Lender [Member] Convertible Debt Agreement [Member] Third Party Investor One [Member] Third Party Investor Two [Member] Third Parties [Member] Chief Financial Officer [Member] Director Of Business Strategy [Member] Three Notes [Member] Investor [Member] Chief Operating Officer [Member] Robert Kohn [Member] Financial Instrument [Axis] Long-Lived Tangible Asset [Axis] Technology [Member] Related Parties [Member] Troy Mac Donald [Member] Notes Payable and Convertible Debt [Member] Consultant [Member] Baruch Halpern [Member] Bonnie Nelson [Member] Stock Purchase Agreement [Member] Indefinite-Lived Intangible Assets [Axis] Digital Art [Member] Sanctum Agreement [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Securities Purchase Agreement [Member] Long-Term Debt, Type [Axis] Convertible Debt [Member] China Energy Partners Note Amendment [Member] Exclusive License Options Year One [Member] PIP Agreement [Member] Exclusive License Options Year Five [Member] Restricted Common Stock [Member] Award Type [Axis] May 31, 2022 to July 30, 2022 [Member] July 31, 2022 to October 28, 2022 [Member] October 29, 2022 to November 27, 2022 [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Statement [Table] Statement [Line Items] Assets Current assets Cash and cash equivalents Accounts receivable Inventory Prepaid expenses Total assets Liabilities and Stockholders’ Deficit Current liabilities Accounts payable and accrued expenses Accounts payable and accrued expenses - related party Notes payable Convertible debt Convertible debt - related parties, Notes payable Senior secured - related party Notes payable Notes payable - related parties Total current liabilities Commitments and Contingencies (Note 9) Stockholders’ deficit Preferred stock, value Common stock, $.0001 par value: 500,000,000 authorized; 45,625,000 and 45,000,000 issued and outstanding on May 31, 2022 and November 30, 2021, respectively Additional paid-in capital Accumulated deficit Total stockholders’ deficit Total liabilities and stockholders’ deficit Preferred stock, par value Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Revenue: Total Revenue Operating expenses Selling, general and administrative expenses Total operating expenses Income / (Loss) from operations Other expenses Interest expense Interest expense -related party Total other expenses Net loss Net loss per common share: basic and diluted Weighted average common shares outstanding: basic and diluted Statement of Cash Flows [Abstract] Cash flows from operating activities Net loss Adjustments to reconcile net loss to net Changes in operating assets and liabilities Increase in accounts receivable Increase in prepaid expenses increase in inventory Accounts payable and accrued expenses Accounts payable and accrued expenses - related party Net cash used in operating activities Cash flow from financing activities Proceeds from issuance of common stock Net cash provided by financing activities Net increase in cash and cash equivalents Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period Supplemental disclosure of cash flow information: Cash paid for interest Cash paid for income taxes Beginning balance, value Beginning balance, shares Net loss, for six months ended May 31, 2022 Sale of common stock Sale of common stock, Shares Ending balance, value Ending balance, shares Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization Accounting Policies [Abstract] Summary of Significant Accounting Policies Debt Disclosure [Abstract] Notes Payable and Convertible Debt Related Party Transactions [Abstract] Related Party Transactions Senior Promissory Note Related Party Senior Promissory Note – related party Equity [Abstract] Stockholders’ deficit Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Subsequent Events [Abstract] Subsequent Events Principles of Consolidation Basis of Presentation Going Concern Use of Estimates Accounts Receivable Inventory Revenue Recognition Concentration Cash and cash equivalents Income taxes Stock-based Compensation Net Loss per Share Recent Accounting Pronouncements Stockholders’ Equity Schedule of Notes Payable Schedule of Amount Owed on Prepayment of Diagonal Lending Note Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Ownership percentage Percentage of outstanding shares Cash consideration, acquisition Number of consideration shares Business combination description Stock conversion, shares Stock conversion, issued shares Number of preferred stock voting rights Debt instrument, principal value Schedule of Product Information [Table] Product Information [Line Items] Accumulated deficit Stockholders equity deficit Proceeds from acquisition NFTs received from acquisition Concentration risk, percentage Cash equivalents Number of restricted stock issued Share issued price per share Value of restricted stock issued Schedule of Short-Term Debt [Table] Short-Term Debt [Line Items] Balance Interest rate Maturity date Notes Payable Debt instrument, interest Debt instrument maturity date Conversion price per share Convertible debt Debt instrument, original percentage Accrued interest Interest expense Schedule of Related Party Transactions, by Related Party [Table] Related Party Transaction [Line Items] Accrued compensation Increase decrease in long term debt Debt instrument, interest rate, stated percentage Debt instrument, maturity date Debt instrument, description Decrease in accrued salaries Notes payable to related parties Debt instrument, face amount Debt instrument, interest rate, effective percentage Reduction in liability insurance Debt instrument, conversion percentage Debt instrument, convertible, conversion price Loans Payable Share price Convertible notes payable to related parties Accrued salary number of tokens issued to purchase assets Value of purchased assets Related party transaction, rate Accrued interest Interest expense related party Debt instrument, interest rate Interest expense Schedule of Stock by Class [Table] Class of Stock [Line Items] Number of shares issued Value of shares issued Issue price per share Number of shares issued Value of shares issued Value of shares issued Stock issued Conversion of stock, description Conversion of stock shares issued Number of shares issued Purchase price Schedule of Indefinite-Lived Intangible Assets [Table] Indefinite-Lived Intangible Assets [Line Items] Number of assets Payment for asset Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Prepayment Percentage Subsequent Event [Table] Subsequent Event [Line Items] Principal amount Debt maturity date Debt principal interest rate Debt description Debt transfer amount Accurued interest Exclusive license Amount Gross sales percentage Shares issued, shares [custom:TokensIssuedDuringPeriodSharesNewIssues] [custom:TokenPrice-0] [custom:TokensIssuedDuringPeriodSharesNewIssuesValue] Purchase of vaults, description Debt payment amount FTZ Exchange LLC [Member] HyFi [Member] HyFi Tokens [Member] China Energy Partners LLC [Member] Redemption Agreement [Member] Going concern [PolicyTextBlock] NFTs received from acquisition. Two Customer [Member] Five Customer [Member] Demand Loans [Member] Reclassification Of Accrued Compensation To Notes Payable [Member] Demand Loan Agreements [Member] Third Party Investor [Member] Lender [Member] Convertible Debt Agreement [Member] Third Party Investor One [Member] Third Parties [Member] Increase decrease in long term debt. Director Of Business Strategy [Member] Three Notes [Member] Reduction in liability share issurance. Convertible notes payable to related parties non current. Robert Kohn [Member] Number of tokens issued to purchase assets. Technology [Member] Related Parties [Member] Troy Mac Donald [Member] Chief Executive Officer And Director [Member] Canadian investor [Member] Senior Promissory Note Related Party Disclosure [Text Block] Consultant [Member] Convertible debt related parties classified. Notes payable senior secured related party. Baruch Halpern [Member] Bonnie Nelson [Member] Number of assets. Digital art [Member] Sanctum agreement [Member] Payments for license. PIP agreement [Member] Agreement terms description. Fair value of license. Restricted common stock [Member] Tokens issued during period shares new issues Tokens issued during period shares new issues value. Token price Purchase of vaults description. Sale of tokens [Member] Bio power corporation [Member] Sale of Tokens - Related Party [Member] Third Party Investor Two [Member] Notes Payable and Convertible Debt [Member] China Energy Partners Note Amendment [Member] Debt transfer amount. Exclusive License Options Year One [Member] Exclusive License Options Year Five [Member] Gross sales customary percentage. Stock Purchase Agreement [Member] Securities Purchase Agreement [Member] Schedule of amount owed on prepayment of diagonal lending note [Table Text Block] Debt prepayment percentage. May 31, 2022 to July 30, 2022 [Member] July 31, 2022 to October 28, 2022 [Member] October 29, 2022 to November 27, 2022 [Member] Assets [Default Label] Other Notes Payable Liabilities, Current Stockholders' Equity Attributable to Parent Liabilities and Equity Operating Expenses Operating Income (Loss) Interest Expense, Other Other Nonoperating Income (Expense) Increase (Decrease) in Accounts Receivable Increase (Decrease) in Prepaid Expense Increase (Decrease) in Inventories Increase (Decrease) in Accounts Payable and Accrued Liabilities Increase (Decrease) in Accounts Payable, Related Parties Net Cash Provided by (Used in) Operating Activities Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Shares, Outstanding Stockholders' Equity Note Disclosure [Text Block] Inventory, Policy [Policy Text Block] Cash and Cash Equivalents, Policy [Policy Text Block] Convertible Debt Interest Payable, Current Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures Shares Granted, Value, Share-Based Payment Arrangement, after Forfeiture Sale of Stock, Number of Shares Issued in Transaction EX-101.PRE 9 bopo-20220531_pre.xml INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 10 R1.htm IDEA: XBRL DOCUMENT v3.22.2
Cover - shares
6 Months Ended
May 31, 2022
Jul. 15, 2022
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date May 31, 2022  
Document Fiscal Period Focus Q2  
Document Fiscal Year Focus 2022  
Current Fiscal Year End Date --11-30  
Entity File Number 000-53274  
Entity Registrant Name BioPower Operations Corporation  
Entity Central Index Key 0001510832  
Entity Tax Identification Number 27-4460232  
Entity Incorporation, State or Country Code NV  
Entity Address, Address Line One 20801 Biscayne Blvd.  
Entity Address, Address Line Two Suite 403  
Entity Address, City or Town Aventura  
Entity Address, State or Province FL  
Entity Address, Postal Zip Code 33180  
City Area Code (786)  
Local Phone Number 923-0272  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   45,625,000
XML 11 R2.htm IDEA: XBRL DOCUMENT v3.22.2
Consolidated Balance Sheets - USD ($)
May 31, 2022
Nov. 30, 2021
Current assets    
Cash and cash equivalents $ 522,356 $ 95,973
Accounts receivable 331  
Inventory 12,893
Prepaid expenses 77,593
Total assets 613,173 95,973
Current liabilities    
Accounts payable and accrued expenses 372,897 563,967
Accounts payable and accrued expenses - related party 2,000,905 1,530,668
Notes payable 130,671 130,671
Convertible debt 368,031 368,031
Convertible debt - related parties, 399,447 399,447
Notes payable Senior secured - related party 1,000,000 1,000,000
Notes payable 193,667 193,667
Notes payable - related parties 1,320,700 1,320,700
Total current liabilities 5,786,318 5,507,151
Commitments and Contingencies (Note 9)
Stockholders’ deficit    
Common stock, $.0001 par value: 500,000,000 authorized; 45,625,000 and 45,000,000 issued and outstanding on May 31, 2022 and November 30, 2021, respectively 4,564 4,501
Additional paid-in capital 4,390,339 4,140,411
Accumulated deficit (9,568,948) (9,556,990)
Total stockholders’ deficit (5,173,145) (5,411,178)
Total liabilities and stockholders’ deficit 613,173 95,973
Series A Preferred Stock [Member]    
Stockholders’ deficit    
Preferred stock, value
Series C Preferred Stock [Member]    
Stockholders’ deficit    
Preferred stock, value $ 900 $ 900
XML 12 R3.htm IDEA: XBRL DOCUMENT v3.22.2
Consolidated Balance Sheets (Parenthetical) - $ / shares
May 31, 2022
Nov. 30, 2021
Jul. 28, 2021
Jun. 29, 2021
Preferred stock, par value   $ 0.0001 $ 1.00  
Preferred stock, shares authorized   5,000,000 10,000  
Preferred stock, shares issued 900,000 1    
Preferred stock, shares outstanding 900,000 1    
Common stock, par value $ 0.0001 $ 0.0001    
Common stock, shares authorized 500,000,000 500,000,000 100,000,000  
Common stock, shares issued 45,625,000 45,000,000    
Common stock, shares outstanding 45,625,000 45,000,000    
Series A Preferred Stock [Member]        
Preferred stock, par value $ 1.00 $ 1.00    
Preferred stock, shares authorized 10,000 10,000    
Preferred stock, shares issued 0 1    
Preferred stock, shares outstanding 0 1    
Series C Preferred Stock [Member]        
Preferred stock, par value $ 0.001 $ 0.001    
Preferred stock, shares authorized 5,000,000 5,000,000   900,000
Preferred stock, shares issued 900,000 0    
Preferred stock, shares outstanding 900,000 0    
XML 13 R4.htm IDEA: XBRL DOCUMENT v3.22.2
Consolidated Statements of Operations - USD ($)
3 Months Ended 6 Months Ended
May 31, 2022
May 31, 2021
May 31, 2022
May 31, 2021
Revenue:        
Total Revenue $ 246,700 $ 446,700
Operating expenses        
Selling, general and administrative expenses 212,443 8,081 363,868 8,081
Total operating expenses 212,443 8,081 363,868 8,081
Income / (Loss) from operations 34,257 (8,081) 82,832 (8,081)
Other expenses        
Interest expense (11,248) (11,247) (22,495) (22,494)
Interest expense -related party (36,147) (21,189) (72,295) (42,378)
Total other expenses (47,395) (32,436) (94,790) (64,872)
Net loss $ (13,138) $ (40,517) $ (11,958) $ (72,953)
Net loss per common share: basic and diluted $ (0.00) $ (0.00) $ (0.00) $ (0.00)
Weighted average common shares outstanding: basic and diluted 45,597,826 43,107,680 45,302,198 43,107,680
Sale of Tokens [Member]        
Revenue:        
Total Revenue $ 136,000 $ 336,000
Sale of Tokens - Related Party [Member]        
Revenue:        
Total Revenue $ 110,700 $ 110,700
XML 14 R5.htm IDEA: XBRL DOCUMENT v3.22.2
Consolidated Statements of Cash Flows - USD ($)
6 Months Ended
May 31, 2022
May 31, 2021
Cash flows from operating activities    
Net loss $ (11,958) $ (72,953)
Changes in operating assets and liabilities    
Increase in accounts receivable (331)
Increase in prepaid expenses (77,593)
increase in inventory (12,893)  
Accounts payable and accrued expenses (191,071) 30,575
Accounts payable and accrued expenses - related party 470,238 42,378
Net cash used in operating activities 176,392
Cash flow from financing activities    
Proceeds from issuance of common stock 249,991
Net cash provided by financing activities 249,991
Net increase in cash and cash equivalents 426,383
Cash and cash equivalents at beginning of period 95,973  
Cash and cash equivalents at end of period 522,356
Supplemental disclosure of cash flow information:    
Cash paid for interest
Cash paid for income taxes
XML 15 R6.htm IDEA: XBRL DOCUMENT v3.22.2
Consolidated Statements of Changes in Stockholders' Deficit (Unaudited) - USD ($)
Series C Preferred Stock [Member]
Preferred Stock [Member]
Series A Preferred Stock [Member]
Preferred Stock [Member]
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Nov. 30, 2020   $ 1 $ 4,312 $ 4,746,884 $ (9,115,666) $ (4,364,469)
Beginning balance, shares at Nov. 30, 2020   1 43,107,680      
Net loss, for six months ended May 31, 2022       (72,953) (72,953)
Ending balance, value at May. 31, 2021 $ 1 $ 4,312 4,746,884 (9,188,619) (4,437,422)
Ending balance, shares at May. 31, 2021   43,107,680      
Beginning balance, value at Feb. 28, 2021 $ 4,312 4,746,884 (9,148,101) (4,396,905)
Beginning balance, shares at Feb. 28, 2021   43,107,680      
Net loss, for six months ended May 31, 2022   (40,517) (40,517)
Ending balance, value at May. 31, 2021 1 $ 4,312 4,746,884 (9,188,619) (4,437,422)
Ending balance, shares at May. 31, 2021   43,107,680      
Beginning balance, value at Nov. 30, 2021   $ 1 $ 900 $ 4,500 4,140,411 (9,556,990) (5,411,178)
Beginning balance, shares at Nov. 30, 2021   1 900,000 45,000,000      
Net loss, for six months ended May 31, 2022   (11,958) (11,958)
Sale of common stock   $ 63 249,928 249,991
Sale of common stock, Shares       625,000      
Ending balance, value at May. 31, 2022 $ 1 $ 900 $ 4,563 4,390,339 (9,568,948) (5,173,145)
Ending balance, shares at May. 31, 2022 1 900,000 45,625,000      
Beginning balance, value at Feb. 28, 2022 $ 900 $ 4,500 4,140,411 (9,555,809) (5,409,998)
Beginning balance, shares at Feb. 28, 2022   900,000 45,000,000      
Net loss, for six months ended May 31, 2022 (13,138) (13,138)
Sale of common stock   $ 63 249,928 249,991
Sale of common stock, Shares       625,000      
Ending balance, value at May. 31, 2022 $ 1 $ 900 $ 4,563 $ 4,390,339 $ (9,568,948) $ (5,173,145)
Ending balance, shares at May. 31, 2022 1 900,000 45,625,000      
XML 16 R7.htm IDEA: XBRL DOCUMENT v3.22.2
Organization
6 Months Ended
May 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Organization

Note 1. Organization:

 

BioPower Corporation (“BioPower” or the “Company”) was incorporated in the State of Florida on September 13, 2010. On January 5, 2011, the Company re-domiciled to Nevada and formed BioPower Operations Corporation, a Nevada corporation. On January 6, 2011, the shareholders of BioPower Corporation contributed their shares of BioPower Corporation to BioPower Operations Corporation and BioPower Corporation became a wholly owned subsidiary.

 

On October 24, 2014, the Company executed a Share Exchange Agreement (“SEA”) with Green3Power Holdings Company (“G3P”) to acquire G3P and its wholly owned subsidiaries Green3Power Operations Inc., a Delaware corporation (“G3P OPS”), and Green3Power International Company, a Nevis corporation (“G3PI”). This transaction was a stock for stock exchange (the “Exchange”), which was accounted for as an acquisition and recorded as an expense based on the fair value of the Company’s common stock as of the date of the exchange. Also exchanged was one share of the Company’s Series B preferred stock, which is convertible into common shares two years from the date of the SEA, if certain milestones are met as required by the SEA. No value was attributed to the preferred share. We conduct all of our operations through G3P and its subsidiaries which are primarily engaged in the development of waste-to-energy projects and services including design, permitting, equipment procurement, construction management and operations and maintenance of the intended facilities. We intend to hold equity interests in the waste-to-energy facilities on a global basis and operate and maintain the facilities. A second business unit is focused on providing waste remediation services globally.

 

The Company’s fiscal year end is November 30.

 

On January 6, 2011, we acquired 100% of BioPower Corporation (“BC”), a Florida corporation incorporated on September 13, 2010, by our then-CEO and Director contributing 100% of the outstanding shares to the Company. As a result, BC became a wholly owned subsidiary of the Company.

 

On May 12, 2012, the Company formed FTZ Energy Exchange Inc., a wholly owned subsidiary, for the future development of an energy exchange. On June 7, 2012, the Company’s then-Chief Executive Officer contributed 100% of his member interest in FTZ Exchange, LLC (“FTZ”), a wholly owned subsidiary, to the Company for no consideration. FTZ is a licensing company that licenses business know-how and technology to build transaction fee-based exchanges for the sale of products and services in vertical markets.

 

On August 2, 2012, the Company formed Agribopo, Inc., a wholly owned subsidiary, for the development of biomass related projects. On November 27, 2012, the Company entered into a non-exclusive global license with Advanced Green Technologies, LLC to convert biomass wastes from animals, humans and cellulosic biomass to cellulosic ethanol, fertilizer and other derivative products.

 

On October 24, 2014, the Company entered into the SEA with G3P to acquire G3P and its wholly owned subsidiaries, G3P OPS and G3PI through the Exchange.

 

By October 24, 2016, G3P had failed to meet the provisions of the SEA that would allow G3P to take over control of the Company. As a result, the Company’s Board of Directors tried to come to an arrangement to separate BioPower from its subsidiaries, but in the end, decided that it would be in the best interests of the Company’s shareholders to move forward looking for a new acquisition. From October 24, 2016 until February 2017, the Company continued project development of waste-to-energy projects with extremely limited funds. In February 2017, the Company ceased all operations. At that time, we became a shell company.

 

In 2019, we entered into a memorandum of understanding with WPP Energy GmbH and China Energy Partners, LLC (“CEP”), but after exhausting all efforts we were unable to negotiate a definitive agreement or close the transaction.

 

 

On June 29, 2021, we entered into an Asset Purchase Agreement (the “APA”) with Rafael Ben Shaya, Troy MacDonald, Adam Benchaya, Thomas Perez, Tom Saban and Edouard Pouchoy (collectively, Messrs. Ben Shaya, MacDonald, Benchaya, Perez, Saban and Pouchoy are referred to herein as the “Sellers”).

 

Pursuant to the terms of the APA, the Company agreed to acquire from the Sellers, and the Sellers agreed to sell to the Company, certain assets comprised of the goodwill, intellectual property, business proprietary know-how and trade secrets, intangible property and other assets of Sellers’ business with respect to HyFi, and any and all rights of Sellers in and to the foregoing (the “Assets”), and certain governance/utility virtual tokens (collectively, the “HyFi Tokens”) expected to be used as a means of payment on the HyFi Platform, as hereinafter defined (the “Acquisition”). The “HyFi Platform” refers to the HyFi Decentralized Finance (“DeFi”) exchange marketplace using blockchain platform technology. The DeFi principles are based on an ecosystem of financial services utilizing tokenization and non-fungible tokens (“NFTs”) in connection with qualifying products, licenses and projects.

 

In addition, the Sellers agreed to (i) pay to the Company, on the closing date of the Acquisition, $300,000 (the “Cash Consideration”), and (ii) transfer to the Company, on the closing date of the Acquisition, 400,000,000 HyFi Tokens (the “HyFi Token Consideration”). The Company used the Cash Consideration to bring the Company into a fully reporting status with the Securities and Exchange Commission (the “SEC”) and for public company operating expenses.

 

Pursuant to the terms of the APA, the Company agreed to file with the State of Nevada the certificate of designation for the Series C preferred stock on or before the date that is 60 calendar days after the closing of the Acquisition. In exchange for the sale of the Assets and the Cash Consideration, the Company agreed to issue to the Sellers an aggregate of 900,000 Series C preferred shares within 30 calendar days after the State of Nevada provides written confirmation of filing of the certificate of designation for the Series C preferred stock.

 

Pursuant to the terms of the APA, the parties agreed that the Series C preferred stock will have the following terms, among others:

 

1. Authorized Shares of Series C Preferred Stock. The number of authorized shares of Series C preferred stock will be 900,000.

 

2. Conversion. Subject to the other terms and conditions in the certificate of designation, a Series C preferred stock holder will have the right from time to time and at any time following the date that is one year after the date on the signature page of the certificate of designations to convert each outstanding share of Series C preferred stock into 450 shares of Company common stock. Based on the number of shares of common stock issued and outstanding as of June 29, 2021, if all of the 900,000 shares of Series C preferred stock are issued and subsequently converted, the holders of the converted stock will hold 90% of the issued and outstanding shares of common stock.

 

3. Voting. Except as otherwise set forth in the certificate of designation, each share of Series C preferred stock will, on any matter submitted to the holders of Company common stock, or any class thereof, for a vote, vote together with the common stock, or any class thereof, as applicable, as one class on such matter, and each share of Series C preferred stock will have 450 votes.

 

4. Dividends. The Series C preferred stock is not entitled to receive dividends or distributions.

 

The Acquisition closed on June 29, 2021 (the “Closing Date”). On the Closing Date, the Sellers delivered the Cash Consideration and the HyFi Token Consideration.

 

On August 27, 2021, the Company filed with the State of Nevada a certificate of designations for the Series C preferred stock.

 

Series A Preferred Stock Redemption Agreement & Senior Promissory Note

 

 

Also on the Closing Date, the Company and CEP entered into a share redemption agreement (the “Redemption Agreement”), dated as of June 29, 2021, pursuant to which the Company redeemed one share of the Company’s Series A preferred stock from CEP (the “Series A Share”). On the Closing Date, as provided in the Redemption Agreement, the Company issued to CEP a senior promissory note (the “Note”) in the principal amount of $1,000,000. The Series A Share will be held in escrow. If an Event of Default (as defined in the Note) occurs under the Note, then the Company will direct the escrow agent to release the Series A Share to CEP; provided, however, that CEP will also retain all rights and privileges under the Note (and the Company will remain bound to all obligations under Note) even if the Series A Share is required to be released by the escrow agent to CEP as provided in the Redemption Agreement. For the avoidance of doubt, CEP will regain all rights, title, and interest in and to the Series A Share upon the occurrence of an Event of Default under the Note, regardless of the amount of the outstanding balance owed under the Note at the time of the occurrence of an Event of Default under the Note.

 

On October 7, 2021, the Company filed a certificate of amendment (the “Certificate of Amendment”) to its amended and restated articles in the State of Nevada and with FINRA, in order to change its corporate name from BioPower Operations Corporation. to HyFi Corp (the “Name Change”). The State of Nevada has officially changed the name of the Company to HYFI Corp. The Name Change and stock symbol change will be effective for Securities and Exchange Commission or trading purposes until it is cleared by the Financial Industry Regulatory Authority (FINRA).

 

XML 17 R8.htm IDEA: XBRL DOCUMENT v3.22.2
Summary of Significant Accounting Policies
6 Months Ended
May 31, 2022
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies

Note 2. Summary of Significant Accounting Policies

 

Management’s Representation of Interim Financial Statements

 

The accompanying unaudited consolidated financial statements have been prepared by the Company without audit pursuant to the rules and regulations of the SEC. Certain information and disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) have been condensed or omitted as allowed by such rules and regulations, and management believes that the disclosures are adequate to make the information presented not misleading. These consolidated financial statements include all of the adjustments, which in the opinion of management are necessary to a fair presentation of financial position and results of operations. All such adjustments are of a normal and recurring nature. Interim results are not necessarily indicative of results for a full year. These unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements at filed as part of the Company’s Annual Report on Form 10-K with the SEC on February 17, 2022.

 

Principles of Consolidation

 

All inter-company accounts and transactions have been eliminated in consolidation.

 

Basis of Presentation

 

The accompanying financial statements have been prepared in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standard Codification (the “ASC”) which is the source of authoritative accounting principles recognized by the FASB to be applied by nongovernmental entities in the preparation of financial statements in conformity with GAAP.

 

Going Concern

 

The accompanying unaudited consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business for the twelve-month period following the date of these financial statements. The Company has incurred significant operating losses since inception. As of May 31, 2022, the Company had an accumulated deficit of $9,568,948 and stockholders’ deficit of $5,173,145.

 

Because the Company does not expect that existing operational cash flow will be sufficient to fund presently anticipated operations, this raises substantial doubt about the Company’s ability to continue as a going concern. Therefore, the Company will need to raise additional funds and is currently exploring alternative sources of financing. Historically, the Company has raised capital through private placements, as an interim measure to finance working capital needs and may continue to raise additional capital through the sale of common stock or other securities and obtaining some short-term loans. The Company will be required to continue to so until its operations become profitable. Also, the Company has, in the past, paid for consulting services with its common stock to maximize working capital, and intends to continue this practice where feasible.

 

 

Use of Estimates

 

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The most significant estimates relate to income taxes and contingencies. The Company bases its estimates on historical experience, known or expected trends and various other assumptions that are believed to be reasonable given the quality of information available as of the date of these financial statements. The results of these assumptions provide the basis for making estimates about the carrying amounts of assets and liabilities that are not readily apparent from other sources. Actual results could differ from these estimates.

 

Accounts Receivable

 

Accounts receivable are recorded at fair value on the date revenue is recognized. The Company provides allowances for doubtful accounts for estimated losses resulting from the inability of its customers to repay their obligation. If the financial condition of the Company’s customers were to deteriorate, resulting in an impairment of their ability to repay, additional allowances may be required. The Company provides for potential uncollectible accounts receivable based on specific customer identification and historical collection experience adjusted for existing market conditions. If market conditions decline, actual collection experience may not meet expectations and may result in decreased cash flows and increased bad debt expense.

 

The policy for determining past due status is based on the contractual payment terms of each customer, which are generally net 30 or net 60 days. Once collection efforts by the Company and its collection agency are exhausted, the determination for charging off uncollectible receivables is made.

 

Inventory

 

Inventories are stated at the lower of cost or net realizable value. Cost is determined by the first-in, first-out basis and net realizable value. Net realizable value is defined as sales price less cost of completion, disposition and transportation and a normal profit margin. As of May 31, 2022 and November 30, 2021, inventory amounted to $12,893 and $0, respectively, which consisted of finished goods.

 

Revenue Recognition

 

On July 1, 2018, the Company adopted ASC Topic 606, Revenue from Contracts with Customers (“ASC 606”). Results for reporting periods beginning after January 1, 2018, are presented under ASC 606.

 

On June 29, 2021, the Sellers agreed to (i) pay to the Company, on the closing date of the Acquisition, $300,000 (the “Cash Consideration”), and (ii) transfer to the Company, on the closing date of the Acquisition, 400,000,000 HyFi Tokens (the “HyFi Token Consideration”). The Company used the Cash Consideration to bring the Company into a fully reporting status with the SEC and for public company operating expenses.

Concentration

 

Two customers, including one related party, account for 100% of sales during the three months ended May 31, 2022.

 

Five customers, including two related parties, account for 100% of sales during the six months ended May 31, 2022.

 

Cash and cash equivalents

 

The Company considers all highly liquid temporary cash investments with an original maturity of three months or less to be cash equivalents. On May 31, 2022, and November 30, 2021, the Company’s cash equivalents totaled $522,356 and $95,973, respectively.

 

Income taxes

 

The Company accounts for income taxes under FASB ASC 740, “Accounting for Income Taxes”. Under FASB ASC 740, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Under FASB ASC 740, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. FASB ASC 740-10-05, “Accounting for Uncertainty in Income Taxes,” prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities.

 

 

The amount recognized is measured as the largest amount of benefit that is greater than 50% likely of being realized upon ultimate settlement. The Company assesses the validity of its conclusions regarding uncertain tax positions quarterly to determine if facts or circumstances have arisen that might cause it to change its judgment regarding the likelihood of a tax position’s sustainability under audit.

 

Stock-based Compensation

 

The Company accounts for stock-based compensation using the fair value method following the guidance outlined in Section 718-10 of the ASC for disclosure about stock-based compensation. This section requires a public entity to measure the cost of employee services received in exchange for an award of equity instruments based on the grant-date fair value of the award (with limited exceptions). That cost will be recognized over the period during which an employee is required to provide service in exchange for the award- the requisite service period (usually the vesting period). No compensation cost is recognized for equity instruments for which employees do not render the requisite service.

 

Net Loss per Share

 

Net loss per common share is computed by dividing net loss by the weighted average common shares outstanding during the period as defined by ASC Topic 260, “Earnings per Share.” Basic earnings per common share calculations are determined by dividing net income by the weighted average number of shares of common stock outstanding during the year. Diluted earnings per common share calculations are determined by dividing net income by the weighted average number of common shares and dilutive common share equivalents outstanding.

 

Recent Accounting Pronouncements

 

In February 2016, the FASB issued Accounting Standards Update (“ASU”) No. 2016-02, Leases (Topic 842), which establishes a new lease accounting model for lessees. The updated guidance requires an entity to recognize assets and liabilities arising from financing and operating leases, along with additional qualitative and quantitative disclosures. The amended guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018, with early adoption permitted. In March 2019, the FASB issued ASU 2019-01, Codification Improvements, which clarifies certain aspects of the new lease standard. The FASB issued ASU 2018-10, Codification Improvements to Topic 842, Leases in July 2018. Also in 2018, the FASB issued ASU 2018-11, Leases (Topic 842) Targeted Improvements, which provides an optional transition method whereby the new lease standard is applied at the adoption date and recognized as an adjustment to retained earnings. The amendments have the same effective date and transition requirements as the new lease standard.

 

We adopted ASC 842 on July 1, 2021. The adoption of ASC 842 did not have any impact on our financial statements.

 

Stockholders’ Equity

 

On July 28, 2021, the Company amended and restated its articles of incorporation, as amended, in order to, among other things, (i) increase the number of authorized shares of common stock from 100,000,000 to 500,000,000, (ii) increase the number of authorized shares of preferred stock from 10,000 to 5,000,000, and (iii) change the par value of the preferred stock from $1.00 par value per share to $0.0001 par value per share. As of November 30, 2021, the Company had authorized 500,000,000 shares of common stock, $0.0001 par value per share, and 5,000,000 shares of preferred stock, $0.0001 par value per share.

 

On March 4, 2022, the Company issued 625,000 shares of restricted common stock to a Canadian investor for $0.40 per share for a total purchase price of $250,000.

 

As of May 31, 2022, and November 30, 2021, respectively, there were 45,625,000 and 45,000,000 shares of common stock issued and outstanding, respectively, and 900,000 and 1 shares of preferred stock issued and outstanding, respectively.

 

 

XML 18 R9.htm IDEA: XBRL DOCUMENT v3.22.2
Notes Payable and Convertible Debt
6 Months Ended
May 31, 2022
Debt Disclosure [Abstract]  
Notes Payable and Convertible Debt

Note 3. Notes Payable and Convertible Debt

 

Notes payable consists of the following:

 

   Balance   Interest Rate   Maturity 
Demand loans  $551,167    4% to 8 %   Various    
Reclassification of accrued compensation to notes payable   143,031    8%   December 1, 2017   
Balance –May 31, 2022 and November 30, 2021  $694,198           

 

As of May 31, 2022 and November 30, 2021, all loans are past due and in default.

 

On July 27, 2016, the Company entered into demand loan agreements with a third-party investor totaling $193,667 at 4% interest, payable upon demand.

 

Between October 28, 2011 and January 7, 2012, the Company issued a total of $70,000 in notes payable, due May 31, 2012. Interest on the notes is payable at 4%. The lender may elect to convert the loan before maturity at a conversion price of $0.25 per share. The loans are currently past due.

 

On December 3, 2013, the Company entered into convertible debt agreements with a third-party investor totaling $62,500 at 8% interest, payable upon demand. The debt is convertible into shares of common stock at a conversion price of $0.10 per share, for any amount up to 50% of the original amount of the notes. As of May 31, 2022 and November 30, 2021, the note was in default.

 

On July 30, 2015, the Company entered into convertible debt agreements with a third-party investor totaling $200,000 at 8% interest, due on December 31, 2015. The debt is convertible into shares of common stock at a conversion price of $0.15 per share. As of May 31, 2022 and November 30, 2021, the note was in default.

 

On May 23, 2016, the Company entered into convertible debt agreements with a third-party investor totaling $25,000 at 8% interest, due on May 23, 2018. The debt is convertible into shares of common stock at a conversion price of $0.10 per share. As of May 31, 2022 and November 30, 2021, the note was in default.

 

On July 30, 2015, the Company entered into convertible debt agreements with a third-party investor totaling $15,000 at 8% interest, due on May 23, 2018. The debt is convertible into shares of common stock at a conversion price of $0.15 per share. As of May 31, 2022 and November 30, 2021, the note was in default.

 

On July 30, 2015, the Company entered into convertible debt agreements with a third-party investor totaling $15,000 at 8% interest, due on May 23, 2018. The debt is convertible into shares of common stock at a conversion price of $0.15 per share. As of May 31, 2022 and November 30, 2021, the note was in default.

 

Between December 3, 2014 and July 28, 2015, the Company issued a total of $113,031 in notes payable. Interest on the notes is payable at 8%. The loans were due prior to December 31, 2015 and are past due.

 

Accrued interest on notes payable and convertible debt at May 31, 2022 and November 30, 2021 amounted to $297,565 and $275,071, respectively, which is included as a component of accounts payable and accrued expenses.

 

Interest expense on notes payable and convertible debt with third parties amounted to $11,247 and $11,247 for the three months ended May 31, 2022 and May 31, 2021 respectively. Interest expense on notes payable and convertible debt with third parties amounted to $22,494 and $22,494 for the six months ended May 31, 2022 and May 31, 2021 respectively.

 

XML 19 R10.htm IDEA: XBRL DOCUMENT v3.22.2
Related Party Transactions
6 Months Ended
May 31, 2022
Related Party Transactions [Abstract]  
Related Party Transactions

Note 4. Related Party Transactions

 

On May 27, 2016, the former Chief Executive Officer, now our Chief Financial Officer, agreed to reduce his accrued compensation by $206,250 as a contribution to additional paid in capital. He also agreed to reclassify $874,000 in accrued compensation to long term debt upon the issuance of a non-convertible 4% interest bearing note with a maturity date of December 1, 2017. The compensation included was accrued during the period from January 2, 2011 to February 29, 2016. This compensation will be paid as bonuses out of future income only and is further subject to a cap of 20% of operating net cash flow in any given period. If bonuses are paid, accrued compensation will be paid with an amount decided by the Board. On June 1, 2016, he agreed to reduce his accrued compensation by $25,000 as a contribution to additional paid in capital. He also agreed to reduce his long term note by $214,000 as a contribution to additional paid in capital. As the Company was not funded prior to December 1, 2016, the Board of Directors reversed the contribution of accrued salaries. As of May 31, 2022 and November 30, 2021, the Chief Financial Officer was owed $445,250 and $445,250, respectively, of accrued compensation and accrued salary was reduced by $15,722.47. As of May 31, 2022 and November 30, 2020, the Chief Financial Officer was owed $805,637 and $805,637, respectively, of notes payable and accrued interest.

 

 

On May 27, 2016, the Director of Strategy agreed to reduce her accrued compensation by $206,250 as a contribution to additional paid in capital. She also agreed to reclassify $660,000 in accrued compensation to long term debt upon the issuance of a non-convertible 4% interest bearing note with a maturity date of December 1, 2017. The total principal amount of $710,000 included three different notes totaling $50,000@ 8% interest. The compensation included was accrued during the period from January 2, 2011 to February 29, 2016. This compensation will be paid as bonuses out of future income only and is further subject to a cap of 20% of operating net cash flow in any given period. If bonuses are paid, accrued compensation will be paid with an amount decided by the Board. On June 1, 2016, she agreed to reduce her accrued compensation by $225,000 as a contribution to additional paid in capital. She also agreed to reduce her long term note by $9,583 as a contribution to additional paid in capital. As the Company was not funded prior to December 1, 2016, the Board of Directors reversed the contribution of accrued salaries. As of May 31, 2022 and November 30, 2021, the Director was owed a total of $440,833 and $440,833, respectively, of accrued compensation. As of May 31, 2022 and November 30, 2021, the Director was owed a total of $883,791 and $883,791, respectively, of notes payable and accrued interest. There was a reduction in the liability by share issuance of $27,308.

 

As of November 30, 2016, a related party investor advanced a total of $99,448 due on or before June 15, 2016. Pursuant to the agreement, the investor is allowed to convert 100% of the debt at a share price of $0.15. As of May 31, 2022 and November 30, 2021, the note was in default.

 

In March 2016, the Chief Operating Officer loaned to the Company $100,000. The loan bears interest at 8% and is due on or before March 2, 2018. Pursuant to the agreement, the investor is allowed to convert 100% of the debt on the maturity date at a share price of $0.15. The Company accounted for the conversion of loan in accordance with ASC 470, “Debt with Conversion and Other Options”. The fair market value of the shares on March 2, 2016 was $0.10 per share and, accordingly, there was deemed to be no Beneficial Conversion Factor. On May 18, 2016, the Chief Operating Officer loaned the Company an additional $50,000 with conversion rights at $0.10 per share. Therefore, effective May 18, 2016, $50,000 of the Chief Operating Officer’s note payable had conversion rights of $0.10 per share. The Company accounted for the conversion of loan in accordance with ASC 470, “Debt with Conversion and Other Options”. The fair market value of the shares on May 18, 2016 was $0.10 per share and accordingly there was deemed to be no Beneficial Conversion Factor. On May 23, 2016, a third-party investor loaned the Company $25,000 with conversion rights at $0.10 per share. Therefore, effective May 23, 2016, an additional $25,000 of the Chief Operating Officer’s $100,000 note payable had conversion rights of $0.10 per share. The Company accounted for the conversion of loan in accordance with ASC 470, “Debt with Conversion and Other Options”. The fair market value of the shares on May 18, 2016 was $0.10 per share and accordingly, was deemed to have no Beneficial Conversion Factor. As of May 31, 2022 and November 30, 2021, the note was in default.

 

In May 2016, the Chief Operating Officer made a loan of $50,000, bearing interest at 8% and due on or before May 18, 2018. The debt is convertible into shares of common stock at a conversion price of $0.10 per share. As of May 31, 2022 and November 30, 2021, the note was in default.

 

In July 2016, the Chief Operating Officer made a loan of $50,000 as collateral, bearing interest at 8% and due on or before July 31, 2018. The debt is convertible into shares of common stock at a conversion price of $0.10 per share. As of May 31, 2022 and November 30, 2021, the note was in default.

 

On June 29, 2021 the Company entered into an employment agreement with Robert Kohn. The Company agreed to an annual salary of $150,000 beginning on September 30, 2021. As of May 31, 2022 and November 30, 2021 the Company accrued $100,000 and $25,000, respectively.

 

 

During the year ended November 30, 2021 the Company issued 17,500,000 HyFi Tokens to related parties for the purchase of technology. The Technology has a historical value of $0. In addition, the Company issued Troy MacDonald 175,000 HyFi Tokens as consideration for his sale of HyFi tokens at 5% of the related token sales.

 

Accrued interest on related party notes payable and convertible debt at May 31, 2022 and November 30, 2021, amounted to $526,534 and $484,156, respectively, and is a component of accounts payable and accrued expenses – related parties.

 

Interest expense on notes payable and convertible debt with related parties amounted to $21,189 and $21,189 for the three months ended May 31, 2022 and May 31, 2021, respectively. Interest expense on notes payable and convertible debt with related parties amounted to $42,378 and $42,378 for the six months ended May 31, 2022 and May 31, 2021, respectively.

 

The Company has separated accounts payable and accrued expenses on the balance sheet to reflect amounts due to related parties primarily consisting of officer compensation, health insurance, interest on notes and reimbursable expenses to officers for travel, meals and entertainment, vehicle and other related business expenses.

 

XML 20 R11.htm IDEA: XBRL DOCUMENT v3.22.2
Senior Promissory Note – related party
6 Months Ended
May 31, 2022
Senior Promissory Note Related Party  
Senior Promissory Note – related party

Note 5. Senior Promissory Note – related party

 

On June 29, 2021, the Closing Date, the Company and CEP entered into the Redemption Agreement, dated as of June 29, 2021, pursuant to which the Company redeemed the Series A Share. On the Closing Date, as provided in the Redemption Agreement, the Company issued to CEP the Note in the principal amount of $1,000,000 with an interest rate of 6% per annum. The Series A Share will be held in escrow. If an Event of Default (as defined in the Note) occurs under the Note, then the Company will direct the escrow agent to release the Series A Share to CEP; provided, however, that CEP will also retain all rights and privileges under the Note (and the Company will remain bound to all obligations under Note) even if the Series A Share is required to be released by the escrow agent to CEP as provided in the Redemption Agreement. For the avoidance of doubt, CEP will regain all rights, title, and interest in and to the Series A Share upon the occurrence of an Event of Default under the Note, regardless of the amount of the outstanding balance owed under the Note at the time of the occurrence of an Event of Default under the Note. Accrued interest parties amounted to $55,234 and $25,315 as of May 31, 2022 and November 30, 2021, respectively. Interest expense for the three and six months ended May 31, 2022 amounted to $15,123 and 29,918, respectively.

 

XML 21 R12.htm IDEA: XBRL DOCUMENT v3.22.2
Stockholders’ deficit
6 Months Ended
May 31, 2022
Equity [Abstract]  
Stockholders’ deficit

Note 6. Stockholders’ deficit

 

On August 5, 2021, Company effected the following share issuances:

 

The Company issued 50,000 shares of common stock valued at $2,500 ($0.05 per share) to a consultant.

 

The Company issued 750,000 shares of common stock valued at $37,500 ($0.05 per share) to Baruch Halpern for severance compensation.

 

The Company issued 546,160 shares of common stock valued at $27,307 ($0.05 per share) to Robert Kohn for partial conversion of accrued compensation.

 

The Company issued 546,160 shares of common stock valued at $27,307 ($0.05 per share) to Bonnie Nelson for partial conversion of accrued compensation.

 

On the Closing Date, the Company and CEP entered into the Redemption Agreement, dated as of June 29, 2021, pursuant to which the Company redeemed the Series A Share. On the Closing Date, as provided in the Redemption Agreement, the Company issued to CEP the Note in the principal amount of $1,000,000 with an interest rate of 6% per annum. The Series A Share will be held in escrow. If an Event of Default (as defined in the Note) occurs under the Note, then the Company will direct the escrow agent to release the Series A Share to CEP; provided, however, that CEP will also retain all rights and privileges under the Note (and the Company will remain bound to all obligations under Note) even if the Series A Share is required to be released by the escrow agent to CEP as provided in the Redemption Agreement. For the avoidance of doubt, CEP will regain all rights, title, and interest in and to the Series A Share upon the occurrence of an Event of Default under the Note, regardless of the amount of the outstanding balance owed under the Note at the time of the occurrence of an Event of Default under the Note.

 

 

On June 29, 2021, the Sellers agreed to (i) pay to the Company, on the closing date of the Acquisition, $300,000 (the “Cash Consideration”), and (ii) transfer to the Company, on the closing date of the Acquisition, 400,000,000 HyFi Tokens (the “HyFi Token Consideration”). The Company used the Cash Consideration to bring the Company into a fully reporting status with the SEC and for public company operating expenses.

 

In exchange for the sale of the Assets and the Cash Consideration, the Company agreed to issue to the Sellers an aggregate of 900,000 Series C preferred shares within 30 calendar days after the State of Nevada provides written confirmation of filing of the certificate of designation for the Series C preferred stock.

 

Pursuant to the terms of the APA, the parties agreed that the Series C preferred stock will have the following terms, among others:

 

1. Authorized Shares of Series C Preferred Stock. The number of authorized shares of Series C preferred stock will be 900,000.

 

2. Conversion. Subject to the other terms and conditions in the certificate of designation, a Series C preferred stock holder will have the right from time to time and at any time following the date that is one year after the date on the signature page of the certificate of designations to convert each outstanding share of Series C preferred stock into 450 shares of Company common stock. Based on the number of shares of common stock issued and outstanding as of November 30, 2021, if all of the 900,000 shares of Series C preferred stock are issued and subsequently converted, the holders of the converted stock will hold 90% of the issued and outstanding shares of common stock.

 

3. Voting. Except as otherwise set forth in the certificate of designation, each share of Series C preferred stock will, on any matter submitted to the holders of Company common stock, or any class thereof, for a vote, vote together with the common stock, or any class thereof, as applicable, as one class on such matter, and each share of Series C preferred stock will have 450 votes.

 

4. Dividends. The Series C preferred stock is not entitled to receive dividends or distributions.

 

On August 27, 2021, the Company filed with the State of Nevada a certificate of designations for the Series C preferred stock.

 

On July 28, 2021, the Company amended and restated its articles of incorporation, as amended, in order to, among other things, (i) increase the number of authorized shares of common stock from 100,000,000 to 500,000,000, (ii) increase the number of authorized shares of preferred stock from 10,000 to 5,000,000, and (iii) change the par value of the preferred stock from $1.00 par value per share to $0.0001 par value per share. As of November 30, 2021, the Company had authorized 500,000,000 shares of common stock, $0.0001 par value per share, and 5,000,000 shares of preferred stock, $0.0001 par value per share. As of May 31, 2022, and November 30, 2021, respectively, there were 45,625,000 and 45,000,000 shares of common stock issued and outstanding, and 900,000 and 1 shares of preferred stock issued and outstanding, respectively.

 

On March 5, 2022, the Company entered into a Stock Purchase Agreement (the “Compton SPA”) by and between the Company and Clarke Compton. Pursuant to the terms of the Compton SPA, the Company agreed to sell, and Mr. Compton agreed to purchase, 625,000 shares of the Company’s common stock for a total purchase price of $250,000.

 

XML 22 R13.htm IDEA: XBRL DOCUMENT v3.22.2
Commitments and Contingencies
6 Months Ended
May 31, 2022
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies

Note 7. Commitments and Contingencies

 

Commitments

 

On April 6, 2022, the Company entered into an agreement (the “Sanctum Agreement”) with Sanctum Studios (“Sanctum”) relating to The Athena Project. Pursuant to the terms of the Sanctum Agreement, Sanctum agreed to conceptualize, create and produce a collection of 20,000 digital art assets based on the Greek Goddess Athena, in exchange for payment by the Company of $121,000 and certain variable rate payments depending on the number of vaults sold by the Company. The $121,000 is payable by the Company in three equal installments of $40,333.33 due on April 4, 2022, May 19, 2022 and July 1, 2022. The Company paid all installments due through May 31, 2022. The Sanctum deliverables are due by July 1, 2022 or earlier, as set forth in the Sanctum Agreement. The Company announced this material definitive agreement and associated Press Release, incorporated by reference, on a Current Report on Form 8-K which was filed with the SEC on April 7, 2022.

 

Contingencies

 

From time to time, the Company may be involved in legal matters arising in the ordinary course of business. While the Company believes that such matters are currently not material, there can be no assurance that matters arising in the ordinary course of business for which the Company is, or could be, involved in litigation, will not have a material adverse effect on its business, financial condition or results of operations.

 

 

XML 23 R14.htm IDEA: XBRL DOCUMENT v3.22.2
Subsequent Events
6 Months Ended
May 31, 2022
Subsequent Events [Abstract]  
Subsequent Events

Note 8. Subsequent Events

 

Diagonal Lending Securities Purchase Agreement & Convertible Note

 

On May 31, 2022, the Company entered into a Securities Purchase Agreement (the “Diagonal Lending SPA”) by and between the Company and 1800 Diagonal Lending LLC (“Diagonal Lending”). Pursuant to the terms of the Diagonal Lending SPA, the Company agreed to sell, and Diagonal Lending agreed to purchase, a convertible note of the Company in the aggregate principal amount of $90,000.

 

On May 31, 2022, pursuant to the terms of the Diagonal Lending SPA, the Company issued to Diagonal Lending a convertible promissory note (the “Diagonal Lending Note”) in the principal amount of $90,000. The Diagonal Lending Note was funded on June 23, 2022. The Diagonal Lending Note bears interest at a rate of 10% per annum and matures on May 31, 2023. The Diagonal Lending Note may not be prepaid in whole or in part except as otherwise explicitly set forth in the Diagonal Lending Note. Any amount of principal or interest which is not paid when due will bear interest at a rate of 22% per annum.

 

Diagonal Lending has the right from time to time, and at any time following November 27, 2022 and ending on the earlier of (i) payment of all amounts due under the Diagonal Lending Note, (ii) May 31, 2023, if all amounts are repaid in full at such time, or (iii) the date full repayment of all indebtedness to convert all or any part of the indebtedness into common stock subject to the terms of the Digital Lending Note at the Conversion Price (as hereinafter defined). The “Conversion Price” means 65% multiplied by the lowest trading price for the Company’s common stock during the 10 trading day period ending on the latest complete trading day prior to the conversion date, subject to a 4.99% equity blocker and subject to the terms of the Diagonal Lending Note.

 

The Diagonal Lending Note may be prepaid; provided, however, that if the Company exercises its right to prepay, the Company will make payment to Diagonal Lending of an amount in cash equal to the percentage as set forth in the table below, multiplied by the sum of: (w) the then outstanding principal amount of the Diagonal Lending Note, plus (x) accrued and unpaid interest on the unpaid principal amount of the Diagonal Lending Note, plus (y) default interest, if any, on the amounts referred to in clauses (w) and (x) plus (z) certain other amounts owed to Diagonal Lending pursuant to the terms of the Diagonal Lending Note.

 

Prepayment Period   Prepayment Percentage
May 31, 2022 to July 30, 2022   120%
July 31, 2022 to October 28, 2022   125%
October 29, 2022 to November 27, 2022   130%

 

After November 27, 2022, prepayment will be subject to agreement of the parties with respect to the applicable prepayment percentage.

 

China Energy Partners Note Amendment

 

On June 22, 2022, the Company entered into the Addendum and Amendment of Promissory Note (the “Note Amendment”) by and between the Company and China Energy Partners, LLC (“China Energy”). Pursuant to the terms of the Note Amendment, the Company and China Energy agreed to amend the Senior Promissory Note issued by the Company to China Energy on June 29, 2021 (the “China Energy Note”) such that (i) the principal amount and accrued interest under the China Energy Note will be repaid in full on or before June 28, 2022, with $800,000 to be paid in cash and $200,000 to be paid via the transfer to China Energy of tokens to an electronic wallet; and (ii) the parties agree that $60,000 in interest previously accrued under the China Energy Note was satisfied via the transfer by the Company to China Energy of 53 HyFi NFT Athena vaults.

 

On June 28, 2022, the China Energy Note, as amended by the Note Amendment, was paid in full.

 

PIP North America ILO and Multi-Agreement 

 

On June 26, 2022 , the Company entered into an ILO and Multi-Agreement (the “PIP Agreement”) with PIP North America Inc. (“PIP”). Pursuant to the terms of the PIP Agreement, the parties agreed as follows:

 

1.The Company agreed to provide PIP the exclusivity to list the first initial license offering (“ILO”) for a minimum of 90 days. PIP can mutually agree to allow the Company to list another ILO during this period and PIP will receive 50% of gross revenues.
2.PIP will not pay any listing fee for its first three ILOs, and the Company will provide free consulting services to help structure the ILOs.
3.The Company agreed to provide services necessary from Super How for the customization of the HyFi technology for the first three PIP ILOs, including smart contracts for each listing.
4.The Company agreed to provide, at the Company’s cost, Prime Trust for anti-money laundering (AML) and know your customer (KYC) services, including processing of the payments, conversion of tokens to fiat currency for the use by the ILO issuer and all other services necessary for any ILOs, projects or bridge loans that PIP agrees to list on HyFi marketplaces to raise capital.
5.The Company agreed to provide PIP with Exclusive License options for one-year $1 million and five-year $10 million exclusives for the agriculture category on the HyFi DeFi marketplaces. Whoever brings the issuer will receive 75% of the gross revenues and whoever does not bring the issuer will receive 25% of the gross revenues. The option for the one-year exclusive must be exercised while the first PIP ILO is listed on the HyFi ILO marketplace and, once exercised, will last for one year. Within 90 days of the expiration of the one-year exclusive license, PIP must exercise the 5-year license.
6.PIP agreed to pay the Company 5% of gross sales of PIP vaults plus usual and customary percentages charged by third party vendors for the vault program.
7.PIP agreed to purchase, and the Company agreed to sell, 500,000 shares of restricted common stock at a purchase price of $0.25 per share.
8.PIP agreed to purchase, and the Company agreed to sell, 3,125,000 HyFi tokens at a purchase price of $0.04 per token for $125,000. The HyFi tokens can be used as utility tokens in conjunction with HyFi DeFi marketplace fees and services, HyFi vaults, HyFi memberships and any other HyFi fees and services.
9.The Company agreed to grant PIP an option to purchase up to 50 HyFi vaults for $1,000. The option will expire on August 30, 2022.
10.The Company agreed to provide a license for the HyFi Vault Program, a blockchain promotional and marketing program, and services necessary from third party vendors, including Super How and Sanctum Studios.
11.In exchange for the above, PIP agreed to pay to the Company $500,000. The Company agreed to use this payment as part of the payments to retire the China Energy Note, as amended.

 

As indicated above, on June 28, 2022, the China Energy Note, as amended by the Note Amendment, was paid in full.

XML 24 R15.htm IDEA: XBRL DOCUMENT v3.22.2
Summary of Significant Accounting Policies (Policies)
6 Months Ended
May 31, 2022
Accounting Policies [Abstract]  
Principles of Consolidation

Principles of Consolidation

 

All inter-company accounts and transactions have been eliminated in consolidation.

 

Basis of Presentation

Basis of Presentation

 

The accompanying financial statements have been prepared in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standard Codification (the “ASC”) which is the source of authoritative accounting principles recognized by the FASB to be applied by nongovernmental entities in the preparation of financial statements in conformity with GAAP.

 

Going Concern

Going Concern

 

The accompanying unaudited consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business for the twelve-month period following the date of these financial statements. The Company has incurred significant operating losses since inception. As of May 31, 2022, the Company had an accumulated deficit of $9,568,948 and stockholders’ deficit of $5,173,145.

 

Because the Company does not expect that existing operational cash flow will be sufficient to fund presently anticipated operations, this raises substantial doubt about the Company’s ability to continue as a going concern. Therefore, the Company will need to raise additional funds and is currently exploring alternative sources of financing. Historically, the Company has raised capital through private placements, as an interim measure to finance working capital needs and may continue to raise additional capital through the sale of common stock or other securities and obtaining some short-term loans. The Company will be required to continue to so until its operations become profitable. Also, the Company has, in the past, paid for consulting services with its common stock to maximize working capital, and intends to continue this practice where feasible.

 

 

Use of Estimates

Use of Estimates

 

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The most significant estimates relate to income taxes and contingencies. The Company bases its estimates on historical experience, known or expected trends and various other assumptions that are believed to be reasonable given the quality of information available as of the date of these financial statements. The results of these assumptions provide the basis for making estimates about the carrying amounts of assets and liabilities that are not readily apparent from other sources. Actual results could differ from these estimates.

 

Accounts Receivable

Accounts Receivable

 

Accounts receivable are recorded at fair value on the date revenue is recognized. The Company provides allowances for doubtful accounts for estimated losses resulting from the inability of its customers to repay their obligation. If the financial condition of the Company’s customers were to deteriorate, resulting in an impairment of their ability to repay, additional allowances may be required. The Company provides for potential uncollectible accounts receivable based on specific customer identification and historical collection experience adjusted for existing market conditions. If market conditions decline, actual collection experience may not meet expectations and may result in decreased cash flows and increased bad debt expense.

 

The policy for determining past due status is based on the contractual payment terms of each customer, which are generally net 30 or net 60 days. Once collection efforts by the Company and its collection agency are exhausted, the determination for charging off uncollectible receivables is made.

 

Inventory

Inventory

 

Inventories are stated at the lower of cost or net realizable value. Cost is determined by the first-in, first-out basis and net realizable value. Net realizable value is defined as sales price less cost of completion, disposition and transportation and a normal profit margin. As of May 31, 2022 and November 30, 2021, inventory amounted to $12,893 and $0, respectively, which consisted of finished goods.

 

Revenue Recognition

Revenue Recognition

 

On July 1, 2018, the Company adopted ASC Topic 606, Revenue from Contracts with Customers (“ASC 606”). Results for reporting periods beginning after January 1, 2018, are presented under ASC 606.

 

On June 29, 2021, the Sellers agreed to (i) pay to the Company, on the closing date of the Acquisition, $300,000 (the “Cash Consideration”), and (ii) transfer to the Company, on the closing date of the Acquisition, 400,000,000 HyFi Tokens (the “HyFi Token Consideration”). The Company used the Cash Consideration to bring the Company into a fully reporting status with the SEC and for public company operating expenses.

Concentration

Concentration

 

Two customers, including one related party, account for 100% of sales during the three months ended May 31, 2022.

 

Five customers, including two related parties, account for 100% of sales during the six months ended May 31, 2022.

 

Cash and cash equivalents

Cash and cash equivalents

 

The Company considers all highly liquid temporary cash investments with an original maturity of three months or less to be cash equivalents. On May 31, 2022, and November 30, 2021, the Company’s cash equivalents totaled $522,356 and $95,973, respectively.

 

Income taxes

Income taxes

 

The Company accounts for income taxes under FASB ASC 740, “Accounting for Income Taxes”. Under FASB ASC 740, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Under FASB ASC 740, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. FASB ASC 740-10-05, “Accounting for Uncertainty in Income Taxes,” prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities.

 

 

The amount recognized is measured as the largest amount of benefit that is greater than 50% likely of being realized upon ultimate settlement. The Company assesses the validity of its conclusions regarding uncertain tax positions quarterly to determine if facts or circumstances have arisen that might cause it to change its judgment regarding the likelihood of a tax position’s sustainability under audit.

 

Stock-based Compensation

Stock-based Compensation

 

The Company accounts for stock-based compensation using the fair value method following the guidance outlined in Section 718-10 of the ASC for disclosure about stock-based compensation. This section requires a public entity to measure the cost of employee services received in exchange for an award of equity instruments based on the grant-date fair value of the award (with limited exceptions). That cost will be recognized over the period during which an employee is required to provide service in exchange for the award- the requisite service period (usually the vesting period). No compensation cost is recognized for equity instruments for which employees do not render the requisite service.

 

Net Loss per Share

Net Loss per Share

 

Net loss per common share is computed by dividing net loss by the weighted average common shares outstanding during the period as defined by ASC Topic 260, “Earnings per Share.” Basic earnings per common share calculations are determined by dividing net income by the weighted average number of shares of common stock outstanding during the year. Diluted earnings per common share calculations are determined by dividing net income by the weighted average number of common shares and dilutive common share equivalents outstanding.

 

Recent Accounting Pronouncements

Recent Accounting Pronouncements

 

In February 2016, the FASB issued Accounting Standards Update (“ASU”) No. 2016-02, Leases (Topic 842), which establishes a new lease accounting model for lessees. The updated guidance requires an entity to recognize assets and liabilities arising from financing and operating leases, along with additional qualitative and quantitative disclosures. The amended guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018, with early adoption permitted. In March 2019, the FASB issued ASU 2019-01, Codification Improvements, which clarifies certain aspects of the new lease standard. The FASB issued ASU 2018-10, Codification Improvements to Topic 842, Leases in July 2018. Also in 2018, the FASB issued ASU 2018-11, Leases (Topic 842) Targeted Improvements, which provides an optional transition method whereby the new lease standard is applied at the adoption date and recognized as an adjustment to retained earnings. The amendments have the same effective date and transition requirements as the new lease standard.

 

We adopted ASC 842 on July 1, 2021. The adoption of ASC 842 did not have any impact on our financial statements.

 

Stockholders’ Equity

Stockholders’ Equity

 

On July 28, 2021, the Company amended and restated its articles of incorporation, as amended, in order to, among other things, (i) increase the number of authorized shares of common stock from 100,000,000 to 500,000,000, (ii) increase the number of authorized shares of preferred stock from 10,000 to 5,000,000, and (iii) change the par value of the preferred stock from $1.00 par value per share to $0.0001 par value per share. As of November 30, 2021, the Company had authorized 500,000,000 shares of common stock, $0.0001 par value per share, and 5,000,000 shares of preferred stock, $0.0001 par value per share.

 

On March 4, 2022, the Company issued 625,000 shares of restricted common stock to a Canadian investor for $0.40 per share for a total purchase price of $250,000.

 

As of May 31, 2022, and November 30, 2021, respectively, there were 45,625,000 and 45,000,000 shares of common stock issued and outstanding, respectively, and 900,000 and 1 shares of preferred stock issued and outstanding, respectively.

XML 25 R16.htm IDEA: XBRL DOCUMENT v3.22.2
Notes Payable and Convertible Debt (Tables)
6 Months Ended
May 31, 2022
Debt Disclosure [Abstract]  
Schedule of Notes Payable

Notes payable consists of the following:

 

   Balance   Interest Rate   Maturity 
Demand loans  $551,167    4% to 8 %   Various    
Reclassification of accrued compensation to notes payable   143,031    8%   December 1, 2017   
Balance –May 31, 2022 and November 30, 2021  $694,198           
XML 26 R17.htm IDEA: XBRL DOCUMENT v3.22.2
Subsequent Events (Tables)
6 Months Ended
May 31, 2022
Subsequent Events [Abstract]  
Schedule of Amount Owed on Prepayment of Diagonal Lending Note

 

Prepayment Period   Prepayment Percentage
May 31, 2022 to July 30, 2022   120%
July 31, 2022 to October 28, 2022   125%
October 29, 2022 to November 27, 2022   130%
XML 27 R18.htm IDEA: XBRL DOCUMENT v3.22.2
Organization (Details Narrative) - USD ($)
Jun. 29, 2021
Jun. 07, 2012
Sep. 13, 2010
May 31, 2022
Nov. 30, 2021
Jul. 28, 2021
Jan. 06, 2011
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Preferred stock, shares authorized         5,000,000 10,000  
Series C Preferred Stock [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Preferred stock, shares authorized 900,000     5,000,000 5,000,000    
Stock conversion, shares 450            
Stock conversion, issued shares 900,000            
Number of preferred stock voting rights Except as otherwise set forth in the certificate of designation, each share of Series C preferred stock will, on any matter submitted to the holders of Company common stock, or any class thereof, for a vote, vote together with the common stock, or any class thereof, as applicable, as one class on such matter, and each share of Series C preferred stock will have 450 votes            
Series A Preferred Stock [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Preferred stock, shares authorized       10,000 10,000    
HyFi [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Cash consideration, acquisition $ 300,000            
Business combination description Pursuant to the terms of the APA, the Company agreed to file with the State of Nevada the certificate of designation for the Series C preferred stock on or before the date that is 60 calendar days after the closing of the Acquisition. In exchange for the sale of the Assets and the Cash Consideration, the Company agreed to issue to the Sellers an aggregate of 900,000 Series C preferred shares within 30 calendar days after the State of Nevada provides written confirmation of filing of the certificate of designation for the Series C preferred stock.            
HyFi Tokens [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Number of consideration shares 400,000,000            
China Energy Partners LLC [Member] | Series A Preferred Stock [Member] | Redemption Agreement [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Debt instrument, principal value $ 1,000,000            
Chief Executive Officer and Director [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Percentage of outstanding shares     100.00%        
Chief Executive Officer [Member] | FTZ Exchange LLC [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Percentage of outstanding shares   100.00%          
BioPower Corporation [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Ownership percentage             100.00%
XML 28 R19.htm IDEA: XBRL DOCUMENT v3.22.2
Summary of Significant Accounting Policies (Details Narrative)
3 Months Ended 6 Months Ended
Mar. 04, 2022
USD ($)
$ / shares
shares
Jun. 29, 2021
USD ($)
Integer
May 31, 2022
USD ($)
$ / shares
shares
May 31, 2022
USD ($)
$ / shares
shares
Feb. 28, 2022
USD ($)
Nov. 30, 2021
USD ($)
$ / shares
shares
Jul. 28, 2021
$ / shares
shares
May 31, 2021
USD ($)
Feb. 28, 2021
USD ($)
Nov. 30, 2020
USD ($)
Product Information [Line Items]                    
Accumulated deficit | $     $ 9,568,948 $ 9,568,948   $ 9,556,990        
Stockholders equity deficit | $     5,173,145 5,173,145 $ 5,409,998 5,411,178   $ 4,437,422 $ 4,396,905 $ 4,364,469
Inventory | $     12,893 12,893          
Cash equivalents | $     $ 522,356 $ 522,356   $ 95,973        
Common stock, shares authorized     500,000,000 500,000,000   500,000,000 100,000,000      
Preferred stock, shares authorized           5,000,000 10,000      
Preferred stock, par value | $ / shares           $ 0.0001 $ 1.00      
Common stock, par value | $ / shares     $ 0.0001 $ 0.0001   $ 0.0001        
Common stock, shares issued     45,625,000 45,625,000   45,000,000        
Common stock, shares outstanding     45,625,000 45,625,000   45,000,000        
Preferred stock, shares issued     900,000 900,000   1        
Preferred stock, shares outstanding     900,000 900,000   1        
Canadian Investor [Member]                    
Product Information [Line Items]                    
Number of restricted stock issued 625,000                  
Share issued price per share | $ / shares $ 0.40                  
Value of restricted stock issued | $ $ 250,000                  
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Two Customer [Member]                    
Product Information [Line Items]                    
Concentration risk, percentage     100.00%              
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Five Customer [Member]                    
Product Information [Line Items]                    
Concentration risk, percentage       100.00%            
HyFi Tokens [Member]                    
Product Information [Line Items]                    
Proceeds from acquisition | $   $ 300,000                
NFTs received from acquisition | Integer   400,000,000                
XML 29 R20.htm IDEA: XBRL DOCUMENT v3.22.2
Schedule of Notes Payable (Details) - USD ($)
6 Months Ended
May 31, 2022
Jul. 28, 2015
Short-Term Debt [Line Items]    
Balance $ 694,198 $ 113,031
Interest rate   8.00%
Demand Loans [Member]    
Short-Term Debt [Line Items]    
Balance $ 551,167  
Maturity date Various  
Demand Loans [Member] | Minimum [Member]    
Short-Term Debt [Line Items]    
Interest rate 4.00%  
Demand Loans [Member] | Maximum [Member]    
Short-Term Debt [Line Items]    
Interest rate 8.00%  
Reclassification of Accrued Compensation To Notes Payable [Member]    
Short-Term Debt [Line Items]    
Balance $ 143,031  
Interest rate 8.00%  
Maturity date December 1, 2017  
XML 30 R21.htm IDEA: XBRL DOCUMENT v3.22.2
Notes Payable and Convertible Debt (Details Narrative) - USD ($)
2 Months Ended 3 Months Ended 6 Months Ended 8 Months Ended
May 23, 2016
Jul. 30, 2015
Jan. 07, 2012
May 31, 2022
May 31, 2021
May 31, 2022
May 31, 2021
Jul. 28, 2015
Nov. 30, 2021
Jul. 27, 2016
Dec. 03, 2013
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                      
Notes Payable       $ 694,198   $ 694,198   $ 113,031      
Debt instrument, interest               8.00%      
Debt instrument maturity date               Dec. 31, 2015      
Accrued interest       297,565   297,565     $ 275,071    
Third Party Investor [Member]                      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                      
Conversion price per share $ 0.10                    
Third Parties [Member]                      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                      
Interest expense       $ 11,247 $ 11,247 $ 22,494 $ 22,494        
Demand Loan Agreements [Member] | Third Party Investor [Member]                      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                      
Notes Payable                   $ 193,667  
Debt instrument, interest                   4.00%  
Demand Loan Agreements [Member] | Lender [Member]                      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                      
Notes Payable     $ 70,000                
Debt instrument, interest     4.00%                
Debt instrument maturity date     May 31, 2012                
Conversion price per share     $ 0.25                
Convertible Debt Agreement [Member] | Third Party Investor [Member]                      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                      
Debt instrument, interest 8.00% 8.00%                 8.00%
Debt instrument maturity date May 23, 2018 Dec. 31, 2015                  
Conversion price per share $ 0.10 $ 0.15                 $ 0.10
Convertible debt $ 25,000 $ 200,000                 $ 62,500
Debt instrument, original percentage                     50.00%
Convertible Debt Agreement [Member] | Third Party Investor One [Member]                      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                      
Debt instrument, interest   8.00%                  
Debt instrument maturity date   May 23, 2018                  
Conversion price per share   $ 0.15                  
Convertible debt   $ 15,000                  
Convertible Debt Agreement [Member] | Third Party Investor Two [Member]                      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                      
Debt instrument, interest   8.00%                  
Debt instrument maturity date   May 23, 2018                  
Conversion price per share   $ 0.15                  
Convertible debt   $ 15,000                  
XML 31 R22.htm IDEA: XBRL DOCUMENT v3.22.2
Related Party Transactions (Details Narrative)
1 Months Ended 3 Months Ended 6 Months Ended 8 Months Ended 12 Months Ended
Nov. 30, 2016
USD ($)
$ / shares
Jun. 02, 2016
USD ($)
May 27, 2016
USD ($)
Jul. 31, 2016
USD ($)
$ / shares
May 31, 2016
USD ($)
$ / shares
Mar. 31, 2016
USD ($)
$ / shares
May 31, 2022
USD ($)
May 31, 2021
USD ($)
May 31, 2022
USD ($)
May 31, 2021
USD ($)
Jul. 28, 2015
Nov. 30, 2021
USD ($)
Integer
Jun. 29, 2021
USD ($)
Nov. 30, 2020
USD ($)
May 23, 2016
USD ($)
$ / shares
May 18, 2016
USD ($)
$ / shares
Mar. 02, 2016
$ / shares
Related Party Transaction [Line Items]                                  
Debt instrument, interest rate, stated percentage                     8.00%            
Debt instrument, maturity date                     Dec. 31, 2015            
Accrued interest             $ 526,534   $ 526,534     $ 484,156          
Interest expense related party             36,147 $ 21,189 72,295 $ 42,378              
Third Party Investor [Member]                                  
Related Party Transaction [Line Items]                                  
Debt instrument, convertible, conversion price | $ / shares                             $ 0.10    
Convertible notes payable to related parties                             $ 25,000    
Robert Kohn [Member]                                  
Related Party Transaction [Line Items]                                  
Accrued salary             100,000   100,000     25,000 $ 150,000        
Related Parties [Member] | Technology [Member]                                  
Related Party Transaction [Line Items]                                  
Value of purchased assets                       $ 0          
Related party transaction, rate                       5.00%          
Related Parties [Member] | HyFi Tokens [Member] | Technology [Member]                                  
Related Party Transaction [Line Items]                                  
number of tokens issued to purchase assets | Integer                       17,500,000          
Troy Mac Donald [Member] | HyFi Tokens [Member] | Technology [Member]                                  
Related Party Transaction [Line Items]                                  
number of tokens issued to purchase assets | Integer                       175,000          
Notes Payable and Convertible Debt [Member]                                  
Related Party Transaction [Line Items]                                  
Interest expense related party             21,189 $ 21,189 42,378 $ 42,378              
Chief Executive Officer [Member]                                  
Related Party Transaction [Line Items]                                  
Accrued compensation   $ 25,000 $ 206,250                            
Increase decrease in long term debt   214,000 $ 874,000                            
Debt instrument, interest rate, stated percentage     4.00%                            
Debt instrument, maturity date     Dec. 01, 2017                            
Debt instrument, description     The compensation included was accrued during the period from January 2, 2011 to February 29, 2016. This compensation will be paid as bonuses out of future income only and is further subject to a cap of 20% of operating net cash flow in any given period. If bonuses are paid, accrued compensation will be paid with an amount decided by the Board                            
Chief Financial Officer [Member]                                  
Related Party Transaction [Line Items]                                  
Accrued compensation                 445,250     $ 445,250          
Decrease in accrued salaries                 15,722.47                
Notes payable to related parties             805,637   805,637         $ 805,637      
Director Of Business Strategy [Member]                                  
Related Party Transaction [Line Items]                                  
Accrued compensation   225,000 $ 206,250           440,833     440,833          
Increase decrease in long term debt   $ 9,583 $ 660,000                            
Debt instrument, interest rate, stated percentage     4.00%                            
Debt instrument, maturity date     Dec. 01, 2017                            
Debt instrument, description     The compensation included was accrued during the period from January 2, 2011 to February 29, 2016. This compensation will be paid as bonuses out of future income only and is further subject to a cap of 20% of operating net cash flow in any given period. If bonuses are paid, accrued compensation will be paid with an amount decided by the Board                            
Notes payable to related parties             $ 883,791   883,791     $ 883,791          
Debt instrument, face amount     $ 710,000                            
Reduction in liability insurance                 $ 27,308                
Director Of Business Strategy [Member] | Three Notes [Member]                                  
Related Party Transaction [Line Items]                                  
Debt instrument, face amount     $ 50,000                            
Debt instrument, interest rate, effective percentage     8.00%                            
Investor [Member]                                  
Related Party Transaction [Line Items]                                  
Debt instrument, maturity date Jun. 15, 2016                                
Notes payable to related parties $ 99,448                                
Debt instrument, conversion percentage 100.00%                                
Debt instrument, convertible, conversion price | $ / shares $ 0.0015                                
Chief Operating Officer [Member]                                  
Related Party Transaction [Line Items]                                  
Debt instrument, interest rate, stated percentage       8.00% 8.00% 8.00%                      
Debt instrument, maturity date       Jul. 31, 2018 May 18, 2018 Mar. 02, 2018                      
Debt instrument, conversion percentage           100.00%                      
Debt instrument, convertible, conversion price | $ / shares       $ 0.10 $ 0.10 $ 0.15                 $ 0.10 $ 0.10  
Loans Payable       $ 50,000 $ 50,000 $ 100,000                 $ 100,000 $ 50,000  
Share price | $ / shares                               $ 0.10 $ 0.10
Convertible notes payable to related parties                             $ 25,000    
XML 32 R23.htm IDEA: XBRL DOCUMENT v3.22.2
Senior Promissory Note – related party (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
May 31, 2022
May 31, 2021
May 31, 2022
May 31, 2021
Nov. 30, 2021
Jun. 29, 2021
Accrued interest $ 526,534   $ 526,534   $ 484,156  
Interest expense 11,248 $ 11,247 22,495 $ 22,494    
China Energy Partners LLC [Member]            
Accrued interest 55,234   55,234   $ 25,315  
Interest expense $ 15,123   $ 29,918      
China Energy Partners LLC [Member] | Redemption Agreement [Member] | Series A Preferred Stock [Member]            
Debt instrument, principal value           $ 1,000,000
Debt instrument, interest rate           6.00%
XML 33 R24.htm IDEA: XBRL DOCUMENT v3.22.2
Stockholders’ deficit (Details Narrative)
3 Months Ended 6 Months Ended
Mar. 05, 2022
USD ($)
shares
Aug. 05, 2021
USD ($)
$ / shares
shares
Jun. 29, 2021
USD ($)
Integer
shares
May 31, 2022
USD ($)
$ / shares
shares
May 31, 2022
USD ($)
$ / shares
shares
Nov. 30, 2021
$ / shares
shares
Jul. 28, 2021
$ / shares
shares
Class of Stock [Line Items]              
Value of shares issued | $       $ 249,991 $ 249,991    
Preferred stock, shares authorized           5,000,000 10,000
Common stock, shares authorized       500,000,000 500,000,000 500,000,000 100,000,000
Preferred stock, par value | $ / shares           $ 0.0001 $ 1.00
Common stock, shares issued       45,625,000 45,625,000 45,000,000  
Common stock, shares outstanding       45,625,000 45,625,000 45,000,000  
Preferred stock, shares issued       900,000 900,000 1  
Preferred stock, shares outstanding       900,000 900,000 1  
HyFi Tokens [Member]              
Class of Stock [Line Items]              
Proceeds from acquisition | $     $ 300,000        
NFTs received from acquisition | Integer     400,000,000        
Series A Preferred Stock [Member]              
Class of Stock [Line Items]              
Preferred stock, shares authorized       10,000 10,000 10,000  
Preferred stock, par value | $ / shares       $ 1.00 $ 1.00 $ 1.00  
Preferred stock, shares issued       0 0 1  
Preferred stock, shares outstanding       0 0 1  
Series C Preferred Stock [Member]              
Class of Stock [Line Items]              
Stock issued | $     $ 900,000        
Preferred stock, shares authorized     900,000 5,000,000 5,000,000 5,000,000  
Conversion of stock, description     Subject to the other terms and conditions in the certificate of designation, a Series C preferred stock holder will have the right from time to time and at any time following the date that is one year after the date on the signature page of the certificate of designations to convert each outstanding share of Series C preferred stock into 450 shares of Company common stock. Based on the number of shares of common stock issued and outstanding as of November 30, 2021, if all of the 900,000 shares of Series C preferred stock are issued and subsequently converted, the holders of the converted stock will hold 90% of the issued and outstanding shares of common stock        
Conversion of stock shares issued     900,000        
Number of preferred stock voting rights     Except as otherwise set forth in the certificate of designation, each share of Series C preferred stock will, on any matter submitted to the holders of Company common stock, or any class thereof, for a vote, vote together with the common stock, or any class thereof, as applicable, as one class on such matter, and each share of Series C preferred stock will have 450 votes        
Preferred stock, par value | $ / shares       $ 0.001 $ 0.001 $ 0.001  
Preferred stock, shares issued       900,000 900,000 0  
Preferred stock, shares outstanding       900,000 900,000 0  
Stock Purchase Agreement [Member]              
Class of Stock [Line Items]              
Number of shares issued 625,000            
Purchase price | $ $ 250,000            
China Energy Partners LLC [Member] | Redemption Agreement [Member] | Series A Preferred Stock [Member]              
Class of Stock [Line Items]              
Debt instrument, principal value | $     $ 1,000,000        
Debt instrument, interest rate     6.00%        
Consultant [Member]              
Class of Stock [Line Items]              
Number of shares issued   50,000          
Value of shares issued | $   $ 2,500          
Issue price per share | $ / shares   $ 0.05          
Baruch Halpern [Member]              
Class of Stock [Line Items]              
Issue price per share | $ / shares   $ 0.05          
Number of shares issued   750,000          
Value of shares issued | $   $ 37,500          
Robert Kohn [Member]              
Class of Stock [Line Items]              
Issue price per share | $ / shares   $ 0.05          
Number of shares issued   546,160          
Value of shares issued | $   $ 27,307          
Bonnie Nelson [Member]              
Class of Stock [Line Items]              
Issue price per share | $ / shares   $ 0.05          
Number of shares issued   546,160          
Value of shares issued | $   $ 27,307          
XML 34 R25.htm IDEA: XBRL DOCUMENT v3.22.2
Commitments and Contingencies (Details Narrative) - Digital Art [Member] - Sanctum Agreement [Member]
Jul. 01, 2022
USD ($)
May 19, 2022
USD ($)
Apr. 06, 2022
USD ($)
Integer
Apr. 04, 2022
USD ($)
Indefinite-Lived Intangible Assets [Line Items]        
Number of assets | Integer     20,000  
Payment for asset   $ 40,333.33 $ 121,000 $ 40,333.33
Subsequent Event [Member]        
Indefinite-Lived Intangible Assets [Line Items]        
Payment for asset $ 40,333.33      
XML 35 R26.htm IDEA: XBRL DOCUMENT v3.22.2
Schedule of Amount Owed on Prepayment of Diagonal Lending Note (Details)
May 31, 2022
May 31, 2022 to July 30, 2022 [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Prepayment Percentage 120.00%
July 31, 2022 to October 28, 2022 [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Prepayment Percentage 125.00%
October 29, 2022 to November 27, 2022 [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Prepayment Percentage 130.00%
XML 36 R27.htm IDEA: XBRL DOCUMENT v3.22.2
Subsequent Events (Details Narrative)
8 Months Ended
Jun. 26, 2022
USD ($)
$ / shares
shares
May 31, 2022
USD ($)
Jul. 28, 2015
Jul. 29, 2022
USD ($)
Jul. 28, 2022
USD ($)
Subsequent Event [Line Items]          
Interest rate     8.00%    
Debt maturity date     Dec. 31, 2015    
China Energy Partners Note Amendment [Member] | Subsequent Event [Member]          
Subsequent Event [Line Items]          
Principal amount         $ 800,000
Debt transfer amount         $ 200,000
Accurued interest       $ 60,000  
Securities Purchase Agreement [Member] | Convertible Debt [Member]          
Subsequent Event [Line Items]          
Principal amount   $ 90,000      
Interest rate   10.00%      
Debt maturity date   May 31, 2023      
Debt principal interest rate   22.00%      
Debt description   Diagonal Lending has the right from time to time, and at any time following November 27, 2022 and ending on the earlier of (i) payment of all amounts due under the Diagonal Lending Note, (ii) May 31, 2023, if all amounts are repaid in full at such time, or (iii) the date full repayment of all indebtedness to convert all or any part of the indebtedness into common stock subject to the terms of the Digital Lending Note at the Conversion Price (as hereinafter defined). The “Conversion Price” means 65% multiplied by the lowest trading price for the Company’s common stock during the 10 trading day period ending on the latest complete trading day prior to the conversion date, subject to a 4.99% equity blocker and subject to the terms of the Diagonal Lending Note.      
PIP Agreement [Member] | Subsequent Event [Member]          
Subsequent Event [Line Items]          
Gross sales percentage 0.05        
PIP Agreement [Member] | Subsequent Event [Member] | Restricted Common Stock [Member]          
Subsequent Event [Line Items]          
Shares issued, shares | shares 500,000        
Share price | $ / shares $ 0.25        
[custom:TokensIssuedDuringPeriodSharesNewIssues] | shares 3,125,000        
[custom:TokenPrice-0] | $ / shares $ 0.04        
[custom:TokensIssuedDuringPeriodSharesNewIssuesValue] | shares 125,000        
Purchase of vaults, description The Company agreed to grant PIP an option to purchase up to 50 HyFi vaults for $1,000. The option will expire on August 30, 2022.        
Debt payment amount $ 500,000        
PIP Agreement [Member] | Subsequent Event [Member] | Exclusive License Options Year One [Member]          
Subsequent Event [Line Items]          
Exclusive license Amount 1,000,000        
PIP Agreement [Member] | Subsequent Event [Member] | Exclusive License Options Year Five [Member]          
Subsequent Event [Line Items]          
Exclusive license Amount $ 10,000,000        
XML 37 form10-q_htm.xml IDEA: XBRL DOCUMENT 0001510832 2021-12-01 2022-05-31 0001510832 2022-07-15 0001510832 2022-05-31 0001510832 2021-11-30 0001510832 us-gaap:SeriesAPreferredStockMember 2022-05-31 0001510832 us-gaap:SeriesAPreferredStockMember 2021-11-30 0001510832 us-gaap:SeriesCPreferredStockMember 2022-05-31 0001510832 us-gaap:SeriesCPreferredStockMember 2021-11-30 0001510832 2022-03-01 2022-05-31 0001510832 2021-03-01 2021-05-31 0001510832 2020-12-01 2021-05-31 0001510832 BOPO:SaleOfTokensMember 2022-03-01 2022-05-31 0001510832 BOPO:SaleOfTokensMember 2021-03-01 2021-05-31 0001510832 BOPO:SaleOfTokensMember 2021-12-01 2022-05-31 0001510832 BOPO:SaleOfTokensMember 2020-12-01 2021-05-31 0001510832 BOPO:SaleOfTokensRelatedPartyMember 2022-03-01 2022-05-31 0001510832 BOPO:SaleOfTokensRelatedPartyMember 2021-03-01 2021-05-31 0001510832 BOPO:SaleOfTokensRelatedPartyMember 2021-12-01 2022-05-31 0001510832 BOPO:SaleOfTokensRelatedPartyMember 2020-12-01 2021-05-31 0001510832 2020-11-30 0001510832 2021-05-31 0001510832 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2021-02-28 0001510832 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2021-02-28 0001510832 us-gaap:PreferredStockMember 2021-02-28 0001510832 us-gaap:CommonStockMember 2021-02-28 0001510832 us-gaap:AdditionalPaidInCapitalMember 2021-02-28 0001510832 us-gaap:RetainedEarningsMember 2021-02-28 0001510832 2021-02-28 0001510832 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2022-02-28 0001510832 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2022-02-28 0001510832 us-gaap:PreferredStockMember 2022-02-28 0001510832 us-gaap:CommonStockMember 2022-02-28 0001510832 us-gaap:AdditionalPaidInCapitalMember 2022-02-28 0001510832 us-gaap:RetainedEarningsMember 2022-02-28 0001510832 2022-02-28 0001510832 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2020-11-30 0001510832 us-gaap:PreferredStockMember 2020-11-30 0001510832 us-gaap:CommonStockMember 2020-11-30 0001510832 us-gaap:AdditionalPaidInCapitalMember 2020-11-30 0001510832 us-gaap:RetainedEarningsMember 2020-11-30 0001510832 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2021-11-30 0001510832 us-gaap:PreferredStockMember 2021-11-30 0001510832 us-gaap:CommonStockMember 2021-11-30 0001510832 us-gaap:AdditionalPaidInCapitalMember 2021-11-30 0001510832 us-gaap:RetainedEarningsMember 2021-11-30 0001510832 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2021-03-01 2021-05-31 0001510832 us-gaap:PreferredStockMember 2021-03-01 2021-05-31 0001510832 us-gaap:CommonStockMember 2021-03-01 2021-05-31 0001510832 us-gaap:AdditionalPaidInCapitalMember 2021-03-01 2021-05-31 0001510832 us-gaap:RetainedEarningsMember 2021-03-01 2021-05-31 0001510832 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2022-03-01 2022-05-31 0001510832 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2022-03-01 2022-05-31 0001510832 us-gaap:PreferredStockMember 2022-03-01 2022-05-31 0001510832 us-gaap:CommonStockMember 2022-03-01 2022-05-31 0001510832 us-gaap:AdditionalPaidInCapitalMember 2022-03-01 2022-05-31 0001510832 us-gaap:RetainedEarningsMember 2022-03-01 2022-05-31 0001510832 us-gaap:CommonStockMember 2020-12-01 2021-05-31 0001510832 us-gaap:AdditionalPaidInCapitalMember 2020-12-01 2021-05-31 0001510832 us-gaap:RetainedEarningsMember 2020-12-01 2021-05-31 0001510832 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2021-12-01 2022-05-31 0001510832 us-gaap:PreferredStockMember 2021-12-01 2022-05-31 0001510832 us-gaap:CommonStockMember 2021-12-01 2022-05-31 0001510832 us-gaap:AdditionalPaidInCapitalMember 2021-12-01 2022-05-31 0001510832 us-gaap:RetainedEarningsMember 2021-12-01 2022-05-31 0001510832 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2021-05-31 0001510832 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2021-05-31 0001510832 us-gaap:PreferredStockMember 2021-05-31 0001510832 us-gaap:CommonStockMember 2021-05-31 0001510832 us-gaap:AdditionalPaidInCapitalMember 2021-05-31 0001510832 us-gaap:RetainedEarningsMember 2021-05-31 0001510832 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2022-05-31 0001510832 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2022-05-31 0001510832 us-gaap:PreferredStockMember 2022-05-31 0001510832 us-gaap:CommonStockMember 2022-05-31 0001510832 us-gaap:AdditionalPaidInCapitalMember 2022-05-31 0001510832 us-gaap:RetainedEarningsMember 2022-05-31 0001510832 BOPO:BioPowerCorporationMember 2011-01-06 0001510832 BOPO:ChiefExecutiveOfficerAndDirectorMember 2010-09-12 2010-09-13 0001510832 srt:ChiefExecutiveOfficerMember BOPO:FTZExchangeLLCMember 2012-06-06 2012-06-07 0001510832 BOPO:HyFiMember 2021-06-28 2021-06-29 0001510832 BOPO:HyFiTokensMember 2021-06-28 2021-06-29 0001510832 us-gaap:SeriesCPreferredStockMember 2021-06-29 0001510832 us-gaap:SeriesCPreferredStockMember 2021-06-28 2021-06-29 0001510832 us-gaap:SeriesAPreferredStockMember BOPO:RedemptionAgreementMember BOPO:ChinaEnergyPartnersLLCMember 2021-06-29 0001510832 BOPO:TwoCustomerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-03-01 2022-05-31 0001510832 BOPO:FiveCustomerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-12-01 2022-05-31 0001510832 2021-07-28 0001510832 BOPO:CanadianInvestorMember 2022-03-03 2022-03-04 0001510832 BOPO:CanadianInvestorMember 2022-03-04 0001510832 BOPO:DemandLoansMember 2022-05-31 0001510832 srt:MinimumMember BOPO:DemandLoansMember 2022-05-31 0001510832 srt:MaximumMember BOPO:DemandLoansMember 2022-05-31 0001510832 BOPO:DemandLoansMember 2021-12-01 2022-05-31 0001510832 BOPO:ReclassificationOfAccruedCompensationToNotesPayableMember 2022-05-31 0001510832 BOPO:ReclassificationOfAccruedCompensationToNotesPayableMember 2021-12-01 2022-05-31 0001510832 BOPO:ThirdPartyInvestorMember BOPO:DemandLoanAgreementsMember 2016-07-27 0001510832 BOPO:LenderMember BOPO:DemandLoanAgreementsMember 2012-01-07 0001510832 BOPO:LenderMember BOPO:DemandLoanAgreementsMember 2011-10-28 2012-01-07 0001510832 BOPO:ThirdPartyInvestorMember BOPO:ConvertibleDebtAgreementMember 2013-12-03 0001510832 BOPO:ThirdPartyInvestorMember BOPO:ConvertibleDebtAgreementMember 2015-07-30 0001510832 BOPO:ThirdPartyInvestorMember BOPO:ConvertibleDebtAgreementMember 2015-07-29 2015-07-30 0001510832 BOPO:ThirdPartyInvestorMember BOPO:ConvertibleDebtAgreementMember 2016-05-23 0001510832 BOPO:ThirdPartyInvestorMember BOPO:ConvertibleDebtAgreementMember 2016-05-22 2016-05-23 0001510832 BOPO:ThirdPartyInvestorOneMember BOPO:ConvertibleDebtAgreementMember 2015-07-30 0001510832 BOPO:ThirdPartyInvestorOneMember BOPO:ConvertibleDebtAgreementMember 2015-07-29 2015-07-30 0001510832 BOPO:ThirdPartyInvestorTwoMember BOPO:ConvertibleDebtAgreementMember 2015-07-30 0001510832 BOPO:ThirdPartyInvestorTwoMember BOPO:ConvertibleDebtAgreementMember 2015-07-29 2015-07-30 0001510832 2015-07-28 0001510832 2014-12-03 2015-07-28 0001510832 BOPO:ThirdPartiesMember 2022-03-01 2022-05-31 0001510832 BOPO:ThirdPartiesMember 2021-03-01 2021-05-31 0001510832 BOPO:ThirdPartiesMember 2021-12-01 2022-05-31 0001510832 BOPO:ThirdPartiesMember 2020-12-01 2021-05-31 0001510832 srt:ChiefExecutiveOfficerMember 2016-05-26 2016-05-27 0001510832 srt:ChiefExecutiveOfficerMember 2016-05-27 0001510832 srt:ChiefExecutiveOfficerMember 2016-06-01 2016-06-02 0001510832 srt:ChiefFinancialOfficerMember 2021-12-01 2022-05-31 0001510832 srt:ChiefFinancialOfficerMember 2020-12-01 2021-11-30 0001510832 srt:ChiefFinancialOfficerMember 2022-05-31 0001510832 srt:ChiefFinancialOfficerMember 2020-11-30 0001510832 BOPO:DirectorOfBusinessStrategyMember 2016-05-26 2016-05-27 0001510832 BOPO:DirectorOfBusinessStrategyMember 2016-05-27 0001510832 BOPO:DirectorOfBusinessStrategyMember BOPO:ThreeNotesMember 2016-05-27 0001510832 BOPO:DirectorOfBusinessStrategyMember 2016-06-01 2016-06-02 0001510832 BOPO:DirectorOfBusinessStrategyMember 2021-12-01 2022-05-31 0001510832 BOPO:DirectorOfBusinessStrategyMember 2020-12-01 2021-11-30 0001510832 BOPO:DirectorOfBusinessStrategyMember 2022-05-31 0001510832 BOPO:DirectorOfBusinessStrategyMember 2021-11-30 0001510832 us-gaap:InvestorMember 2016-11-30 0001510832 us-gaap:InvestorMember 2016-11-29 2016-11-30 0001510832 srt:ChiefOperatingOfficerMember 2016-03-31 0001510832 srt:ChiefOperatingOfficerMember 2016-03-01 2016-03-31 0001510832 srt:ChiefOperatingOfficerMember 2016-03-02 0001510832 srt:ChiefOperatingOfficerMember 2016-05-18 0001510832 BOPO:ThirdPartyInvestorMember 2016-05-23 0001510832 srt:ChiefOperatingOfficerMember 2016-05-23 0001510832 srt:ChiefOperatingOfficerMember 2016-05-31 0001510832 srt:ChiefOperatingOfficerMember 2016-05-01 2016-05-31 0001510832 srt:ChiefOperatingOfficerMember 2016-07-31 0001510832 srt:ChiefOperatingOfficerMember 2016-07-01 2016-07-31 0001510832 BOPO:RobertKohnMember 2021-06-29 0001510832 BOPO:RobertKohnMember 2022-05-31 0001510832 BOPO:RobertKohnMember 2021-11-30 0001510832 BOPO:HyFiTokensMember BOPO:TechnologyMember BOPO:RelatedPartiesMember 2020-12-01 2021-11-30 0001510832 BOPO:TechnologyMember BOPO:RelatedPartiesMember 2021-11-30 0001510832 BOPO:HyFiTokensMember BOPO:TechnologyMember BOPO:TroyMacDonaldMember 2020-12-01 2021-11-30 0001510832 BOPO:TechnologyMember BOPO:RelatedPartiesMember 2020-12-01 2021-11-30 0001510832 BOPO:NotesPayableAndConvertibleDebtMember 2022-03-01 2022-05-31 0001510832 BOPO:NotesPayableAndConvertibleDebtMember 2021-03-01 2021-05-31 0001510832 BOPO:NotesPayableAndConvertibleDebtMember 2021-12-01 2022-05-31 0001510832 BOPO:NotesPayableAndConvertibleDebtMember 2020-12-01 2021-05-31 0001510832 BOPO:ChinaEnergyPartnersLLCMember 2022-05-31 0001510832 BOPO:ChinaEnergyPartnersLLCMember 2021-11-30 0001510832 BOPO:ChinaEnergyPartnersLLCMember 2022-03-01 2022-05-31 0001510832 BOPO:ChinaEnergyPartnersLLCMember 2021-12-01 2022-05-31 0001510832 BOPO:ConsultantMember 2021-08-04 2021-08-05 0001510832 BOPO:ConsultantMember 2021-08-05 0001510832 BOPO:BaruchHalpernMember 2021-08-04 2021-08-05 0001510832 BOPO:BaruchHalpernMember 2021-08-05 0001510832 BOPO:RobertKohnMember 2021-08-04 2021-08-05 0001510832 BOPO:RobertKohnMember 2021-08-05 0001510832 BOPO:BonnieNelsonMember 2021-08-04 2021-08-05 0001510832 BOPO:BonnieNelsonMember 2021-08-05 0001510832 BOPO:StockPurchaseAgreementMember 2022-03-05 2022-03-05 0001510832 BOPO:DigitalArtMember BOPO:SanctumAgreementMember 2022-04-05 2022-04-06 0001510832 BOPO:DigitalArtMember BOPO:SanctumAgreementMember 2022-04-03 2022-04-04 0001510832 BOPO:DigitalArtMember BOPO:SanctumAgreementMember 2022-05-18 2022-05-19 0001510832 BOPO:DigitalArtMember us-gaap:SubsequentEventMember BOPO:SanctumAgreementMember 2022-06-30 2022-07-01 0001510832 us-gaap:ConvertibleDebtMember BOPO:SecuritiesPurchaseAgreementMember 2022-05-31 0001510832 us-gaap:ConvertibleDebtMember BOPO:SecuritiesPurchaseAgreementMember 2022-05-31 2022-05-31 0001510832 BOPO:ChinaEnergyPartnersNoteAmendmentMember us-gaap:SubsequentEventMember 2022-07-28 0001510832 BOPO:ChinaEnergyPartnersNoteAmendmentMember us-gaap:SubsequentEventMember 2022-07-29 0001510832 BOPO:ExclusiveLicenseOptionsYearOneMember us-gaap:SubsequentEventMember BOPO:PIPAgreementMember 2022-06-26 0001510832 BOPO:ExclusiveLicenseOptionsYearFiveMember us-gaap:SubsequentEventMember BOPO:PIPAgreementMember 2022-06-26 0001510832 us-gaap:SubsequentEventMember BOPO:PIPAgreementMember 2022-06-26 0001510832 BOPO:RestrictedCommonStockMember us-gaap:SubsequentEventMember BOPO:PIPAgreementMember 2022-06-25 2022-06-26 0001510832 BOPO:RestrictedCommonStockMember us-gaap:SubsequentEventMember BOPO:PIPAgreementMember 2022-06-26 0001510832 BOPO:PrepaymentPeriodOneMember 2022-05-31 0001510832 BOPO:PrepaymentPeriodTwoMember 2022-05-31 0001510832 BOPO:PrepaymentPeriodThreeMember 2022-05-31 iso4217:USD shares iso4217:USD shares pure BOPO:Integer 0001510832 false Q2 --11-30 10-Q true 2022-05-31 2022 false 000-53274 BioPower Operations Corporation NV 27-4460232 20801 Biscayne Blvd. Suite 403 Aventura FL 33180 (786) 923-0272 Yes Yes Non-accelerated Filer true false false 45625000 522356 95973 331 12893 77593 613173 95973 372897 563967 2000905 1530668 130671 130671 368031 368031 399447 399447 1000000 1000000 193667 193667 1320700 1320700 5786318 5507151 1.00 1.00 10000 10000 0 0 1 1 0.001 0.001 5000000 5000000 900000 900000 0 0 900 900 900 900 0.0001 0.0001 500000000 500000000 45625000 45625000 45000000 45000000 4564 4501 4390339 4140411 -9568948 -9556990 -5173145 -5411178 613173 95973 136000 336000 110700 110700 246700 446700 212443 8081 363868 8081 212443 8081 363868 8081 34257 -8081 82832 -8081 11248 11247 22495 22494 36147 21189 72295 42378 -47395 -32436 -94790 -64872 -13138 -40517 -11958 -72953 -0.00 -0.00 -0.00 -0.00 45597826 43107680 45302198 43107680 -11958 -72953 331 77593 12893 -191071 30575 470238 42378 176392 249991 249991 426383 95973 522356 43107680 4312 4746884 -9148101 -4396905 -40517 -40517 1 43107680 4312 4746884 -9188619 -4437422 900000 900 45000000 4500 4140411 -9555809 -5409998 625000 63 249928 249991 -13138 -13138 1 900000 900 45625000 4563 4390339 -9568948 -5173145 1 1 43107680 4312 4746884 -9115666 -4364469 -72953 -72953 1 1 43107680 4312 4746884 -9188619 -4437422 1 1 900000 900 45000000 4500 4140411 -9556990 -5411178 625000 63 249928 249991 -11958 -11958 1 1 900000 900 45625000 4563 4390339 -9568948 -5173145 <p id="xdx_800_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_zPub27VpnoCk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note 1. <span id="xdx_821_zldNzWah9eR7">Organization</span>:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">BioPower Corporation (“BioPower” or the “Company”) was incorporated in the State of Florida on September 13, 2010. On January 5, 2011, the Company re-domiciled to Nevada and formed BioPower Operations Corporation, a Nevada corporation. On January 6, 2011, the shareholders of BioPower Corporation contributed their shares of BioPower Corporation to BioPower Operations Corporation and BioPower Corporation became a wholly owned subsidiary.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On October 24, 2014, the Company executed a Share Exchange Agreement (“SEA”) with Green3Power Holdings Company (“G3P”) to acquire G3P and its wholly owned subsidiaries Green3Power Operations Inc., a Delaware corporation (“G3P OPS”), and Green3Power International Company, a Nevis corporation (“G3PI”). This transaction was a stock for stock exchange (the “Exchange”), which was accounted for as an acquisition and recorded as an expense based on the fair value of the Company’s common stock as of the date of the exchange. Also exchanged was one share of the Company’s Series B preferred stock, which is convertible into common shares two years from the date of the SEA, if certain milestones are met as required by the SEA. No value was attributed to the preferred share. We conduct all of our operations through G3P and its subsidiaries which are primarily engaged in the development of waste-to-energy projects and services including design, permitting, equipment procurement, construction management and operations and maintenance of the intended facilities. We intend to hold equity interests in the waste-to-energy facilities on a global basis and operate and maintain the facilities. A second business unit is focused on providing waste remediation services globally.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s fiscal year end is November 30.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 6, 2011, we acquired <span id="xdx_904_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20110106__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--BioPowerCorporationMember_zsHOmywvrRpb" title="Ownership percentage">100%</span> of BioPower Corporation (“BC”), a Florida corporation incorporated on September 13, 2010, by our then-CEO and Director contributing <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_pid_dp_uPure_c20100912__20100913__srt--TitleOfIndividualAxis__custom--ChiefExecutiveOfficerAndDirectorMember_z5eoBMRZUUt4" title="Percentage of outstanding shares">100%</span> of the outstanding shares to the Company. As a result, BC became a wholly owned subsidiary of the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 12, 2012, the Company formed FTZ Energy Exchange Inc., a wholly owned subsidiary, for the future development of an energy exchange. On June 7, 2012, the Company’s then-Chief Executive Officer contributed <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_pid_dp_c20120606__20120607__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__dei--LegalEntityAxis__custom--FTZExchangeLLCMember_zlkRTs06dRa2" title="Percentage of outstanding shares">100%</span> of his member interest in FTZ Exchange, LLC (“FTZ”), a wholly owned subsidiary, to the Company for no consideration. FTZ is a licensing company that licenses business know-how and technology to build transaction fee-based exchanges for the sale of products and services in vertical markets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 2, 2012, the Company formed Agribopo, Inc., a wholly owned subsidiary, for the development of biomass related projects. On November 27, 2012, the Company entered into a non-exclusive global license with Advanced Green Technologies, LLC to convert biomass wastes from animals, humans and cellulosic biomass to cellulosic ethanol, fertilizer and other derivative products.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On October 24, 2014, the Company entered into the SEA with G3P to acquire G3P and its wholly owned subsidiaries, G3P OPS and G3PI through the Exchange.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By October 24, 2016, G3P had failed to meet the provisions of the SEA that would allow G3P to take over control of the Company. As a result, the Company’s Board of Directors tried to come to an arrangement to separate BioPower from its subsidiaries, but in the end, decided that it would be in the best interests of the Company’s shareholders to move forward looking for a new acquisition. From October 24, 2016 until February 2017, the Company continued project development of waste-to-energy projects with extremely limited funds. In February 2017, the Company ceased all operations. At that time, we became a shell company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In 2019, we entered into a memorandum of understanding with WPP Energy GmbH and China Energy Partners, LLC (“CEP”), but after exhausting all efforts we were unable to negotiate a definitive agreement or close the transaction.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 29, 2021, we entered into an Asset Purchase Agreement (the “APA”) with Rafael Ben Shaya, Troy MacDonald, Adam Benchaya, Thomas Perez, Tom Saban and Edouard Pouchoy (collectively, Messrs. Ben Shaya, MacDonald, Benchaya, Perez, Saban and Pouchoy are referred to herein as the “Sellers”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to the terms of the APA, the Company agreed to acquire from the Sellers, and the Sellers agreed to sell to the Company, certain assets comprised of the goodwill, intellectual property, business proprietary know-how and trade secrets, intangible property and other assets of Sellers’ business with respect to HyFi, and any and all rights of Sellers in and to the foregoing (the “Assets”), and certain governance/utility virtual tokens (collectively, the “HyFi Tokens”) expected to be used as a means of payment on the HyFi Platform, as hereinafter defined (the “Acquisition”). The “HyFi Platform” refers to the HyFi Decentralized Finance (“DeFi”) exchange marketplace using blockchain platform technology. The DeFi principles are based on an ecosystem of financial services utilizing tokenization and non-fungible tokens (“NFTs”) in connection with qualifying products, licenses and projects.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In addition, the Sellers agreed to (i) pay to the Company, on the closing date of the Acquisition, $<span id="xdx_900_eus-gaap--BusinessCombinationConsiderationTransferred1_pp0p0_c20210628__20210629__us-gaap--BusinessAcquisitionAxis__custom--HyFiMember_zKGrd6TPrnIg" title="Cash consideration, acquisition">300,000</span> (the “Cash Consideration”), and (ii) transfer to the Company, on the closing date of the Acquisition, <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20210628__20210629__us-gaap--BusinessAcquisitionAxis__custom--HyFiTokensMember_zkjw7fPTe7Wg" title="Number of consideration shares">400,000,000</span> HyFi Tokens (the “HyFi Token Consideration”). The Company used the Cash Consideration to bring the Company into a fully reporting status with the Securities and Exchange Commission (the “SEC”) and for public company operating expenses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--BusinessAcquisitionDescriptionOfAcquiredEntity_c20210628__20210629__us-gaap--BusinessAcquisitionAxis__custom--HyFiMember_zkczqrdmv3qe" title="Business combination description">Pursuant to the terms of the APA, the Company agreed to file with the State of Nevada the certificate of designation for the Series C preferred stock on or before the date that is 60 calendar days after the closing of the Acquisition. In exchange for the sale of the Assets and the Cash Consideration, the Company agreed to issue to the Sellers an aggregate of <span id="xdx_90D_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20210629__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zyMCGwBEgrL5" title="Preferred stock, shares authorized">900,000</span> Series C preferred shares within 30 calendar days after the State of Nevada provides written confirmation of filing of the certificate of designation for the Series C preferred stock.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to the terms of the APA, the parties agreed that the Series C preferred stock will have the following terms, among others:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1. Authorized Shares of Series C Preferred Stock. The number of authorized shares of Series C preferred stock will be <span id="xdx_903_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20210629__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zn3qYoTGTXrd" title="Preferred stock, shares authorized">900,000</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2. Conversion. Subject to the other terms and conditions in the certificate of designation, a Series C preferred stock holder will have the right from time to time and at any time following the date that is one year after the date on the signature page of the certificate of designations to convert each outstanding share of Series C preferred stock into <span id="xdx_90B_eus-gaap--ConversionOfStockSharesConverted1_pid_c20210628__20210629__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zLTvEiHmGnQf" title="Stock conversion, shares">450</span> shares of Company common stock. Based on the number of shares of common stock issued and outstanding as of June 29, 2021, if all of the <span id="xdx_90F_eus-gaap--ConversionOfStockSharesIssued1_pid_c20210628__20210629__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zzkDiNvxz2Uc" title="Stock conversion, issued shares">900,000</span> shares of Series C preferred stock are issued and subsequently converted, the holders of the converted stock will hold 90% of the issued and outstanding shares of common stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3. Voting. <span id="xdx_902_eus-gaap--PreferredStockVotingRights_c20210628__20210629__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zq9H7RucNUH5" title="Number of preferred stock voting rights">Except as otherwise set forth in the certificate of designation, each share of Series C preferred stock will, on any matter submitted to the holders of Company common stock, or any class thereof, for a vote, vote together with the common stock, or any class thereof, as applicable, as one class on such matter, and each share of Series C preferred stock will have 450 votes</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4. Dividends. The Series C preferred stock is not entitled to receive dividends or distributions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Acquisition closed on June 29, 2021 (the “Closing Date”). On the Closing Date, the Sellers delivered the Cash Consideration and the HyFi Token Consideration.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 27, 2021, the Company filed with the State of Nevada a certificate of designations for the Series C preferred stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Series A Preferred Stock Redemption Agreement &amp; Senior Promissory Note</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Also on the Closing Date, the Company and CEP entered into a share redemption agreement (the “Redemption Agreement”), dated as of June 29, 2021, pursuant to which the Company redeemed one share of the Company’s Series A preferred stock from CEP (the “Series A Share”). On the Closing Date, as provided in the Redemption Agreement, the Company issued to CEP a senior promissory note (the “Note”) in the principal amount of $<span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_iI_pdp0_c20210629__dei--LegalEntityAxis__custom--ChinaEnergyPartnersLLCMember__us-gaap--TypeOfArrangementAxis__custom--RedemptionAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zudoB8YpUpJ5" title="Debt instrument, principal value">1,000,000</span>. The Series A Share will be held in escrow. If an Event of Default (as defined in the Note) occurs under the Note, then the Company will direct the escrow agent to release the Series A Share to CEP; provided, however, that CEP will also retain all rights and privileges under the Note (and the Company will remain bound to all obligations under Note) even if the Series A Share is required to be released by the escrow agent to CEP as provided in the Redemption Agreement. For the avoidance of doubt, CEP will regain all rights, title, and interest in and to the Series A Share upon the occurrence of an Event of Default under the Note, regardless of the amount of the outstanding balance owed under the Note at the time of the occurrence of an Event of Default under the Note.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On October 7, 2021, the Company filed a certificate of amendment (the “Certificate of Amendment”) to its amended and restated articles in the State of Nevada and with FINRA, in order to change its corporate name from BioPower Operations Corporation. to HyFi Corp (the “Name Change”). The State of Nevada has officially changed the name of the Company to HYFI Corp. The Name Change and stock symbol change will be effective for Securities and Exchange Commission or trading purposes until it is cleared by the Financial Industry Regulatory Authority (FINRA).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 1 1 1 300000 400000000 Pursuant to the terms of the APA, the Company agreed to file with the State of Nevada the certificate of designation for the Series C preferred stock on or before the date that is 60 calendar days after the closing of the Acquisition. In exchange for the sale of the Assets and the Cash Consideration, the Company agreed to issue to the Sellers an aggregate of 900,000 Series C preferred shares within 30 calendar days after the State of Nevada provides written confirmation of filing of the certificate of designation for the Series C preferred stock. 900000 900000 450 900000 Except as otherwise set forth in the certificate of designation, each share of Series C preferred stock will, on any matter submitted to the holders of Company common stock, or any class thereof, for a vote, vote together with the common stock, or any class thereof, as applicable, as one class on such matter, and each share of Series C preferred stock will have 450 votes 1000000 <p id="xdx_808_eus-gaap--SignificantAccountingPoliciesTextBlock_zNxpaaYPYF04" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note 2. <span id="xdx_827_zBIhiingavKi">Summary of Significant Accounting Policies</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Management’s Representation of Interim Financial Statements</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying unaudited consolidated financial statements have been prepared by the Company without audit pursuant to the rules and regulations of the SEC. Certain information and disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) have been condensed or omitted as allowed by such rules and regulations, and management believes that the disclosures are adequate to make the information presented not misleading. These consolidated financial statements include all of the adjustments, which in the opinion of management are necessary to a fair presentation of financial position and results of operations. All such adjustments are of a normal and recurring nature. Interim results are not necessarily indicative of results for a full year. These unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements at filed as part of the Company’s Annual Report on Form 10-K with the SEC on February 17, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--ConsolidationPolicyTextBlock_z1DFGGRKHmY1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_869_zyKjlqnCjwK7">Principles of Consolidation</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All inter-company accounts and transactions have been eliminated in consolidation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_ztNlwAj65nu" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86B_zPsK4aHPWje3">Basis of Presentation</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying financial statements have been prepared in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standard Codification (the “ASC”) which is the source of authoritative accounting principles recognized by the FASB to be applied by nongovernmental entities in the preparation of financial statements in conformity with GAAP.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84A_ecustom--GoingConcernPolicyTextBlock_zyCKhak0qfE2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_868_zDktsR11IeLb">Going Concern</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying unaudited consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business for the twelve-month period following the date of these financial statements. The Company has incurred significant operating losses since inception. As of May 31, 2022, the Company had an accumulated deficit of $<span id="xdx_907_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_di_c20220531_zT0jO3vlTIg5" title="Accumulated deficit">9,568,948</span> and stockholders’ deficit of $<span id="xdx_908_eus-gaap--StockholdersEquity_iNI_pp0p0_di_c20220531_zLOVUWbnO6jj" title="Stockholders equity deficit">5,173,145</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because the Company does not expect that existing operational cash flow will be sufficient to fund presently anticipated operations, this raises substantial doubt about the Company’s ability to continue as a going concern. Therefore, the Company will need to raise additional funds and is currently exploring alternative sources of financing. Historically, the Company has raised capital through private placements, as an interim measure to finance working capital needs and may continue to raise additional capital through the sale of common stock or other securities and obtaining some short-term loans. The Company will be required to continue to so until its operations become profitable. Also, the Company has, in the past, paid for consulting services with its common stock to maximize working capital, and intends to continue this practice where feasible.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_eus-gaap--UseOfEstimates_znegSkgT1zdd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_869_zSETYXLY9ZC3">Use of Estimates</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The most significant estimates relate to income taxes and contingencies. The Company bases its estimates on historical experience, known or expected trends and various other assumptions that are believed to be reasonable given the quality of information available as of the date of these financial statements. The results of these assumptions provide the basis for making estimates about the carrying amounts of assets and liabilities that are not readily apparent from other sources. Actual results could differ from these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zVuWVqXttF1l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_862_zu1E6vusLKEc">Accounts Receivable</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts receivable are recorded at fair value on the date revenue is recognized. The Company provides allowances for doubtful accounts for estimated losses resulting from the inability of its customers to repay their obligation. If the financial condition of the Company’s customers were to deteriorate, resulting in an impairment of their ability to repay, additional allowances may be required. The Company provides for potential uncollectible accounts receivable based on specific customer identification and historical collection experience adjusted for existing market conditions. If market conditions decline, actual collection experience may not meet expectations and may result in decreased cash flows and increased bad debt expense.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The policy for determining past due status is based on the contractual payment terms of each customer, which are generally net 30 or net 60 days. Once collection efforts by the Company and its collection agency are exhausted, the determination for charging off uncollectible receivables is made.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84A_eus-gaap--InventoryPolicyTextBlock_zJw70C1X3Itf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_866_zNKaOTUompm1">Inventory</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories are stated at the lower of cost or net realizable value. Cost is determined by the first-in, first-out basis and net realizable value. Net realizable value is defined as sales price less cost of completion, disposition and transportation and a normal profit margin. As of May 31, 2022 and November 30, 2021, inventory amounted to $<span id="xdx_906_eus-gaap--InventoryNet_iI_c20220531_zY4VxH1THaW" title="Inventory">12,893</span> and $<span id="xdx_90C_eus-gaap--InventoryNet_iI_dxL_c20211130_zk788OgfwTkk" title="Inventory::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl0501">0</span></span>, respectively, which consisted of finished goods.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_846_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zguTXek6EhW3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_866_z4BJlRfugOj2">Revenue Recognition</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 1, 2018, the Company adopted ASC Topic 606, Revenue from Contracts with Customers (“ASC 606”). Results for reporting periods beginning after January 1, 2018, are presented under ASC 606.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 29, 2021, the Sellers agreed to (i) pay to the Company, on the closing date of the Acquisition, $<span id="xdx_90F_eus-gaap--CashAcquiredFromAcquisition_pp0p0_c20210628__20210629__us-gaap--BusinessAcquisitionAxis__custom--HyFiTokensMember_z5ZxXWQw17Tk" title="Proceeds from acquisition">300,000</span> (the “Cash Consideration”), and (ii) transfer to the Company, on the closing date of the Acquisition, <span id="xdx_902_ecustom--NFTsReceivedFromAcquisition_pid_uInteger_c20210628__20210629__us-gaap--BusinessAcquisitionAxis__custom--HyFiTokensMember_zGBoKXeV4ck6" title="NFTs received from acquisition">400,000,000</span> HyFi Tokens (the “HyFi Token Consideration”). The Company used the Cash Consideration to bring the Company into a fully reporting status with the SEC and for public company operating expenses.</span></p> <p id="xdx_848_eus-gaap--ConcentrationRiskCreditRisk_zddIM95jSSBd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_867_z9FObhhxL4Qa">Concentration</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Two customers, including one related party, account for <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220301__20220531__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--TwoCustomerMember_zDE9h9u3b66d" title="Concentration risk, percentage">100%</span> of sales during the three months ended May 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Five customers, including two related parties, account for <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20211201__20220531__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--FiveCustomerMember_zXl7yqv3KZca" title="Concentration risk, percentage">100%</span> of sales during the six months ended May 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zF08hz9ojV5g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86E_zYZg6nKRwami">Cash and cash equivalents</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company considers all highly liquid temporary cash investments with an original maturity of three months or less to be cash equivalents. On May 31, 2022, and November 30, 2021, the Company’s cash equivalents totaled $<span id="xdx_906_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pp0p0_c20220531_zBVPTYYlqHo" title="Cash equivalents">522,356</span> and $<span id="xdx_909_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pp0p0_c20211130_zBekHTV9Na8h" title="Cash equivalents">95,973</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_eus-gaap--IncomeTaxPolicyTextBlock_z1KodCdYKc3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86D_zvZwzIJHTRec">Income taxes</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for income taxes under FASB ASC 740, “Accounting for Income Taxes”. Under FASB ASC 740, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Under FASB ASC 740, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. FASB ASC 740-10-05, “Accounting for Uncertainty in Income Taxes,” prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The amount recognized is measured as the largest amount of benefit that is greater than 50% likely of being realized upon ultimate settlement. The Company assesses the validity of its conclusions regarding uncertain tax positions quarterly to determine if facts or circumstances have arisen that might cause it to change its judgment regarding the likelihood of a tax position’s sustainability under audit.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84A_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zppL9E6TTOHk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_866_zeGUpn3odrcf">Stock-based Compensation</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for stock-based compensation using the fair value method following the guidance outlined in Section 718-10 of the ASC for disclosure about stock-based compensation. This section requires a public entity to measure the cost of employee services received in exchange for an award of equity instruments based on the grant-date fair value of the award (with limited exceptions). That cost will be recognized over the period during which an employee is required to provide service in exchange for the award- the requisite service period (usually the vesting period). No compensation cost is recognized for equity instruments for which employees do not render the requisite service.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eus-gaap--EarningsPerSharePolicyTextBlock_z0qO7TIWmM0d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_860_zQRqgG7OMGo6">Net Loss per Share</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net loss per common share is computed by dividing net loss by the weighted average common shares outstanding during the period as defined by ASC Topic 260, “Earnings per Share.” Basic earnings per common share calculations are determined by dividing net income by the weighted average number of shares of common stock outstanding during the year. Diluted earnings per common share calculations are determined by dividing net income by the weighted average number of common shares and dilutive common share equivalents outstanding.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zVI9Cip0Yh03" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_868_zpKvrwHKjJff">Recent Accounting Pronouncements</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In February 2016, the FASB issued Accounting Standards Update (“ASU”) No. 2016-02, Leases (Topic 842), which establishes a new lease accounting model for lessees. The updated guidance requires an entity to recognize assets and liabilities arising from financing and operating leases, along with additional qualitative and quantitative disclosures. The amended guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018, with early adoption permitted. In March 2019, the FASB issued ASU 2019-01, Codification Improvements, which clarifies certain aspects of the new lease standard. The FASB issued ASU 2018-10, Codification Improvements to Topic 842, Leases in July 2018. Also in 2018, the FASB issued ASU 2018-11, Leases (Topic 842) Targeted Improvements, which provides an optional transition method whereby the new lease standard is applied at the adoption date and recognized as an adjustment to retained earnings. The amendments have the same effective date and transition requirements as the new lease standard.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We adopted ASC 842 on July 1, 2021. The adoption of ASC 842 did not have any impact on our financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_eus-gaap--StockholdersEquityPolicyTextBlock_z4hXiSP6V3Bk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_863_zt1zGDUL83f5">Stockholders’ Equity</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 28, 2021, the Company amended and restated its articles of incorporation, as amended, in order to, among other things, (i) increase the number of authorized shares of common stock from <span id="xdx_90B_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20210728_zbvc5Z64kzNb" title="Common stock, shares authorized">100,000,000</span> to <span id="xdx_90F_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20220531_ztLiQ4QD3V8j" title="Common stock, shares authorized">500,000,000</span>, (ii) increase the number of authorized shares of preferred stock from <span id="xdx_90F_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20210728_z6tHhp7V9OGh" title="Preferred stock, shares authorized">10,000</span> to <span id="xdx_90E_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20211130_zFhtEdCaBOB7" title="Preferred stock, shares authorized">5,000,000</span>, and (iii) change the par value of the preferred stock from $<span id="xdx_906_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20210728_zmuxqcmuIoM5" title="Preferred stock, par value">1.00</span> par value per share to $<span id="xdx_90A_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20211130_zW3ar43Op6ia" title="Preferred stock, par value">0.0001</span> par value per share. As of November 30, 2021, the Company had authorized <span id="xdx_90C_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20211130_zT8XSZfrIeo9" title="Common stock, shares authorized">500,000,000</span> shares of common stock, $<span id="xdx_901_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20211130_zsHvEKXWNNkg" title="Common stock, par value">0.0001</span> par value per share, and <span id="xdx_907_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20211130_zaCK8zsjMMmi" title="Preferred stock, shares authorized">5,000,000</span> shares of preferred stock, $<span id="xdx_900_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20211130_zfHpiZmWldW6" title="Preferred stock, par value">0.0001</span> par value per share.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 4, 2022, the Company issued <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20220303__20220304__srt--TitleOfIndividualAxis__custom--CanadianInvestorMember_ziXfHkdMm6S8" title="Number of restricted stock issued">625,000</span> shares of restricted common stock to a Canadian investor for $<span id="xdx_90F_eus-gaap--SharesIssuedPricePerShare_iI_c20220304__srt--TitleOfIndividualAxis__custom--CanadianInvestorMember_zkjgMBDqBu16" title="Share issued price per share">0.40</span> per share for a total purchase price of $<span id="xdx_901_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_c20220303__20220304__srt--TitleOfIndividualAxis__custom--CanadianInvestorMember_z9w38OEZ920j" title="Value of restricted stock issued">250,000</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of May 31, 2022, and November 30, 2021, respectively, there were <span id="xdx_90F_eus-gaap--CommonStockSharesIssued_iI_c20220531_zyZsiT4qhze6" title="Common stock, shares issued"><span id="xdx_90A_eus-gaap--CommonStockSharesOutstanding_iI_c20220531_zUuniDkJpKb1" title="Common stock, shares outstanding">45,625,000</span></span> and <span id="xdx_902_eus-gaap--CommonStockSharesIssued_iI_c20211130_zkuzOfThRtg7" title="Common stock, shares issued"><span id="xdx_904_eus-gaap--CommonStockSharesOutstanding_iI_c20211130_zlwYIvDSraed" title="Common stock, shares outstanding">45,000,000</span></span> shares of common stock issued and outstanding, respectively, and <span id="xdx_90C_eus-gaap--PreferredStockSharesIssued_iI_c20220531_zeh5JkTbpFpk" title="Preferred stock, shares issued"><span id="xdx_90E_eus-gaap--PreferredStockSharesOutstanding_iI_c20220531_zIuGxhMwT5Ue" title="Preferred stock, shares outstanding">900,000</span></span> and <span id="xdx_904_eus-gaap--PreferredStockSharesIssued_iI_c20211130_zqBKFiHSiLmg" title="Preferred stock, shares issued"><span id="xdx_90A_eus-gaap--PreferredStockSharesOutstanding_iI_c20211130_zRIzDrpiWcg9" title="Preferred stock, shares outstanding">1</span></span> shares of preferred stock issued and outstanding, respectively.</span></p> <p id="xdx_859_zFjhCVKPwZd4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--ConsolidationPolicyTextBlock_z1DFGGRKHmY1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_869_zyKjlqnCjwK7">Principles of Consolidation</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All inter-company accounts and transactions have been eliminated in consolidation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_ztNlwAj65nu" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86B_zPsK4aHPWje3">Basis of Presentation</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying financial statements have been prepared in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standard Codification (the “ASC”) which is the source of authoritative accounting principles recognized by the FASB to be applied by nongovernmental entities in the preparation of financial statements in conformity with GAAP.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84A_ecustom--GoingConcernPolicyTextBlock_zyCKhak0qfE2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_868_zDktsR11IeLb">Going Concern</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying unaudited consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business for the twelve-month period following the date of these financial statements. The Company has incurred significant operating losses since inception. As of May 31, 2022, the Company had an accumulated deficit of $<span id="xdx_907_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_di_c20220531_zT0jO3vlTIg5" title="Accumulated deficit">9,568,948</span> and stockholders’ deficit of $<span id="xdx_908_eus-gaap--StockholdersEquity_iNI_pp0p0_di_c20220531_zLOVUWbnO6jj" title="Stockholders equity deficit">5,173,145</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because the Company does not expect that existing operational cash flow will be sufficient to fund presently anticipated operations, this raises substantial doubt about the Company’s ability to continue as a going concern. Therefore, the Company will need to raise additional funds and is currently exploring alternative sources of financing. Historically, the Company has raised capital through private placements, as an interim measure to finance working capital needs and may continue to raise additional capital through the sale of common stock or other securities and obtaining some short-term loans. The Company will be required to continue to so until its operations become profitable. Also, the Company has, in the past, paid for consulting services with its common stock to maximize working capital, and intends to continue this practice where feasible.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> -9568948 -5173145 <p id="xdx_847_eus-gaap--UseOfEstimates_znegSkgT1zdd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_869_zSETYXLY9ZC3">Use of Estimates</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The most significant estimates relate to income taxes and contingencies. The Company bases its estimates on historical experience, known or expected trends and various other assumptions that are believed to be reasonable given the quality of information available as of the date of these financial statements. The results of these assumptions provide the basis for making estimates about the carrying amounts of assets and liabilities that are not readily apparent from other sources. Actual results could differ from these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zVuWVqXttF1l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_862_zu1E6vusLKEc">Accounts Receivable</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts receivable are recorded at fair value on the date revenue is recognized. The Company provides allowances for doubtful accounts for estimated losses resulting from the inability of its customers to repay their obligation. If the financial condition of the Company’s customers were to deteriorate, resulting in an impairment of their ability to repay, additional allowances may be required. The Company provides for potential uncollectible accounts receivable based on specific customer identification and historical collection experience adjusted for existing market conditions. If market conditions decline, actual collection experience may not meet expectations and may result in decreased cash flows and increased bad debt expense.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The policy for determining past due status is based on the contractual payment terms of each customer, which are generally net 30 or net 60 days. Once collection efforts by the Company and its collection agency are exhausted, the determination for charging off uncollectible receivables is made.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84A_eus-gaap--InventoryPolicyTextBlock_zJw70C1X3Itf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_866_zNKaOTUompm1">Inventory</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories are stated at the lower of cost or net realizable value. Cost is determined by the first-in, first-out basis and net realizable value. Net realizable value is defined as sales price less cost of completion, disposition and transportation and a normal profit margin. As of May 31, 2022 and November 30, 2021, inventory amounted to $<span id="xdx_906_eus-gaap--InventoryNet_iI_c20220531_zY4VxH1THaW" title="Inventory">12,893</span> and $<span id="xdx_90C_eus-gaap--InventoryNet_iI_dxL_c20211130_zk788OgfwTkk" title="Inventory::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl0501">0</span></span>, respectively, which consisted of finished goods.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 12893 <p id="xdx_846_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zguTXek6EhW3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_866_z4BJlRfugOj2">Revenue Recognition</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 1, 2018, the Company adopted ASC Topic 606, Revenue from Contracts with Customers (“ASC 606”). Results for reporting periods beginning after January 1, 2018, are presented under ASC 606.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 29, 2021, the Sellers agreed to (i) pay to the Company, on the closing date of the Acquisition, $<span id="xdx_90F_eus-gaap--CashAcquiredFromAcquisition_pp0p0_c20210628__20210629__us-gaap--BusinessAcquisitionAxis__custom--HyFiTokensMember_z5ZxXWQw17Tk" title="Proceeds from acquisition">300,000</span> (the “Cash Consideration”), and (ii) transfer to the Company, on the closing date of the Acquisition, <span id="xdx_902_ecustom--NFTsReceivedFromAcquisition_pid_uInteger_c20210628__20210629__us-gaap--BusinessAcquisitionAxis__custom--HyFiTokensMember_zGBoKXeV4ck6" title="NFTs received from acquisition">400,000,000</span> HyFi Tokens (the “HyFi Token Consideration”). The Company used the Cash Consideration to bring the Company into a fully reporting status with the SEC and for public company operating expenses.</span></p> 300000 400000000 <p id="xdx_848_eus-gaap--ConcentrationRiskCreditRisk_zddIM95jSSBd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_867_z9FObhhxL4Qa">Concentration</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Two customers, including one related party, account for <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220301__20220531__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--TwoCustomerMember_zDE9h9u3b66d" title="Concentration risk, percentage">100%</span> of sales during the three months ended May 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Five customers, including two related parties, account for <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20211201__20220531__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--FiveCustomerMember_zXl7yqv3KZca" title="Concentration risk, percentage">100%</span> of sales during the six months ended May 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 1 1 <p id="xdx_849_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zF08hz9ojV5g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86E_zYZg6nKRwami">Cash and cash equivalents</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company considers all highly liquid temporary cash investments with an original maturity of three months or less to be cash equivalents. On May 31, 2022, and November 30, 2021, the Company’s cash equivalents totaled $<span id="xdx_906_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pp0p0_c20220531_zBVPTYYlqHo" title="Cash equivalents">522,356</span> and $<span id="xdx_909_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pp0p0_c20211130_zBekHTV9Na8h" title="Cash equivalents">95,973</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 522356 95973 <p id="xdx_843_eus-gaap--IncomeTaxPolicyTextBlock_z1KodCdYKc3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86D_zvZwzIJHTRec">Income taxes</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for income taxes under FASB ASC 740, “Accounting for Income Taxes”. Under FASB ASC 740, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Under FASB ASC 740, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. FASB ASC 740-10-05, “Accounting for Uncertainty in Income Taxes,” prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The amount recognized is measured as the largest amount of benefit that is greater than 50% likely of being realized upon ultimate settlement. The Company assesses the validity of its conclusions regarding uncertain tax positions quarterly to determine if facts or circumstances have arisen that might cause it to change its judgment regarding the likelihood of a tax position’s sustainability under audit.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84A_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zppL9E6TTOHk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_866_zeGUpn3odrcf">Stock-based Compensation</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for stock-based compensation using the fair value method following the guidance outlined in Section 718-10 of the ASC for disclosure about stock-based compensation. This section requires a public entity to measure the cost of employee services received in exchange for an award of equity instruments based on the grant-date fair value of the award (with limited exceptions). That cost will be recognized over the period during which an employee is required to provide service in exchange for the award- the requisite service period (usually the vesting period). No compensation cost is recognized for equity instruments for which employees do not render the requisite service.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eus-gaap--EarningsPerSharePolicyTextBlock_z0qO7TIWmM0d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_860_zQRqgG7OMGo6">Net Loss per Share</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net loss per common share is computed by dividing net loss by the weighted average common shares outstanding during the period as defined by ASC Topic 260, “Earnings per Share.” Basic earnings per common share calculations are determined by dividing net income by the weighted average number of shares of common stock outstanding during the year. Diluted earnings per common share calculations are determined by dividing net income by the weighted average number of common shares and dilutive common share equivalents outstanding.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zVI9Cip0Yh03" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_868_zpKvrwHKjJff">Recent Accounting Pronouncements</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In February 2016, the FASB issued Accounting Standards Update (“ASU”) No. 2016-02, Leases (Topic 842), which establishes a new lease accounting model for lessees. The updated guidance requires an entity to recognize assets and liabilities arising from financing and operating leases, along with additional qualitative and quantitative disclosures. The amended guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018, with early adoption permitted. In March 2019, the FASB issued ASU 2019-01, Codification Improvements, which clarifies certain aspects of the new lease standard. The FASB issued ASU 2018-10, Codification Improvements to Topic 842, Leases in July 2018. Also in 2018, the FASB issued ASU 2018-11, Leases (Topic 842) Targeted Improvements, which provides an optional transition method whereby the new lease standard is applied at the adoption date and recognized as an adjustment to retained earnings. The amendments have the same effective date and transition requirements as the new lease standard.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We adopted ASC 842 on July 1, 2021. The adoption of ASC 842 did not have any impact on our financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_eus-gaap--StockholdersEquityPolicyTextBlock_z4hXiSP6V3Bk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_863_zt1zGDUL83f5">Stockholders’ Equity</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 28, 2021, the Company amended and restated its articles of incorporation, as amended, in order to, among other things, (i) increase the number of authorized shares of common stock from <span id="xdx_90B_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20210728_zbvc5Z64kzNb" title="Common stock, shares authorized">100,000,000</span> to <span id="xdx_90F_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20220531_ztLiQ4QD3V8j" title="Common stock, shares authorized">500,000,000</span>, (ii) increase the number of authorized shares of preferred stock from <span id="xdx_90F_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20210728_z6tHhp7V9OGh" title="Preferred stock, shares authorized">10,000</span> to <span id="xdx_90E_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20211130_zFhtEdCaBOB7" title="Preferred stock, shares authorized">5,000,000</span>, and (iii) change the par value of the preferred stock from $<span id="xdx_906_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20210728_zmuxqcmuIoM5" title="Preferred stock, par value">1.00</span> par value per share to $<span id="xdx_90A_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20211130_zW3ar43Op6ia" title="Preferred stock, par value">0.0001</span> par value per share. As of November 30, 2021, the Company had authorized <span id="xdx_90C_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20211130_zT8XSZfrIeo9" title="Common stock, shares authorized">500,000,000</span> shares of common stock, $<span id="xdx_901_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20211130_zsHvEKXWNNkg" title="Common stock, par value">0.0001</span> par value per share, and <span id="xdx_907_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20211130_zaCK8zsjMMmi" title="Preferred stock, shares authorized">5,000,000</span> shares of preferred stock, $<span id="xdx_900_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20211130_zfHpiZmWldW6" title="Preferred stock, par value">0.0001</span> par value per share.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 4, 2022, the Company issued <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20220303__20220304__srt--TitleOfIndividualAxis__custom--CanadianInvestorMember_ziXfHkdMm6S8" title="Number of restricted stock issued">625,000</span> shares of restricted common stock to a Canadian investor for $<span id="xdx_90F_eus-gaap--SharesIssuedPricePerShare_iI_c20220304__srt--TitleOfIndividualAxis__custom--CanadianInvestorMember_zkjgMBDqBu16" title="Share issued price per share">0.40</span> per share for a total purchase price of $<span id="xdx_901_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_c20220303__20220304__srt--TitleOfIndividualAxis__custom--CanadianInvestorMember_z9w38OEZ920j" title="Value of restricted stock issued">250,000</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of May 31, 2022, and November 30, 2021, respectively, there were <span id="xdx_90F_eus-gaap--CommonStockSharesIssued_iI_c20220531_zyZsiT4qhze6" title="Common stock, shares issued"><span id="xdx_90A_eus-gaap--CommonStockSharesOutstanding_iI_c20220531_zUuniDkJpKb1" title="Common stock, shares outstanding">45,625,000</span></span> and <span id="xdx_902_eus-gaap--CommonStockSharesIssued_iI_c20211130_zkuzOfThRtg7" title="Common stock, shares issued"><span id="xdx_904_eus-gaap--CommonStockSharesOutstanding_iI_c20211130_zlwYIvDSraed" title="Common stock, shares outstanding">45,000,000</span></span> shares of common stock issued and outstanding, respectively, and <span id="xdx_90C_eus-gaap--PreferredStockSharesIssued_iI_c20220531_zeh5JkTbpFpk" title="Preferred stock, shares issued"><span id="xdx_90E_eus-gaap--PreferredStockSharesOutstanding_iI_c20220531_zIuGxhMwT5Ue" title="Preferred stock, shares outstanding">900,000</span></span> and <span id="xdx_904_eus-gaap--PreferredStockSharesIssued_iI_c20211130_zqBKFiHSiLmg" title="Preferred stock, shares issued"><span id="xdx_90A_eus-gaap--PreferredStockSharesOutstanding_iI_c20211130_zRIzDrpiWcg9" title="Preferred stock, shares outstanding">1</span></span> shares of preferred stock issued and outstanding, respectively.</span></p> 100000000 500000000 10000 5000000 1.00 0.0001 500000000 0.0001 5000000 0.0001 625000 0.40 250000 45625000 45625000 45000000 45000000 900000 900000 1 1 <p id="xdx_806_eus-gaap--DebtDisclosureTextBlock_zVdBIrutZCLe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note 3. <span id="xdx_826_zAa3MziIc8pe">Notes Payable and Convertible Debt</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_890_eus-gaap--ScheduleOfDebtTableTextBlock_zPamcn5eJhL3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes payable consists of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BD_zxnC1crP8KP4" style="display: none">Schedule of Notes Payable</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center; font-size: 11pt"> </td><td style="text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Balance</td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Interest Rate</td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Maturity</td><td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%; text-align: left">Demand loans</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--NotesPayable_iI_c20220531__us-gaap--DebtInstrumentAxis__custom--DemandLoansMember_zJFXw3OR2K47" style="width: 14%; text-align: right" title="Balance">551,167</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20220531__us-gaap--DebtInstrumentAxis__custom--DemandLoansMember__srt--RangeAxis__srt--MinimumMember_zVbUhui3OaLl" title="Interest rate">4%</span> to <span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20220531__srt--RangeAxis__srt--MaximumMember__us-gaap--DebtInstrumentAxis__custom--DemandLoansMember_zhJHJHW3Z7pa" title="Interest rate">8</span></span></td><td style="width: 1%; text-align: left"> %</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--DebtInstrumentMaturityDateDescription_c20211201__20220531__us-gaap--DebtInstrumentAxis__custom--DemandLoansMember_zoynp8MEL3Zi" title="Maturity date">Various</span>   </span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Reclassification of accrued compensation to notes payable</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--NotesPayable_iI_c20220531__us-gaap--DebtInstrumentAxis__custom--ReclassificationOfAccruedCompensationToNotesPayableMember_zhbr69YlIoXg" style="text-align: right" title="Balance">143,031</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20220531__us-gaap--DebtInstrumentAxis__custom--ReclassificationOfAccruedCompensationToNotesPayableMember_zDYcz7NYQ8R1" style="text-align: right" title="Interest rate">8</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--DebtInstrumentMaturityDateDescription_c20211201__20220531__us-gaap--DebtInstrumentAxis__custom--ReclassificationOfAccruedCompensationToNotesPayableMember_zW9bvJD0h6D" title="Maturity date">December 1, 2017</span>  </span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Balance –May 31, 2022 and November 30, 2021</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--NotesPayable_iI_c20220531_zSirvW6ui1G8" style="text-align: right" title="Balance">694,198</td><td style="text-align: left"> </td><td style="font-size: 11pt"> </td> <td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt; text-align: right"> </td><td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt"> </td> <td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt; text-align: right"> </td><td style="font-size: 11pt; text-align: left"> </td></tr> </table> <p id="xdx_8A7_zxT3Yu3uqwdf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of May 31, 2022 and November 30, 2021, all loans are past due and in default.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 27, 2016, the Company entered into demand loan agreements with a third-party investor totaling $<span id="xdx_90E_eus-gaap--NotesPayable_iI_pp0p0_c20160727__us-gaap--TypeOfArrangementAxis__custom--DemandLoanAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThirdPartyInvestorMember_zsfzN3l1PeDb" title="Notes payable">193,667</span> at <span id="xdx_907_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20160727__us-gaap--TypeOfArrangementAxis__custom--DemandLoanAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThirdPartyInvestorMember_zX5HCXx6uFpb" title="Debt instrument, interest">4%</span> interest, payable upon demand.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Between October 28, 2011 and January 7, 2012, the Company issued a total of $<span id="xdx_90C_eus-gaap--NotesPayable_iI_pp0p0_c20120107__us-gaap--TypeOfArrangementAxis__custom--DemandLoanAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LenderMember_zaS4QDiyOJ9l" title="Notes payable">70,000</span> in notes payable, due <span id="xdx_909_eus-gaap--DebtInstrumentMaturityDate_c20111028__20120107__us-gaap--TypeOfArrangementAxis__custom--DemandLoanAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LenderMember_zYfgHiXOEEei" title="Debt maturity date">May 31, 2012</span>. Interest on the notes is payable at <span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20120107__us-gaap--TypeOfArrangementAxis__custom--DemandLoanAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LenderMember_zDFqurIPsez5" title="Debt instrument, interest rate, stated percentage">4%</span>. The lender may elect to convert the loan before maturity at a conversion price of $<span id="xdx_90D_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20120107__us-gaap--TypeOfArrangementAxis__custom--DemandLoanAgreementsMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LenderMember_zR4ZShwdYUZ9" title="Conversion price per share">0.25</span> per share. The loans are currently past due.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 3, 2013, the Company entered into convertible debt agreements with a third-party investor totaling $<span id="xdx_90F_eus-gaap--ConvertibleDebt_iI_pp0p0_c20131203__us-gaap--TypeOfArrangementAxis__custom--ConvertibleDebtAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThirdPartyInvestorMember_zrzjq5V34om7" title="Convertible debt">62,500</span> at <span id="xdx_900_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20131203__us-gaap--TypeOfArrangementAxis__custom--ConvertibleDebtAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThirdPartyInvestorMember_zXdnCuhi9zXk" title="Debt instrument, interest">8%</span> interest, payable upon demand. The debt is convertible into shares of common stock at a conversion price of $<span id="xdx_904_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20131203__us-gaap--TypeOfArrangementAxis__custom--ConvertibleDebtAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThirdPartyInvestorMember_z2t8VDG0Gh36" title="Conversion price per share">0.10</span> per share, for any amount up to <span id="xdx_901_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_uPure_c20131203__us-gaap--TypeOfArrangementAxis__custom--ConvertibleDebtAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThirdPartyInvestorMember_zbTyfU7jwg99" title="Debt instrument, original percentage">50%</span> of the original amount of the notes. As of May 31, 2022 and November 30, 2021, the note was in default.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 30, 2015, the Company entered into convertible debt agreements with a third-party investor totaling $<span id="xdx_902_eus-gaap--ConvertibleDebt_iI_pp0p0_c20150730__us-gaap--TypeOfArrangementAxis__custom--ConvertibleDebtAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThirdPartyInvestorMember_zboKPcX6YAB5" title="Debt instrument, interest">200,000</span> at <span id="xdx_902_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20150730__us-gaap--TypeOfArrangementAxis__custom--ConvertibleDebtAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThirdPartyInvestorMember_zBry5fiM1li" title="Debt instrument, interest">8%</span> interest, due on <span id="xdx_905_eus-gaap--DebtInstrumentMaturityDate_dd_c20150729__20150730__us-gaap--TypeOfArrangementAxis__custom--ConvertibleDebtAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThirdPartyInvestorMember_z1q7LzAGEFe1" title="Debt instrument, maturity date">December 31, 2015</span>. The debt is convertible into shares of common stock at a conversion price of $<span id="xdx_90F_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20150730__us-gaap--TypeOfArrangementAxis__custom--ConvertibleDebtAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThirdPartyInvestorMember_zsCl3lNZitbe" title="Conversion price per share">0.15</span> per share. As of May 31, 2022 and November 30, 2021, the note was in default.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 23, 2016, the Company entered into convertible debt agreements with a third-party investor totaling $<span id="xdx_903_eus-gaap--ConvertibleDebt_iI_pp0p0_c20160523__us-gaap--TypeOfArrangementAxis__custom--ConvertibleDebtAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThirdPartyInvestorMember_z1mcFIbr1zSl" title="Convertible debt">25,000</span> at <span id="xdx_904_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20160523__us-gaap--TypeOfArrangementAxis__custom--ConvertibleDebtAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThirdPartyInvestorMember_zn2hJ3MgVw1k" title="Debt instrument, interest">8%</span> interest, due on <span id="xdx_901_eus-gaap--DebtInstrumentMaturityDate_dd_c20160522__20160523__us-gaap--TypeOfArrangementAxis__custom--ConvertibleDebtAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThirdPartyInvestorMember_zZW507EwJHc" title="Debt Instrument, Maturity Date">May 23, 2018</span>. The debt is convertible into shares of common stock at a conversion price of $<span id="xdx_900_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20160523__us-gaap--TypeOfArrangementAxis__custom--ConvertibleDebtAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThirdPartyInvestorMember_zTLzBM3wiAWd" title="Conversion price per share">0.10</span> per share. As of May 31, 2022 and November 30, 2021, the note was in default.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 30, 2015, the Company entered into convertible debt agreements with a third-party investor totaling $<span id="xdx_900_eus-gaap--ConvertibleDebt_iI_pp0p0_c20150730__us-gaap--TypeOfArrangementAxis__custom--ConvertibleDebtAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThirdPartyInvestorOneMember_zB2cGWhHsiZ2" title="Convertible debt">15,000</span> at <span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20150730__us-gaap--TypeOfArrangementAxis__custom--ConvertibleDebtAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThirdPartyInvestorOneMember_z7z19oUYkKJd" title="Debt instrument, interest">8%</span> interest, due on <span id="xdx_90F_eus-gaap--DebtInstrumentMaturityDate_dd_c20150729__20150730__us-gaap--TypeOfArrangementAxis__custom--ConvertibleDebtAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThirdPartyInvestorOneMember_zEoCo6Cavna2" title="Debt Instrument, Maturity Date">May 23, 2018</span>. The debt is convertible into shares of common stock at a conversion price of $<span id="xdx_90D_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20150730__us-gaap--TypeOfArrangementAxis__custom--ConvertibleDebtAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThirdPartyInvestorOneMember_zF0MfdNZ38r5" title="Conversion price per share">0.15</span> per share. As of May 31, 2022 and November 30, 2021, the note was in default.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 30, 2015, the Company entered into convertible debt agreements with a third-party investor totaling $<span id="xdx_907_eus-gaap--ConvertibleDebt_iI_pp0p0_c20150730__us-gaap--TypeOfArrangementAxis__custom--ConvertibleDebtAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThirdPartyInvestorTwoMember_zBFIBETXNzrc" title="Convertible debt">15,000</span> at <span id="xdx_90F_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20150730__us-gaap--TypeOfArrangementAxis__custom--ConvertibleDebtAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThirdPartyInvestorTwoMember_zdK3dlHFvFii" title="Debt instrument, interest">8%</span> interest, due on <span id="xdx_908_eus-gaap--DebtInstrumentMaturityDate_dd_c20150729__20150730__us-gaap--TypeOfArrangementAxis__custom--ConvertibleDebtAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThirdPartyInvestorTwoMember_zfIceQudMPk" title="Debt Instrument, Maturity Date">May 23, 2018</span>. The debt is convertible into shares of common stock at a conversion price of $<span id="xdx_902_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20150730__us-gaap--TypeOfArrangementAxis__custom--ConvertibleDebtAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThirdPartyInvestorTwoMember_zZBi6ShztpAb" title="Conversion price per share">0.15</span> per share. As of May 31, 2022 and November 30, 2021, the note was in default.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Between December 3, 2014 and July 28, 2015, the Company issued a total of $<span id="xdx_905_eus-gaap--NotesPayable_iI_pp0p0_c20150728_zQkJZUa9GPw2" title="Notes Payable">113,031</span> in notes payable. Interest on the notes is payable at <span id="xdx_907_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20150728_zCCPdX0wv5Ac" title="Debt instrument, interest">8%</span>. The loans were due prior to <span id="xdx_902_eus-gaap--DebtInstrumentMaturityDate_c20141203__20150728_zwQhkgvHoP6a" title="Debt instrument maturity date">December 31, 2015</span> and are past due.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued interest on notes payable and convertible debt at May 31, 2022 and November 30, 2021 amounted to $<span id="xdx_90B_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20220531_zK1mLW0AFrkb" title="Accrued interest">297,565</span> and $<span id="xdx_90A_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20211130_zGH92lLJ6ROf" title="Accrued interest">275,071</span>, respectively, which is included as a component of accounts payable and accrued expenses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest expense on notes payable and convertible debt with third parties amounted to $<span id="xdx_90C_eus-gaap--InterestExpenseDebt_pp0p0_c20220301__20220531__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThirdPartiesMember_zDtY4a1y0fAk" title="Interest expense">11,247</span> and $<span id="xdx_901_eus-gaap--InterestExpenseDebt_pp0p0_c20210301__20210531__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThirdPartiesMember_zTI6ZJElLXc5" title="Interest expense">11,247</span> for the three months ended May 31, 2022 and May 31, 2021 respectively. Interest expense on notes payable and convertible debt with third parties amounted to $<span id="xdx_903_eus-gaap--InterestExpenseDebt_pp0p0_c20211201__20220531__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThirdPartiesMember_zxCeaHl48iY6" title="Interest expense">22,494</span> and $<span id="xdx_90A_eus-gaap--InterestExpenseDebt_pp0p0_c20201201__20210531__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThirdPartiesMember_zmnEduQNoYBh" title="Interest expense">22,494</span> for the six months ended May 31, 2022 and May 31, 2021 respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_890_eus-gaap--ScheduleOfDebtTableTextBlock_zPamcn5eJhL3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes payable consists of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BD_zxnC1crP8KP4" style="display: none">Schedule of Notes Payable</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center; font-size: 11pt"> </td><td style="text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Balance</td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Interest Rate</td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Maturity</td><td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%; text-align: left">Demand loans</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--NotesPayable_iI_c20220531__us-gaap--DebtInstrumentAxis__custom--DemandLoansMember_zJFXw3OR2K47" style="width: 14%; text-align: right" title="Balance">551,167</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20220531__us-gaap--DebtInstrumentAxis__custom--DemandLoansMember__srt--RangeAxis__srt--MinimumMember_zVbUhui3OaLl" title="Interest rate">4%</span> to <span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20220531__srt--RangeAxis__srt--MaximumMember__us-gaap--DebtInstrumentAxis__custom--DemandLoansMember_zhJHJHW3Z7pa" title="Interest rate">8</span></span></td><td style="width: 1%; text-align: left"> %</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--DebtInstrumentMaturityDateDescription_c20211201__20220531__us-gaap--DebtInstrumentAxis__custom--DemandLoansMember_zoynp8MEL3Zi" title="Maturity date">Various</span>   </span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Reclassification of accrued compensation to notes payable</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--NotesPayable_iI_c20220531__us-gaap--DebtInstrumentAxis__custom--ReclassificationOfAccruedCompensationToNotesPayableMember_zhbr69YlIoXg" style="text-align: right" title="Balance">143,031</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20220531__us-gaap--DebtInstrumentAxis__custom--ReclassificationOfAccruedCompensationToNotesPayableMember_zDYcz7NYQ8R1" style="text-align: right" title="Interest rate">8</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--DebtInstrumentMaturityDateDescription_c20211201__20220531__us-gaap--DebtInstrumentAxis__custom--ReclassificationOfAccruedCompensationToNotesPayableMember_zW9bvJD0h6D" title="Maturity date">December 1, 2017</span>  </span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Balance –May 31, 2022 and November 30, 2021</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--NotesPayable_iI_c20220531_zSirvW6ui1G8" style="text-align: right" title="Balance">694,198</td><td style="text-align: left"> </td><td style="font-size: 11pt"> </td> <td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt; text-align: right"> </td><td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt"> </td> <td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt; text-align: right"> </td><td style="font-size: 11pt; text-align: left"> </td></tr> </table> 551167 0.04 0.08 Various 143031 0.08 December 1, 2017 694198 193667 0.04 70000 2012-05-31 0.04 0.25 62500 0.08 0.10 0.50 200000 0.08 2015-12-31 0.15 25000 0.08 2018-05-23 0.10 15000 0.08 2018-05-23 0.15 15000 0.08 2018-05-23 0.15 113031 0.08 2015-12-31 297565 275071 11247 11247 22494 22494 <p id="xdx_80B_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_z0w5b7cJqyg7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note 4. <span id="xdx_825_zFAVENYYFR39">Related Party Transactions</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 27, 2016, the former Chief Executive Officer, now our Chief Financial Officer, agreed to reduce his accrued compensation by $<span id="xdx_903_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20160526__20160527__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zUOsTMQl5wq6" title="Accrued compensation">206,250</span> as a contribution to additional paid in capital. He also agreed to reclassify $<span id="xdx_906_ecustom--IncreaseDecreaseInLongTermDebt_c20160526__20160527__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zynb35bXNNuk" title="Reduction in long term debt">874,000</span> in accrued compensation to long term debt upon the issuance of a non-convertible <span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20160527__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zHLlDl2ApZq2" title="Debt instrument bearing interest">4%</span> interest bearing note with a maturity date of <span id="xdx_904_eus-gaap--DebtInstrumentMaturityDate_c20160526__20160527__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zA9vBTNxpaGd" title="Debt instrument maturity date">December 1, 2017</span>. <span id="xdx_90A_eus-gaap--DebtInstrumentDescription_c20160526__20160527__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zSMyHusmBpQj" title="Debt instrument, description">The compensation included was accrued during the period from January 2, 2011 to February 29, 2016. This compensation will be paid as bonuses out of future income only and is further subject to a cap of 20% of operating net cash flow in any given period. If bonuses are paid, accrued compensation will be paid with an amount decided by the Board</span>. On June 1, 2016, he agreed to reduce his accrued compensation by $<span id="xdx_90C_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20160601__20160602__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zTU7yjUpFGM" title="Accrued compensation">25,000</span> as a contribution to additional paid in capital. He also agreed to reduce his long term note by $<span id="xdx_905_ecustom--IncreaseDecreaseInLongTermDebt_c20160601__20160602__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zs0lBaMYaha4" title="Reduction in long term debt">214,000</span> as a contribution to additional paid in capital. As the Company was not funded prior to December 1, 2016, the Board of Directors reversed the contribution of accrued salaries. As of May 31, 2022 and November 30, 2021, the Chief Financial Officer was owed $<span id="xdx_902_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20211201__20220531__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember_zGD0bHc6LXz3" title="Accrued compensation">445,250</span> and $<span id="xdx_90C_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20201201__20211130__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember_zx9fEnVkq3Ci" title="Accrued compensation">445,250</span>, respectively, of accrued compensation and accrued salary was reduced by $<span id="xdx_906_eus-gaap--IncreaseDecreaseInAccruedSalaries_pp2p0_c20211201__20220531__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember_zsKQ337JtySj" title="Decrease in accrued salaries">15,722.47</span>. As of May 31, 2022 and November 30, 2020, the Chief Financial Officer was owed $<span id="xdx_90E_eus-gaap--NotesPayableRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20220531__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember_zlFKKfcDpnA6" title="Notes payable to related parties">805,637</span> and $<span id="xdx_90D_eus-gaap--NotesPayableRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20201130__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember_ziGwavmmSTf7" title="Notes payable to related parties">805,637</span>, respectively, of notes payable and accrued interest.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 27, 2016, the Director of Strategy agreed to reduce her accrued compensation by $<span id="xdx_902_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20160526__20160527__srt--TitleOfIndividualAxis__custom--DirectorOfBusinessStrategyMember_zLRj7WetFnX5" title="Accrued compensation">206,250</span> as a contribution to additional paid in capital. She also agreed to reclassify $<span id="xdx_905_ecustom--IncreaseDecreaseInLongTermDebt_c20160526__20160527__srt--TitleOfIndividualAxis__custom--DirectorOfBusinessStrategyMember_zSGSi3jfl9R8" title="Reduction in long term debt">660,000</span> in accrued compensation to long term debt upon the issuance of a non-convertible <span id="xdx_905_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20160527__srt--TitleOfIndividualAxis__custom--DirectorOfBusinessStrategyMember_zKIA3W8sSalf" title="Debt instrument, interest">4%</span> interest bearing note with a maturity date of <span id="xdx_901_eus-gaap--DebtInstrumentMaturityDate_c20160526__20160527__srt--TitleOfIndividualAxis__custom--DirectorOfBusinessStrategyMember_zAWlc6kftSQ6" title="Debt instrument maturity date">December 1, 2017</span>. The total principal amount of $<span id="xdx_906_eus-gaap--DebtInstrumentFaceAmount_iI_c20160527__srt--TitleOfIndividualAxis__custom--DirectorOfBusinessStrategyMember_zSgVBman1f2d" title="Debt instrument, face amount">710,000</span> included three different notes totaling $<span id="xdx_909_eus-gaap--DebtInstrumentFaceAmount_iI_c20160527__srt--TitleOfIndividualAxis__custom--DirectorOfBusinessStrategyMember__us-gaap--DebtInstrumentAxis__custom--ThreeNotesMember_z9nrUkibiOj4" title="Debt instrument, face amount">50,000</span>@ <span id="xdx_905_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_c20160527__srt--TitleOfIndividualAxis__custom--DirectorOfBusinessStrategyMember__us-gaap--DebtInstrumentAxis__custom--ThreeNotesMember_zOitiFWTWTVd" title="Debt instrument, interest rate, effective percentage">8%</span> interest. <span id="xdx_90A_eus-gaap--DebtInstrumentDescription_c20160526__20160527__srt--TitleOfIndividualAxis__custom--DirectorOfBusinessStrategyMember_zzyFieRgcQoe" title="Debt instrument, description">The compensation included was accrued during the period from January 2, 2011 to February 29, 2016. This compensation will be paid as bonuses out of future income only and is further subject to a cap of 20% of operating net cash flow in any given period. If bonuses are paid, accrued compensation will be paid with an amount decided by the Board</span>. On June 1, 2016, she agreed to reduce her accrued compensation by $<span id="xdx_901_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20160601__20160602__srt--TitleOfIndividualAxis__custom--DirectorOfBusinessStrategyMember_zjk1jl4Qo1L6" title="Accrued compensation">225,000</span> as a contribution to additional paid in capital. She also agreed to reduce her long term note by $<span id="xdx_909_ecustom--IncreaseDecreaseInLongTermDebt_c20160601__20160602__srt--TitleOfIndividualAxis__custom--DirectorOfBusinessStrategyMember_zlBhgbAbB5Y5" title="Increase decrease in long term debt">9,583</span> as a contribution to additional paid in capital. As the Company was not funded prior to December 1, 2016, the Board of Directors reversed the contribution of accrued salaries. As of May 31, 2022 and November 30, 2021, the Director was owed a total of $<span id="xdx_905_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20211201__20220531__srt--TitleOfIndividualAxis__custom--DirectorOfBusinessStrategyMember_z21qPJm9TDz1" title="Accrued compensation">440,833</span> and $<span id="xdx_903_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20201201__20211130__srt--TitleOfIndividualAxis__custom--DirectorOfBusinessStrategyMember_zSWazfFc6KCa" title="Accrued compensation">440,833</span>, respectively, of accrued compensation. As of May 31, 2022 and November 30, 2021, the Director was owed a total of $<span id="xdx_906_eus-gaap--NotesPayableRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20220531__srt--TitleOfIndividualAxis__custom--DirectorOfBusinessStrategyMember_zvuUXCzUYo42" title="Notes payable, related parties">883,791</span> and $<span id="xdx_904_eus-gaap--NotesPayableRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20211130__srt--TitleOfIndividualAxis__custom--DirectorOfBusinessStrategyMember_zUyRDzmLyG7c" title="Notes payable, related parties">883,791</span>, respectively, of notes payable and accrued interest. There was a reduction in the liability by share issuance of $<span id="xdx_904_ecustom--ReductionInLiabilityShareIssurance_c20211201__20220531__srt--TitleOfIndividualAxis__custom--DirectorOfBusinessStrategyMember_zobBw5WzN7Ng" title="Reduction in liability insurance">27,308</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of November 30, 2016, a related party investor advanced a total of $<span id="xdx_907_eus-gaap--NotesPayableRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20161130__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_z9oNw0VutGVl" title="Notes payable to related parties">99,448</span> due on or before <span id="xdx_906_eus-gaap--DebtInstrumentMaturityDate_c20161129__20161130__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_z5LHNguaabkh" title="Debt instrument maturity date">June 15, 2016</span>. Pursuant to the agreement, the investor is allowed to convert <span id="xdx_905_eus-gaap--DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_pid_dp_uPure_c20161129__20161130__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_z5XqheyRgQV6" title="Debt instrument, conversion percentage">100%</span> of the debt at a share price of $<span id="xdx_909_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_dp_c20161130__srt--TitleOfIndividualAxis__us-gaap--InvestorMember_za2u4cH0UZA6" title="Debt instrument, convertible, conversion price">0.15</span>. As of May 31, 2022 and November 30, 2021, the note was in default.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In March 2016, the Chief Operating Officer loaned to the Company $<span id="xdx_908_eus-gaap--LoansPayable_iI_pp0p0_c20160331__srt--TitleOfIndividualAxis__srt--ChiefOperatingOfficerMember_zUwHTp3C1b1" title="Loan amount">100,000</span>. The loan bears interest at <span id="xdx_90F_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20160331__srt--TitleOfIndividualAxis__srt--ChiefOperatingOfficerMember_zVc59Qrwz615" title="Debt instrument bearing interest">8%</span> and is due on or before <span id="xdx_90A_eus-gaap--DebtInstrumentMaturityDate_dd_c20160301__20160331__srt--TitleOfIndividualAxis__srt--ChiefOperatingOfficerMember_zBSqWZGxpyOb" title="Debt Instrument, Maturity Date">March 2, 2018</span>. Pursuant to the agreement, the investor is allowed to convert <span id="xdx_902_eus-gaap--DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_pid_dp_uPure_c20160301__20160331__srt--TitleOfIndividualAxis__srt--ChiefOperatingOfficerMember_z5rHs18zdSIk" title="Debt instrument, conversion percentage">100%</span> of the debt on the maturity date at a share price of $<span id="xdx_901_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20160331__srt--TitleOfIndividualAxis__srt--ChiefOperatingOfficerMember_zQVVAe9qNYC1" title="Debt instrument, price per share">0.15</span>. The Company accounted for the conversion of loan in accordance with ASC 470, “Debt with Conversion and Other Options”. The fair market value of the shares on March 2, 2016 was $<span id="xdx_901_eus-gaap--SharePrice_iI_pid_c20160302__srt--TitleOfIndividualAxis__srt--ChiefOperatingOfficerMember_zvDBmLiyn3c2" title="Share price">0.10</span> per share and, accordingly, there was deemed to be no Beneficial Conversion Factor. On May 18, 2016, the Chief Operating Officer loaned the Company an additional $<span id="xdx_90D_eus-gaap--LoansPayable_iI_pp0p0_c20160518__srt--TitleOfIndividualAxis__srt--ChiefOperatingOfficerMember_z9S7y30O2NTj" title="Loans Payable">50,000</span> with conversion rights at $<span id="xdx_90C_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20160518__srt--TitleOfIndividualAxis__srt--ChiefOperatingOfficerMember_zJTirCELZ6D2">0.10</span> per share. Therefore, effective May 18, 2016, $<span id="xdx_904_eus-gaap--LoansPayable_iI_pp0p0_c20160518__srt--TitleOfIndividualAxis__srt--ChiefOperatingOfficerMember_zP2u8T0jkghl" title="Loan amount">50,000</span> of the Chief Operating Officer’s note payable had conversion rights of $<span id="xdx_90F_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20160518__srt--TitleOfIndividualAxis__srt--ChiefOperatingOfficerMember_zDdRR98Ex9x" title="Debt instrument, price per share">0.10</span> per share. The Company accounted for the conversion of loan in accordance with ASC 470, “Debt with Conversion and Other Options”. The fair market value of the shares on May 18, 2016 was $<span id="xdx_90E_eus-gaap--SharePrice_iI_pid_c20160518__srt--TitleOfIndividualAxis__srt--ChiefOperatingOfficerMember_zXQ8D5DqWXel" title="Share price">0.10</span> per share and accordingly there was deemed to be no Beneficial Conversion Factor. On May 23, 2016, a third-party investor loaned the Company $<span id="xdx_908_ecustom--ConvertibleNotesPayableToRelatedPartiesNonCurrent_iI_c20160523__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThirdPartyInvestorMember_zPk7wX48vrsc" title="Convertible notes payable to related parties">25,000</span> with conversion rights at $<span id="xdx_909_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20160523__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThirdPartyInvestorMember_zGku7UicTrS8">0.10</span> per share. Therefore, effective May 23, 2016, an additional $<span id="xdx_909_ecustom--ConvertibleNotesPayableToRelatedPartiesNonCurrent_iI_pp0p0_c20160523__srt--TitleOfIndividualAxis__srt--ChiefOperatingOfficerMember_zcpmtqWwKfqf" title="Convertible notes payable to related parties">25,000</span> of the Chief Operating Officer’s $<span id="xdx_90F_eus-gaap--LoansPayable_iI_pp0p0_c20160523__srt--TitleOfIndividualAxis__srt--ChiefOperatingOfficerMember_zo7H1QtjiGQk" title="Loan amount">100,000</span> note payable had conversion rights of $<span id="xdx_905_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20160523__srt--TitleOfIndividualAxis__srt--ChiefOperatingOfficerMember_zHiZ5nYpg7mb" title="Debt instrument, price per share">0.10</span> per share. The Company accounted for the conversion of loan in accordance with ASC 470, “Debt with Conversion and Other Options”. The fair market value of the shares on May 18, 2016 was $<span id="xdx_90E_eus-gaap--SharePrice_iI_c20160518__srt--TitleOfIndividualAxis__srt--ChiefOperatingOfficerMember_z4cKurHG2Fqa" title="Share price">0.10</span> per share and accordingly, was deemed to have no Beneficial Conversion Factor. As of May 31, 2022 and November 30, 2021, the note was in default.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In May 2016, the Chief Operating Officer made a loan of $<span id="xdx_90C_eus-gaap--LoansPayable_iI_pp0p0_c20160531__srt--TitleOfIndividualAxis__srt--ChiefOperatingOfficerMember_zmapirkDOXwb" title="Loans Payable">50,000</span>, bearing interest at <span id="xdx_90A_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20160531__srt--TitleOfIndividualAxis__srt--ChiefOperatingOfficerMember_zTon2g4vr4Q8" title="Debt instrument, interest rate, stated percentage">8%</span> and due on or before <span id="xdx_903_eus-gaap--DebtInstrumentMaturityDate_c20160501__20160531__srt--TitleOfIndividualAxis__srt--ChiefOperatingOfficerMember_zofoAKBCc8j8" title="Debt Instrument, Maturity Date">May 18, 2018</span>. The debt is convertible into shares of common stock at a conversion price of $<span id="xdx_900_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20160531__srt--TitleOfIndividualAxis__srt--ChiefOperatingOfficerMember_znjSOlqpo7wj">0.10</span> per share. As of May 31, 2022 and November 30, 2021, the note was in default.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In July 2016, the Chief Operating Officer made a loan of $<span id="xdx_902_eus-gaap--LoansPayable_iI_pp0p0_c20160731__srt--TitleOfIndividualAxis__srt--ChiefOperatingOfficerMember_zcAuunS6SHZ7">50,000</span> as collateral, bearing interest at <span id="xdx_903_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20160731__srt--TitleOfIndividualAxis__srt--ChiefOperatingOfficerMember_z21m9hIF3xY2" title="Debt instrument, interest rate, stated percentage">8%</span> and due on or before <span id="xdx_908_eus-gaap--DebtInstrumentMaturityDate_dd_c20160701__20160731__srt--TitleOfIndividualAxis__srt--ChiefOperatingOfficerMember_zZhvgHLS0m1a" title="Debt instrument, maturity date">July 31, 2018</span>. The debt is convertible into shares of common stock at a conversion price of $<span id="xdx_90E_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20160731__srt--TitleOfIndividualAxis__srt--ChiefOperatingOfficerMember_zIeMKxWLLCm4" title="Debt instrument, convertible, conversion price">0.10</span> per share. As of May 31, 2022 and November 30, 2021, the note was in default.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 29, 2021 the Company entered into an employment agreement with Robert Kohn. The Company agreed to an annual salary of $<span id="xdx_900_eus-gaap--AccruedSalariesCurrentAndNoncurrent_iI_c20210629__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RobertKohnMember_zTKHnbxHehu3" title="Accrued salary">150,000</span> beginning on September 30, 2021. As of May 31, 2022 and November 30, 2021 the Company accrued $<span id="xdx_90F_eus-gaap--AccruedSalariesCurrentAndNoncurrent_iI_c20220531__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RobertKohnMember_zfelSnBgZU29" title="Accrued salary">100,000</span> and $<span id="xdx_90A_eus-gaap--AccruedSalariesCurrentAndNoncurrent_iI_c20211130__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RobertKohnMember_zAfs4OnzWSZi" title="Accrued salary">25,000</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended November 30, 2021 the Company issued <span id="xdx_901_ecustom--NumberOfTokensIssuedToPurchaseAssets_pid_uInteger_c20201201__20211130__us-gaap--FinancialInstrumentAxis__custom--HyFiTokensMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TechnologyMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RelatedPartiesMember_zwsHILIkkPul" title="Number of tokens issued to purchase assets">17,500,000</span> HyFi Tokens to related parties for the purchase of technology. The Technology has a historical value of $<span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentNet_iI_pid_c20211130__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TechnologyMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RelatedPartiesMember_z4oOZ7mfT9Aj" title="Value of purchased assets">0</span>. In addition, the Company issued Troy MacDonald <span id="xdx_90E_ecustom--NumberOfTokensIssuedToPurchaseAssets_pid_uInteger_c20201201__20211130__us-gaap--FinancialInstrumentAxis__custom--HyFiTokensMember__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TechnologyMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TroyMacDonaldMember_zM0C87Xq3REj" title="number of tokens issued to purchase assets">175,000</span> HyFi Tokens as consideration for his sale of HyFi tokens at <span id="xdx_907_eus-gaap--RelatedPartyTransactionRate_pid_dp_uPure_c20201201__20211130__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TechnologyMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RelatedPartiesMember_zPbDrQer3btl" title="Related party transaction, rate">5%</span> of the related token sales.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued interest on related party notes payable and convertible debt at May 31, 2022 and November 30, 2021, amounted to $<span id="xdx_905_eus-gaap--InterestPayableCurrent_iI_pp0p0_c20220531_zo1rHxpndieb" title="Accrued interest">526,534</span> and $<span id="xdx_907_eus-gaap--InterestPayableCurrent_iI_pp0p0_c20211130_z3FwOjI9qWM5" title="Accrued interest">484,156</span>, respectively, and is a component of accounts payable and accrued expenses – related parties.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest expense on notes payable and convertible debt with related parties amounted to $<span id="xdx_909_eus-gaap--InterestExpenseRelatedParty_pp0p0_c20220301__20220531__us-gaap--DebtInstrumentAxis__custom--NotesPayableAndConvertibleDebtMember_zgsWZKL8AfC1" title="Interest expense related party">21,189</span> and $<span id="xdx_900_eus-gaap--InterestExpenseRelatedParty_pp0p0_c20210301__20210531__us-gaap--DebtInstrumentAxis__custom--NotesPayableAndConvertibleDebtMember_ztqAwJaexf5e" title="Interest expense related party">21,189</span> for the three months ended May 31, 2022 and May 31, 2021, respectively. Interest expense on notes payable and convertible debt with related parties amounted to $<span id="xdx_908_eus-gaap--InterestExpenseRelatedParty_pp0p0_c20211201__20220531__us-gaap--DebtInstrumentAxis__custom--NotesPayableAndConvertibleDebtMember_zxQm72gdho4b" title="Interest expense related party">42,378</span> and $<span id="xdx_903_eus-gaap--InterestExpenseRelatedParty_pp0p0_c20201201__20210531__us-gaap--DebtInstrumentAxis__custom--NotesPayableAndConvertibleDebtMember_z7BwA9wjjEMk" title="Interest expense related party">42,378</span> for the six months ended May 31, 2022 and May 31, 2021, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has separated accounts payable and accrued expenses on the balance sheet to reflect amounts due to related parties primarily consisting of officer compensation, health insurance, interest on notes and reimbursable expenses to officers for travel, meals and entertainment, vehicle and other related business expenses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 206250 874000 0.04 2017-12-01 The compensation included was accrued during the period from January 2, 2011 to February 29, 2016. This compensation will be paid as bonuses out of future income only and is further subject to a cap of 20% of operating net cash flow in any given period. If bonuses are paid, accrued compensation will be paid with an amount decided by the Board 25000 214000 445250 445250 15722.47 805637 805637 206250 660000 0.04 2017-12-01 710000 50000 0.08 The compensation included was accrued during the period from January 2, 2011 to February 29, 2016. This compensation will be paid as bonuses out of future income only and is further subject to a cap of 20% of operating net cash flow in any given period. If bonuses are paid, accrued compensation will be paid with an amount decided by the Board 225000 9583 440833 440833 883791 883791 27308 99448 2016-06-15 1 0.0015 100000 0.08 2018-03-02 1 0.15 0.10 50000 0.10 50000 0.10 0.10 25000 0.10 25000 100000 0.10 0.10 50000 0.08 2018-05-18 0.10 50000 0.08 2018-07-31 0.10 150000 100000 25000 17500000 0 175000 0.05 526534 484156 21189 21189 42378 42378 <p id="xdx_807_ecustom--SeniorPromissoryNoteRelatedPartyDisclosureTextBlock_zQusU34PY4b2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note 5. <span id="xdx_82E_z5iGs3PzibEa">Senior Promissory Note – related party</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 29, 2021, the Closing Date, the Company and CEP entered into the Redemption Agreement, dated as of June 29, 2021, pursuant to which the Company redeemed the Series A Share. On the Closing Date, as provided in the Redemption Agreement, the Company issued to CEP the Note in the principal amount of $<span id="xdx_90A_eus-gaap--DebtInstrumentFaceAmount_iI_pdp0_c20210629__dei--LegalEntityAxis__custom--ChinaEnergyPartnersLLCMember__us-gaap--TypeOfArrangementAxis__custom--RedemptionAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zAk3mbl29961" title="Debt instrument, principal value">1,000,000</span> with an interest rate of <span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_uPure_c20210629__dei--LegalEntityAxis__custom--ChinaEnergyPartnersLLCMember__us-gaap--TypeOfArrangementAxis__custom--RedemptionAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_z4b53NVJtLUc" title="Debt instrument, interest rate">6</span>% per annum. The Series A Share will be held in escrow. If an Event of Default (as defined in the Note) occurs under the Note, then the Company will direct the escrow agent to release the Series A Share to CEP; provided, however, that CEP will also retain all rights and privileges under the Note (and the Company will remain bound to all obligations under Note) even if the Series A Share is required to be released by the escrow agent to CEP as provided in the Redemption Agreement. For the avoidance of doubt, CEP will regain all rights, title, and interest in and to the Series A Share upon the occurrence of an Event of Default under the Note, regardless of the amount of the outstanding balance owed under the Note at the time of the occurrence of an Event of Default under the Note. Accrued interest parties amounted to $<span id="xdx_909_eus-gaap--InterestPayableCurrent_iI_c20220531__dei--LegalEntityAxis__custom--ChinaEnergyPartnersLLCMember_z9DJqngvN1R4" title="Accrued interest">55,234</span> and $<span id="xdx_900_eus-gaap--InterestPayableCurrent_iI_c20211130__dei--LegalEntityAxis__custom--ChinaEnergyPartnersLLCMember_zWHxLRs8hVrj" title="Accrued interest">25,315</span> as of May 31, 2022 and November 30, 2021, respectively. Interest expense for the three and six months ended May 31, 2022 amounted to $<span id="xdx_902_eus-gaap--InterestExpenseOther_pp0p0_c20220301__20220531__dei--LegalEntityAxis__custom--ChinaEnergyPartnersLLCMember_zny8lngYcie3" title="Interest expense">15,123</span> and <span id="xdx_90E_eus-gaap--InterestExpenseOther_pp0p0_c20211201__20220531__dei--LegalEntityAxis__custom--ChinaEnergyPartnersLLCMember_zWWtNXpZRjKf" title="Interest expense">29,918</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 1000000 0.06 55234 25315 15123 29918 <p id="xdx_804_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_z03CIjcP1rKj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note 6. <span id="xdx_82B_zBRAID9aEJVl">Stockholders’ deficit</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 5, 2021, Company effected the following share issuances:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company issued <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20210804__20210805__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ConsultantMember_zHfQmSRYVEDf" title="Number of shares issued">50,000</span> shares of common stock valued at $<span id="xdx_905_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pp0p0_c20210804__20210805__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ConsultantMember_zPtqgQD3qfq9" title="Value of shares issued">2,500</span> ($<span id="xdx_909_eus-gaap--SharesIssuedPricePerShare_iI_c20210805__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ConsultantMember_zBLdPEeZX8v" title="Issue price per share">0.05</span> per share) to a consultant.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company issued <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20210804__20210805__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--BaruchHalpernMember_zhl8ryXXLcqk" title="Number of shares issued">750,000</span> shares of common stock valued at $<span id="xdx_908_eus-gaap--StockGrantedDuringPeriodValueSharebasedCompensation_pp0p0_c20210804__20210805__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--BaruchHalpernMember_zObmo7SAsJSb" title="Value of shares issued">37,500</span> ($<span id="xdx_901_eus-gaap--SharesIssuedPricePerShare_iI_c20210805__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--BaruchHalpernMember_zu2ofWCLGmxa" title="Issue price per share">0.05</span> per share) to Baruch Halpern for severance compensation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company issued <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20210804__20210805__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RobertKohnMember_zRoRz1ldG29c" title="Number of shares issued">546,160</span> shares of common stock valued at $<span id="xdx_906_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pp0p0_c20210804__20210805__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RobertKohnMember_z60UqoNJ7Toc" title="Value of shares issued">27,307</span> ($<span id="xdx_907_eus-gaap--SharesIssuedPricePerShare_iI_c20210805__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RobertKohnMember_zKAx7zKVjmda" title="Issue price per share">0.05</span> per share) to Robert Kohn for partial conversion of accrued compensation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company issued <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20210804__20210805__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--BonnieNelsonMember_zaeLN4xhTaQb" title="Number of shares issued">546,160</span> shares of common stock valued at $<span id="xdx_909_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pp0p0_c20210804__20210805__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--BonnieNelsonMember_zTaSSBPMY9D5" title="Value of shares issued">27,307</span> ($<span id="xdx_90D_eus-gaap--SharesIssuedPricePerShare_iI_c20210805__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--BonnieNelsonMember_z0UWd2jK64qc" title="Issue price per share">0.05</span> per share) to Bonnie Nelson for partial conversion of accrued compensation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On the Closing Date, the Company and CEP entered into the Redemption Agreement, dated as of June 29, 2021, pursuant to which the Company redeemed the Series A Share. On the Closing Date, as provided in the Redemption Agreement, the Company issued to CEP the Note in the principal amount of $<span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_iI_pdp0_c20210629__dei--LegalEntityAxis__custom--ChinaEnergyPartnersLLCMember__us-gaap--TypeOfArrangementAxis__custom--RedemptionAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zSI3gMZem7Xh" title="Debt instrument, principal value">1,000,000</span> with an interest rate of <span id="xdx_902_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_uPure_c20210629__dei--LegalEntityAxis__custom--ChinaEnergyPartnersLLCMember__us-gaap--TypeOfArrangementAxis__custom--RedemptionAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zhaDClRKm9W4" title="Debt instrument, interest rate">6</span>% per annum. The Series A Share will be held in escrow. If an Event of Default (as defined in the Note) occurs under the Note, then the Company will direct the escrow agent to release the Series A Share to CEP; provided, however, that CEP will also retain all rights and privileges under the Note (and the Company will remain bound to all obligations under Note) even if the Series A Share is required to be released by the escrow agent to CEP as provided in the Redemption Agreement. For the avoidance of doubt, CEP will regain all rights, title, and interest in and to the Series A Share upon the occurrence of an Event of Default under the Note, regardless of the amount of the outstanding balance owed under the Note at the time of the occurrence of an Event of Default under the Note.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 29, 2021, the Sellers agreed to (i) pay to the Company, on the closing date of the Acquisition, $<span id="xdx_905_eus-gaap--CashAcquiredFromAcquisition_pp0p0_c20210628__20210629__us-gaap--BusinessAcquisitionAxis__custom--HyFiTokensMember_z3M3R7IwSHga" title="Proceeds from acquisition">300,000</span> (the “Cash Consideration”), and (ii) transfer to the Company, on the closing date of the Acquisition, <span id="xdx_900_ecustom--NFTsReceivedFromAcquisition_uInteger_c20210628__20210629__us-gaap--BusinessAcquisitionAxis__custom--HyFiTokensMember_zGEl7KynqDJa" title="NFTs received from acquisition">400,000,000</span> HyFi Tokens (the “HyFi Token Consideration”). The Company used the Cash Consideration to bring the Company into a fully reporting status with the SEC and for public company operating expenses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In exchange for the sale of the Assets and the Cash Consideration, the Company agreed to issue to the Sellers an aggregate of <span id="xdx_90E_eus-gaap--StockIssued1_c20210628__20210629__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zMQu2g1FV1G3" title="Stock issued">900,000</span> Series C preferred shares within 30 calendar days after the State of Nevada provides written confirmation of filing of the certificate of designation for the Series C preferred stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to the terms of the APA, the parties agreed that the Series C preferred stock will have the following terms, among others:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1. Authorized Shares of Series C Preferred Stock. The number of authorized shares of Series C preferred stock will be <span id="xdx_909_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20210629__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zWxAQn762Sv1" title="Preferred stock shares authorized">900,000</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2. Conversion. <span id="xdx_908_eus-gaap--ConversionOfStockDescription_c20210628__20210629__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zdDyfzC5hjk9" title="Conversion of stock, description">Subject to the other terms and conditions in the certificate of designation, a Series C preferred stock holder will have the right from time to time and at any time following the date that is one year after the date on the signature page of the certificate of designations to convert each outstanding share of Series C preferred stock into 450 shares of Company common stock. Based on the number of shares of common stock issued and outstanding as of November 30, 2021, if all of the <span id="xdx_905_eus-gaap--ConversionOfStockSharesIssued1_pid_c20210628__20210629__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zg2e6uvC8PV8" title="Conversion of stock shares issued">900,000</span> shares of Series C preferred stock are issued and subsequently converted, the holders of the converted stock will hold 90% of the issued and outstanding shares of common stock</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3. Voting. <span id="xdx_908_eus-gaap--PreferredStockVotingRights_c20210628__20210629__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_z6k7K6nvavJj" title="Number of preferred stock voting rights">Except as otherwise set forth in the certificate of designation, each share of Series C preferred stock will, on any matter submitted to the holders of Company common stock, or any class thereof, for a vote, vote together with the common stock, or any class thereof, as applicable, as one class on such matter, and each share of Series C preferred stock will have 450 votes</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4. Dividends. The Series C preferred stock is not entitled to receive dividends or distributions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 27, 2021, the Company filed with the State of Nevada a certificate of designations for the Series C preferred stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 28, 2021, the Company amended and restated its articles of incorporation, as amended, in order to, among other things, (i) increase the number of authorized shares of common stock from <span id="xdx_904_eus-gaap--CommonStockSharesAuthorized_iI_c20210728_zSETbc3ZDAzh" title="Common stock, shares authorized">100,000,000</span> to <span id="xdx_906_eus-gaap--CommonStockSharesAuthorized_iI_c20220531_zh11lZp07XSi" title="Common stock, shares authorized">500,000,000</span>, (ii) increase the number of authorized shares of preferred stock from <span id="xdx_907_eus-gaap--PreferredStockSharesAuthorized_iI_c20210728_zbU2vkSabkaf" title="Preferred stock, shares authorized">10,000</span> to <span id="xdx_905_eus-gaap--PreferredStockSharesAuthorized_iI_c20211130_z45AvnpixDhf" title="Preferred stock, shares authorized">5,000,000</span>, and (iii) change the par value of the preferred stock from $<span id="xdx_90E_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20210728_zhchIcwL77Bg" title="Preferred stock, par value">1.00</span> par value per share to $<span id="xdx_906_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20211130_zizNlNdhR2J6" title="Preferred stock, par value">0.0001</span> par value per share. As of November 30, 2021, the Company had authorized <span id="xdx_908_eus-gaap--CommonStockSharesAuthorized_iI_c20211130_zdTIr1z0NHT8" title="Common stock, shares authorized">500,000,000</span> shares of common stock, $<span id="xdx_90B_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20211130_zvBiXr3TW3il" title="Preferred stock, par value">0.0001</span> par value per share, and <span id="xdx_909_eus-gaap--PreferredStockSharesAuthorized_iI_c20211130_zwi2VxJ1XF9a" title="Preferred stock, shares authorized">5,000,000</span> shares of preferred stock, $<span id="xdx_90B_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20211130_zDQCwNcNVG69" title="Preferred stock, par value">0.0001 </span>par value per share. As of May 31, 2022, and November 30, 2021, respectively, there were <span id="xdx_909_eus-gaap--CommonStockSharesIssued_iI_c20220531_zafJ1SeOcNk2" title="Common stock, shares issued"><span id="xdx_905_eus-gaap--CommonStockSharesOutstanding_iI_c20220531_zuTYQ22lk38h" title="Common stock, shares outstanding">45,625,000</span></span> and <span id="xdx_905_eus-gaap--CommonStockSharesIssued_iI_c20211130_zPCsK3DdfHEj" title="Common stock, shares issued"><span id="xdx_90D_eus-gaap--CommonStockSharesOutstanding_iI_c20211130_zO61QYHv5Aig" title="Common stock, shares outstanding">45,000,000</span></span> shares of common stock issued and outstanding, and <span id="xdx_90E_eus-gaap--PreferredStockSharesIssued_iI_c20220531_z7ssA8W3vd7e" title="Preferred stock, shares issued"><span id="xdx_907_eus-gaap--PreferredStockSharesOutstanding_iI_c20220531_zeT6hZMFE3ia" title="Preferred stock, shares outstanding">900,000</span></span> and <span id="xdx_900_eus-gaap--PreferredStockSharesIssued_iI_c20211130_z5xNEXtUiN24" title="Preferred stock, shares issued"><span id="xdx_90D_eus-gaap--PreferredStockSharesOutstanding_iI_c20211130_zephRFRukSR5" title="Preferred stock, shares outstanding">1</span></span> shares of preferred stock issued and outstanding, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">On March 5, 2022, the Company entered into a Stock Purchase Agreement (the “Compton SPA”) by and between the Company and Clarke Compton. Pursuant to the terms of the Compton SPA, the Company agreed to sell, and Mr. Compton agreed to purchase, <span id="xdx_909_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20220305__20220305__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember_zr1XUalfuVO4" title="Number of shares issued">625,000</span> shares of the Company’s common stock for a total purchase price of $<span id="xdx_90F_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20220305__20220305__us-gaap--TypeOfArrangementAxis__custom--StockPurchaseAgreementMember_zse417WpAbal" title="Purchase price">250,000</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 50000 2500 0.05 750000 37500 0.05 546160 27307 0.05 546160 27307 0.05 1000000 0.06 300000 400000000 900000 900000 Subject to the other terms and conditions in the certificate of designation, a Series C preferred stock holder will have the right from time to time and at any time following the date that is one year after the date on the signature page of the certificate of designations to convert each outstanding share of Series C preferred stock into 450 shares of Company common stock. Based on the number of shares of common stock issued and outstanding as of November 30, 2021, if all of the 900,000 shares of Series C preferred stock are issued and subsequently converted, the holders of the converted stock will hold 90% of the issued and outstanding shares of common stock 900000 Except as otherwise set forth in the certificate of designation, each share of Series C preferred stock will, on any matter submitted to the holders of Company common stock, or any class thereof, for a vote, vote together with the common stock, or any class thereof, as applicable, as one class on such matter, and each share of Series C preferred stock will have 450 votes 100000000 500000000 10000 5000000 1.00 0.0001 500000000 0.0001 5000000 0.0001 45625000 45625000 45000000 45000000 900000 900000 1 1 625000 250000 <p id="xdx_806_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zZmQb6so7x6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note 7. <span id="xdx_828_zinjldZNtm64">Commitments and Contingencies</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commitments</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 6, 2022, the Company entered into an agreement (the “Sanctum Agreement”) with Sanctum Studios (“Sanctum”) relating to The Athena Project. Pursuant to the terms of the Sanctum Agreement, Sanctum agreed to conceptualize, create and produce a collection of <span id="xdx_90D_ecustom--NumberOfAssets_uInteger_c20220405__20220406__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--DigitalArtMember__us-gaap--TypeOfArrangementAxis__custom--SanctumAgreementMember_zBLjTpaVSxpb" title="Number of assets">20,000</span> digital art assets based on the Greek Goddess Athena, in exchange for payment by the Company of $<span id="xdx_90C_eus-gaap--PaymentsToAcquireIntangibleAssets_c20220405__20220406__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--DigitalArtMember__us-gaap--TypeOfArrangementAxis__custom--SanctumAgreementMember_zk1OjcvivRV2" title="Payment for asset">121,000</span> and certain variable rate payments depending on the number of vaults sold by the Company. The $<span id="xdx_908_eus-gaap--PaymentsToAcquireIntangibleAssets_c20220405__20220406__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--DigitalArtMember__us-gaap--TypeOfArrangementAxis__custom--SanctumAgreementMember_znDK0b3cXxpj" title="Payment for asset">121,000</span> is payable by the Company in three equal installments of $<span id="xdx_903_eus-gaap--PaymentsToAcquireIntangibleAssets_pp2d_c20220403__20220404__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--DigitalArtMember__us-gaap--TypeOfArrangementAxis__custom--SanctumAgreementMember_zsyxZ6JaP48f" title="Payment of exchange"><span id="xdx_90D_eus-gaap--PaymentsToAcquireIntangibleAssets_pp2d_c20220518__20220519__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--DigitalArtMember__us-gaap--TypeOfArrangementAxis__custom--SanctumAgreementMember_zO0JVUjWXjFa" title="Payment of exchange"><span id="xdx_904_eus-gaap--PaymentsToAcquireIntangibleAssets_pp2d_c20220630__20220701__us-gaap--IndefiniteLivedIntangibleAssetsByMajorClassAxis__custom--DigitalArtMember__us-gaap--TypeOfArrangementAxis__custom--SanctumAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z3E7Ybdn4AI7" title="Payment for asset">40,333.33</span></span></span> due on April 4, 2022, May 19, 2022 and July 1, 2022. The Company paid all installments due through May 31, 2022. The Sanctum deliverables are due by July 1, 2022 or earlier, as set forth in the Sanctum Agreement. The Company announced this material definitive agreement and associated Press Release, incorporated by reference, on a Current Report on Form 8-K which was filed with the SEC on April 7, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contingencies</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From time to time, the Company may be involved in legal matters arising in the ordinary course of business. While the Company believes that such matters are currently not material, there can be no assurance that matters arising in the ordinary course of business for which the Company is, or could be, involved in litigation, will not have a material adverse effect on its business, financial condition or results of operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 20000 121000 121000 40333.33 40333.33 40333.33 <p id="xdx_80D_eus-gaap--SubsequentEventsTextBlock_zR1xkPPydX5k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note 8. <span id="xdx_820_zsGcBBO6AN14">Subsequent Events</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Diagonal Lending Securities Purchase Agreement &amp; Convertible Note</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 31, 2022, the Company entered into a Securities Purchase Agreement (the “Diagonal Lending SPA”) by and between the Company and 1800 Diagonal Lending LLC (“Diagonal Lending”). Pursuant to the terms of the Diagonal Lending SPA, the Company agreed to sell, and Diagonal Lending agreed to purchase, a convertible note of the Company in the aggregate principal amount of $<span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_c20220531__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zWRl4DrAb3m4" title="Debt principal amount">90,000</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 31, 2022, pursuant to the terms of the Diagonal Lending SPA, the Company issued to Diagonal Lending a convertible promissory note (the “Diagonal Lending Note”) in the principal amount of $<span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_c20220531__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zwODOlRcRqKf" title="Debt principal amount">90,000</span>. The Diagonal Lending Note was funded on June 23, 2022. The Diagonal Lending Note bears interest at a rate of <span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20220531__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zx47JS3UtnMg" title="Debt interest rate">10</span>% per annum and matures on <span id="xdx_90E_eus-gaap--DebtInstrumentMaturityDate_dd_c20220531__20220531__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zYVzTCu1czIk" title="Debt maturity date">May 31, 2023</span>. The Diagonal Lending Note may not be prepaid in whole or in part except as otherwise explicitly set forth in the Diagonal Lending Note. Any amount of principal or interest which is not paid when due will bear interest at a rate of <span id="xdx_900_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pid_dp_uPure_c20220531__20220531__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zUP1bxMGnOaj" title="Debt principal interest rate">22</span>% per annum.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--DebtInstrumentDescription_c20220531__20220531__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zOLEnPT2J8Uk" title="Debt description">Diagonal Lending has the right from time to time, and at any time following November 27, 2022 and ending on the earlier of (i) payment of all amounts due under the Diagonal Lending Note, (ii) May 31, 2023, if all amounts are repaid in full at such time, or (iii) the date full repayment of all indebtedness to convert all or any part of the indebtedness into common stock subject to the terms of the Digital Lending Note at the Conversion Price (as hereinafter defined). The “Conversion Price” means 65% multiplied by the lowest trading price for the Company’s common stock during the 10 trading day period ending on the latest complete trading day prior to the conversion date, subject to a 4.99% equity blocker and subject to the terms of the Diagonal Lending Note.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Diagonal Lending Note may be prepaid; provided, however, that if the Company exercises its right to prepay, the Company will make payment to Diagonal Lending of an amount in cash equal to the percentage as set forth in the table below, multiplied by the sum of: (w) the then outstanding principal amount of the Diagonal Lending Note, plus (x) accrued and unpaid interest on the unpaid principal amount of the Diagonal Lending Note, plus (y) default interest, if any, on the amounts referred to in clauses (w) and (x) plus (z) certain other amounts owed to Diagonal Lending pursuant to the terms of the Diagonal Lending Note.</span></p> <p id="xdx_893_ecustom--ScheduleOfAmountOwedOnPrepaymentOfDiagonalLendingNoteTableTextBlock_zZmxNP63mPh7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span id="xdx_8B5_zs3hSBkkWE54" style="display: none">Schedule of Amount Owed on Prepayment of Diagonal Lending Note</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Prepayment Period</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 53%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Prepayment Percentage</b></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May 31, 2022 to July 30, 2022</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_ecustom--DebtInstrumentPrepaymentPercentage_iI_pid_dp_uPure_c20220531__us-gaap--AwardTypeAxis__custom--PrepaymentPeriodOneMember_zBgiZIIWtz49" title="Prepayment Percentage">120</span>%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">July 31, 2022 to October 28, 2022</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_ecustom--DebtInstrumentPrepaymentPercentage_iI_pid_dp_uPure_c20220531__us-gaap--AwardTypeAxis__custom--PrepaymentPeriodTwoMember_zDyjHe5GHb92" title="Prepayment Percentage">125</span>%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">October 29, 2022 to November 27, 2022</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_ecustom--DebtInstrumentPrepaymentPercentage_iI_pid_dp_uPure_c20220531__us-gaap--AwardTypeAxis__custom--PrepaymentPeriodThreeMember_zAZ4F3NGmZBl" title="Prepayment Percentage">130</span>%</span></td></tr> </table> <p id="xdx_8A5_zlQlQFKf0Pn1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">After November 27, 2022, prepayment will be subject to agreement of the parties with respect to the applicable prepayment percentage.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>China Energy Partners Note Amendment</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 22, 2022, the Company entered into the Addendum and Amendment of Promissory Note (the “Note Amendment”) by and between the Company and China Energy Partners, LLC (“China Energy”). Pursuant to the terms of the Note Amendment, the Company and China Energy agreed to amend the Senior Promissory Note issued by the Company to China Energy on June 29, 2021 (the “China Energy Note”) such that (i) the principal amount and accrued interest under the China Energy Note will be repaid in full on or before June 28, 2022, with $<span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_c20220728__us-gaap--DebtInstrumentAxis__custom--ChinaEnergyPartnersNoteAmendmentMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zJi9gEHTCd7b" title="Principal amount">800,000</span> to be paid in cash and $<span id="xdx_908_ecustom--DebtTransferAmount_iI_c20220728__us-gaap--DebtInstrumentAxis__custom--ChinaEnergyPartnersNoteAmendmentMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zWHuQAPnixt6" title="Debt transfer amount">200,000</span> to be paid via the transfer to China Energy of tokens to an electronic wallet; and (ii) the parties agree that $<span id="xdx_90D_eus-gaap--InterestReceivable_iI_c20220729__us-gaap--DebtInstrumentAxis__custom--ChinaEnergyPartnersNoteAmendmentMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zpYrmEIzaJ0e" title="Accurued interest">60,000</span> in interest previously accrued under the China Energy Note was satisfied via the transfer by the Company to China Energy of 53 HyFi NFT Athena vaults.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 28, 2022, the China Energy Note, as amended by the Note Amendment, was paid in full.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>PIP North America ILO and Multi-Agreement</i> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 26, 2022 , the Company entered into an ILO and Multi-Agreement (the “PIP Agreement”) with PIP North America Inc. (“PIP”). Pursuant to the terms of the PIP Agreement, the parties agreed as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: -0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company agreed to provide PIP the exclusivity to list the first initial license offering (“ILO”) for a minimum of 90 days. PIP can mutually agree to allow the Company to list another ILO during this period and PIP will receive 50% of gross revenues.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PIP will not pay any listing fee for its first three ILOs, and the Company will provide free consulting services to help structure the ILOs.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company agreed to provide services necessary from Super How for the customization of the HyFi technology for the first three PIP ILOs, including smart contracts for each listing.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company agreed to provide, at the Company’s cost, Prime Trust for anti-money laundering (AML) and know your customer (KYC) services, including processing of the payments, conversion of tokens to fiat currency for the use by the ILO issuer and all other services necessary for any ILOs, projects or bridge loans that PIP agrees to list on HyFi marketplaces to raise capital.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company agreed to provide PIP with Exclusive License options for one-year $<span id="xdx_90A_eus-gaap--IndefiniteLivedLicenseAgreements_iI_pn6n6_c20220626__srt--ProductOrServiceAxis__custom--ExclusiveLicenseOptionsYearOneMember__us-gaap--TypeOfArrangementAxis__custom--PIPAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zQFPrwXRbun8" title="Exclusive license Amount">1</span> million and five-year $<span id="xdx_909_eus-gaap--IndefiniteLivedLicenseAgreements_iI_pn6n6_c20220626__srt--ProductOrServiceAxis__custom--ExclusiveLicenseOptionsYearFiveMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--PIPAgreementMember_zQ9nnLDEgXyg">10</span> million exclusives for the agriculture category on the HyFi DeFi marketplaces. Whoever brings the issuer will receive 75% of the gross revenues and whoever does not bring the issuer will receive 25% of the gross revenues. The option for the one-year exclusive must be exercised while the first PIP ILO is listed on the HyFi ILO marketplace and, once exercised, will last for one year. Within 90 days of the expiration of the one-year exclusive license, PIP must exercise the 5-year license.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PIP agreed to pay the Company <span id="xdx_909_ecustom--GrossSalesCustomaryPercentage_iI_pid_dp_c20220626__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--PIPAgreementMember_zB4K16nj3Zob" title="Gross sales percentage">5</span>% of gross sales of PIP vaults plus usual and customary percentages charged by third party vendors for the vault program.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PIP agreed to purchase, and the Company agreed to sell, <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220625__20220626__us-gaap--TypeOfArrangementAxis__custom--PIPAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__custom--RestrictedCommonStockMember_zoxusPsMA2z8" title="Shares issued, shares">500,000</span> shares of restricted common stock at a purchase price of $<span id="xdx_907_eus-gaap--SharePrice_iI_pid_c20220626__us-gaap--TypeOfArrangementAxis__custom--PIPAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__custom--RestrictedCommonStockMember_zlgQLC03sspc" title="Share price">0.25</span> per share.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PIP agreed to purchase, and the Company agreed to sell, <span id="xdx_90E_ecustom--TokensIssuedDuringPeriodSharesNewIssues_pid_c20220625__20220626__us-gaap--TypeOfArrangementAxis__custom--PIPAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__custom--RestrictedCommonStockMember_z9oM0iY0BVgj">3,125,000</span> HyFi tokens at a purchase price of $<span id="xdx_90A_ecustom--TokenPrice_iI_pid_c20220626__us-gaap--TypeOfArrangementAxis__custom--PIPAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__custom--RestrictedCommonStockMember_zgFLwaNwhnv">0.04</span> per token for $<span id="xdx_903_ecustom--TokensIssuedDuringPeriodSharesNewIssuesValue_pid_c20220625__20220626__us-gaap--TypeOfArrangementAxis__custom--PIPAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__custom--RestrictedCommonStockMember_zpPWx1rqkg3e">125,000</span>. The HyFi tokens can be used as utility tokens in conjunction with HyFi DeFi marketplace fees and services, HyFi vaults, HyFi memberships and any other HyFi fees and services.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_ecustom--PurchaseOfVaultsDescription_pid_c20220625__20220626__us-gaap--TypeOfArrangementAxis__custom--PIPAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__custom--RestrictedCommonStockMember_zSXtpfigoGbh" title="Purchase of vaults, description">The Company agreed to grant PIP an option to purchase up to 50 HyFi vaults for $1,000. The option will expire on August 30, 2022.</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company agreed to provide a license for the HyFi Vault Program, a blockchain promotional and marketing program, and services necessary from third party vendors, including Super How and Sanctum Studios.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In exchange for the above, PIP agreed to pay to the Company $<span id="xdx_90B_eus-gaap--DebtInstrumentAnnualPrincipalPayment_iI_pid_c20220626__us-gaap--TypeOfArrangementAxis__custom--PIPAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__custom--RestrictedCommonStockMember_zdw23a190g16" title="Debt payment amount">500,000</span>. The Company agreed to use this payment as part of the payments to retire the China Energy Note, as amended.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As indicated above, on June 28, 2022, the China Energy Note, as amended by the Note Amendment, was paid in full.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"/> 90000 90000 0.10 2023-05-31 0.22 Diagonal Lending has the right from time to time, and at any time following November 27, 2022 and ending on the earlier of (i) payment of all amounts due under the Diagonal Lending Note, (ii) May 31, 2023, if all amounts are repaid in full at such time, or (iii) the date full repayment of all indebtedness to convert all or any part of the indebtedness into common stock subject to the terms of the Digital Lending Note at the Conversion Price (as hereinafter defined). The “Conversion Price” means 65% multiplied by the lowest trading price for the Company’s common stock during the 10 trading day period ending on the latest complete trading day prior to the conversion date, subject to a 4.99% equity blocker and subject to the terms of the Diagonal Lending Note. <p id="xdx_893_ecustom--ScheduleOfAmountOwedOnPrepaymentOfDiagonalLendingNoteTableTextBlock_zZmxNP63mPh7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span id="xdx_8B5_zs3hSBkkWE54" style="display: none">Schedule of Amount Owed on Prepayment of Diagonal Lending Note</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Prepayment Period</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 53%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Prepayment Percentage</b></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May 31, 2022 to July 30, 2022</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_ecustom--DebtInstrumentPrepaymentPercentage_iI_pid_dp_uPure_c20220531__us-gaap--AwardTypeAxis__custom--PrepaymentPeriodOneMember_zBgiZIIWtz49" title="Prepayment Percentage">120</span>%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">July 31, 2022 to October 28, 2022</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_ecustom--DebtInstrumentPrepaymentPercentage_iI_pid_dp_uPure_c20220531__us-gaap--AwardTypeAxis__custom--PrepaymentPeriodTwoMember_zDyjHe5GHb92" title="Prepayment Percentage">125</span>%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">October 29, 2022 to November 27, 2022</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_ecustom--DebtInstrumentPrepaymentPercentage_iI_pid_dp_uPure_c20220531__us-gaap--AwardTypeAxis__custom--PrepaymentPeriodThreeMember_zAZ4F3NGmZBl" title="Prepayment Percentage">130</span>%</span></td></tr> </table> 1.20 1.25 1.30 800000 200000 60000 1000000 10000000 0.05 500000 0.25 3125000 0.04 125000 The Company agreed to grant PIP an option to purchase up to 50 HyFi vaults for $1,000. The option will expire on August 30, 2022. 500000 EXCEL 38 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 39 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 40 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 41 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.2 html 180 165 1 false 60 0 false 5 false false R1.htm 00000001 - Document - Cover Sheet http://biopowercorp.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - Consolidated Balance Sheets Sheet http://biopowercorp.com/role/BalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://biopowercorp.com/role/BalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Consolidated Statements of Operations Sheet http://biopowercorp.com/role/StatementsOfOperations Consolidated Statements of Operations Statements 4 false false R5.htm 00000005 - Statement - Consolidated Statements of Cash Flows Sheet http://biopowercorp.com/role/StatementsOfCashFlows Consolidated Statements of Cash Flows Statements 5 false false R6.htm 00000006 - Statement - Consolidated Statements of Changes in Stockholders' Deficit (Unaudited) Sheet http://biopowercorp.com/role/StatementsOfChangesInStockholdersDeficit Consolidated Statements of Changes in Stockholders' Deficit (Unaudited) Statements 6 false false R7.htm 00000007 - Disclosure - Organization Sheet http://biopowercorp.com/role/Organization Organization Notes 7 false false R8.htm 00000008 - Disclosure - Summary of Significant Accounting Policies Sheet http://biopowercorp.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 8 false false R9.htm 00000009 - Disclosure - Notes Payable and Convertible Debt Notes http://biopowercorp.com/role/NotesPayableAndConvertibleDebt Notes Payable and Convertible Debt Notes 9 false false R10.htm 00000010 - Disclosure - Related Party Transactions Sheet http://biopowercorp.com/role/RelatedPartyTransactions Related Party Transactions Notes 10 false false R11.htm 00000011 - Disclosure - Senior Promissory Note ??? related party Sheet http://biopowercorp.com/role/SeniorPromissoryNoteRelatedParty Senior Promissory Note ??? related party Notes 11 false false R12.htm 00000012 - Disclosure - Stockholders??? deficit Sheet http://biopowercorp.com/role/StockholdersDeficit Stockholders??? deficit Notes 12 false false R13.htm 00000013 - Disclosure - Commitments and Contingencies Sheet http://biopowercorp.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 13 false false R14.htm 00000014 - Disclosure - Subsequent Events Sheet http://biopowercorp.com/role/SubsequentEvents Subsequent Events Notes 14 false false R15.htm 00000015 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://biopowercorp.com/role/SummaryOfSignificantAccountingPolicies 15 false false R16.htm 00000016 - Disclosure - Notes Payable and Convertible Debt (Tables) Notes http://biopowercorp.com/role/NotesPayableAndConvertibleDebtTables Notes Payable and Convertible Debt (Tables) Tables http://biopowercorp.com/role/NotesPayableAndConvertibleDebt 16 false false R17.htm 00000017 - Disclosure - Subsequent Events (Tables) Sheet http://biopowercorp.com/role/SubsequentEventsTables Subsequent Events (Tables) Tables http://biopowercorp.com/role/SubsequentEvents 17 false false R18.htm 00000018 - Disclosure - Organization (Details Narrative) Sheet http://biopowercorp.com/role/OrganizationDetailsNarrative Organization (Details Narrative) Details http://biopowercorp.com/role/Organization 18 false false R19.htm 00000019 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) Sheet http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative Summary of Significant Accounting Policies (Details Narrative) Details http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies 19 false false R20.htm 00000020 - Disclosure - Schedule of Notes Payable (Details) Notes http://biopowercorp.com/role/ScheduleOfNotesPayableDetails Schedule of Notes Payable (Details) Details 20 false false R21.htm 00000021 - Disclosure - Notes Payable and Convertible Debt (Details Narrative) Notes http://biopowercorp.com/role/NotesPayableAndConvertibleDebtDetailsNarrative Notes Payable and Convertible Debt (Details Narrative) Details http://biopowercorp.com/role/NotesPayableAndConvertibleDebtTables 21 false false R22.htm 00000022 - Disclosure - Related Party Transactions (Details Narrative) Sheet http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative Related Party Transactions (Details Narrative) Details http://biopowercorp.com/role/RelatedPartyTransactions 22 false false R23.htm 00000023 - Disclosure - Senior Promissory Note ??? related party (Details Narrative) Sheet http://biopowercorp.com/role/SeniorPromissoryNoteRelatedPartyDetailsNarrative Senior Promissory Note ??? related party (Details Narrative) Details http://biopowercorp.com/role/SeniorPromissoryNoteRelatedParty 23 false false R24.htm 00000024 - Disclosure - Stockholders??? deficit (Details Narrative) Sheet http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative Stockholders??? deficit (Details Narrative) Details http://biopowercorp.com/role/StockholdersDeficit 24 false false R25.htm 00000025 - Disclosure - Commitments and Contingencies (Details Narrative) Sheet http://biopowercorp.com/role/CommitmentsAndContingenciesDetailsNarrative Commitments and Contingencies (Details Narrative) Details http://biopowercorp.com/role/CommitmentsAndContingencies 25 false false R26.htm 00000026 - Disclosure - Schedule of Amount Owed on Prepayment of Diagonal Lending Note (Details) Sheet http://biopowercorp.com/role/ScheduleOfAmountOwedOnPrepaymentOfDiagonalLendingNoteDetails Schedule of Amount Owed on Prepayment of Diagonal Lending Note (Details) Details 26 false false R27.htm 00000027 - Disclosure - Subsequent Events (Details Narrative) Sheet http://biopowercorp.com/role/SubsequentEventsDetailsNarrative Subsequent Events (Details Narrative) Details http://biopowercorp.com/role/SubsequentEventsTables 27 false false All Reports Book All Reports form10-q.htm bopo-20220531.xsd bopo-20220531_cal.xml bopo-20220531_def.xml bopo-20220531_lab.xml bopo-20220531_pre.xml ex31-1.htm ex31-2.htm ex32-1.htm http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 43 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "form10-q.htm": { "axisCustom": 0, "axisStandard": 20, "contextCount": 180, "dts": { "calculationLink": { "local": [ "bopo-20220531_cal.xml" ] }, "definitionLink": { "local": [ "bopo-20220531_def.xml" ] }, "inline": { "local": [ "form10-q.htm" ] }, "labelLink": { "local": [ "bopo-20220531_lab.xml" ] }, "presentationLink": { "local": [ "bopo-20220531_pre.xml" ] }, "schema": { "local": [ "bopo-20220531.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 339, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2022": 63, "http://xbrl.sec.gov/dei/2022": 4, "total": 67 }, "keyCustom": 18, "keyStandard": 147, "memberCustom": 43, "memberStandard": 16, "nsprefix": "BOPO", "nsuri": "http://biopowercorp.com/20220531", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-12-01to2022-05-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "role": "http://biopowercorp.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-12-01to2022-05-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-12-01to2022-05-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000010 - Disclosure - Related Party Transactions", "role": "http://biopowercorp.com/role/RelatedPartyTransactions", "shortName": "Related Party Transactions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-12-01to2022-05-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-12-01to2022-05-31", "decimals": null, "first": true, "lang": "en-US", "name": "BOPO:SeniorPromissoryNoteRelatedPartyDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000011 - Disclosure - Senior Promissory Note \u2013 related party", "role": "http://biopowercorp.com/role/SeniorPromissoryNoteRelatedParty", "shortName": "Senior Promissory Note \u2013 related party", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-12-01to2022-05-31", "decimals": null, "first": true, "lang": "en-US", "name": "BOPO:SeniorPromissoryNoteRelatedPartyDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-12-01to2022-05-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000012 - Disclosure - Stockholders\u2019 deficit", "role": "http://biopowercorp.com/role/StockholdersDeficit", "shortName": "Stockholders\u2019 deficit", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-12-01to2022-05-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-12-01to2022-05-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000013 - Disclosure - Commitments and Contingencies", "role": "http://biopowercorp.com/role/CommitmentsAndContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-12-01to2022-05-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-12-01to2022-05-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000014 - Disclosure - Subsequent Events", "role": "http://biopowercorp.com/role/SubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-12-01to2022-05-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-12-01to2022-05-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConsolidationPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000015 - Disclosure - Summary of Significant Accounting Policies (Policies)", "role": "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies", "shortName": "Summary of Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-12-01to2022-05-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConsolidationPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-12-01to2022-05-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000016 - Disclosure - Notes Payable and Convertible Debt (Tables)", "role": "http://biopowercorp.com/role/NotesPayableAndConvertibleDebtTables", "shortName": "Notes Payable and Convertible Debt (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-12-01to2022-05-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-12-01to2022-05-31", "decimals": null, "first": true, "lang": "en-US", "name": "BOPO:ScheduleOfAmountOwedOnPrepaymentOfDiagonalLendingNoteTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000017 - Disclosure - Subsequent Events (Tables)", "role": "http://biopowercorp.com/role/SubsequentEventsTables", "shortName": "Subsequent Events (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-12-01to2022-05-31", "decimals": null, "first": true, "lang": "en-US", "name": "BOPO:ScheduleOfAmountOwedOnPrepaymentOfDiagonalLendingNoteTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:StockholdersEquityPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-11-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockSharesAuthorized", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000018 - Disclosure - Organization (Details Narrative)", "role": "http://biopowercorp.com/role/OrganizationDetailsNarrative", "shortName": "Organization (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-06-282021-06-29_us-gaap_SeriesCPreferredStockMember", "decimals": "INF", "lang": null, "name": "us-gaap:ConversionOfStockSharesConverted1", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-05-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RetainedEarningsAccumulatedDeficit", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000019 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)", "role": "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "shortName": "Summary of Significant Accounting Policies (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:StockholdersEquityPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-03-032022-03-04_custom_CanadianInvestorMember", "decimals": "INF", "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-05-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000002 - Statement - Consolidated Balance Sheets", "role": "http://biopowercorp.com/role/BalanceSheets", "shortName": "Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-05-31", "decimals": "0", "lang": null, "name": "us-gaap:AccountsReceivableNetCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-05-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NotesPayable", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000020 - Disclosure - Schedule of Notes Payable (Details)", "role": "http://biopowercorp.com/role/ScheduleOfNotesPayableDetails", "shortName": "Schedule of Notes Payable (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-05-31_custom_DemandLoansMember", "decimals": "0", "lang": null, "name": "us-gaap:NotesPayable", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-05-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NotesPayable", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000021 - Disclosure - Notes Payable and Convertible Debt (Details Narrative)", "role": "http://biopowercorp.com/role/NotesPayableAndConvertibleDebtDetailsNarrative", "shortName": "Notes Payable and Convertible Debt (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-11-30", "decimals": "0", "lang": null, "name": "us-gaap:InterestPayableCurrentAndNoncurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2015-07-28", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage", "reportCount": 1, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000022 - Disclosure - Related Party Transactions (Details Narrative)", "role": "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative", "shortName": "Related Party Transactions (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2016-05-23_custom_ThirdPartyInvestorMember", "decimals": "0", "lang": null, "name": "BOPO:ConvertibleNotesPayableToRelatedPartiesNonCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-05-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InterestPayableCurrent", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000023 - Disclosure - Senior Promissory Note \u2013 related party (Details Narrative)", "role": "http://biopowercorp.com/role/SeniorPromissoryNoteRelatedPartyDetailsNarrative", "shortName": "Senior Promissory Note \u2013 related party (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "BOPO:SeniorPromissoryNoteRelatedPartyDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-11-30_custom_ChinaEnergyPartnersLLCMember", "decimals": "0", "lang": null, "name": "us-gaap:InterestPayableCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-03-012022-05-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000024 - Disclosure - Stockholders\u2019 deficit (Details Narrative)", "role": "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative", "shortName": "Stockholders\u2019 deficit (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-06-282021-06-29_us-gaap_SeriesCPreferredStockMember", "decimals": "0", "lang": null, "name": "us-gaap:StockIssued1", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-04-052022-04-06_custom_DigitalArtMember_custom_SanctumAgreementMember", "decimals": "INF", "first": true, "lang": null, "name": "BOPO:NumberOfAssets", "reportCount": 1, "unique": true, "unitRef": "Integer", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000025 - Disclosure - Commitments and Contingencies (Details Narrative)", "role": "http://biopowercorp.com/role/CommitmentsAndContingenciesDetailsNarrative", "shortName": "Commitments and Contingencies (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-04-052022-04-06_custom_DigitalArtMember_custom_SanctumAgreementMember", "decimals": "INF", "first": true, "lang": null, "name": "BOPO:NumberOfAssets", "reportCount": 1, "unique": true, "unitRef": "Integer", "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "BOPO:ScheduleOfAmountOwedOnPrepaymentOfDiagonalLendingNoteTableTextBlock", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-05-31_custom_PrepaymentPeriodOneMember", "decimals": "INF", "first": true, "lang": null, "name": "BOPO:DebtInstrumentPrepaymentPercentage", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000026 - Disclosure - Schedule of Amount Owed on Prepayment of Diagonal Lending Note (Details)", "role": "http://biopowercorp.com/role/ScheduleOfAmountOwedOnPrepaymentOfDiagonalLendingNoteDetails", "shortName": "Schedule of Amount Owed on Prepayment of Diagonal Lending Note (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "BOPO:ScheduleOfAmountOwedOnPrepaymentOfDiagonalLendingNoteTableTextBlock", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-05-31_custom_PrepaymentPeriodOneMember", "decimals": "INF", "first": true, "lang": null, "name": "BOPO:DebtInstrumentPrepaymentPercentage", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2015-07-28", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage", "reportCount": 1, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000027 - Disclosure - Subsequent Events (Details Narrative)", "role": "http://biopowercorp.com/role/SubsequentEventsDetailsNarrative", "shortName": "Subsequent Events (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-07-28_custom_ChinaEnergyPartnersNoteAmendmentMember_us-gaap_SubsequentEventMember", "decimals": "0", "lang": null, "name": "us-gaap:DebtInstrumentFaceAmount", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:StockholdersEquityPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-11-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000003 - Statement - Consolidated Balance Sheets (Parenthetical)", "role": "http://biopowercorp.com/role/BalanceSheetsParenthetical", "shortName": "Consolidated Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": null }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-03-012022-05-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000004 - Statement - Consolidated Statements of Operations", "role": "http://biopowercorp.com/role/StatementsOfOperations", "shortName": "Consolidated Statements of Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-03-012022-05-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-12-01to2022-05-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000005 - Statement - Consolidated Statements of Cash Flows", "role": "http://biopowercorp.com/role/StatementsOfCashFlows", "shortName": "Consolidated Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-12-01to2022-05-31", "decimals": "0", "lang": null, "name": "us-gaap:IncreaseDecreaseInAccountsReceivable", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2020-11-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000006 - Statement - Consolidated Statements of Changes in Stockholders' Deficit (Unaudited)", "role": "http://biopowercorp.com/role/StatementsOfChangesInStockholdersDeficit", "shortName": "Consolidated Statements of Changes in Stockholders' Deficit (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2020-11-30_us-gaap_SeriesAPreferredStockMember_us-gaap_PreferredStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-12-01to2022-05-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000007 - Disclosure - Organization", "role": "http://biopowercorp.com/role/Organization", "shortName": "Organization", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-12-01to2022-05-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-12-01to2022-05-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000008 - Disclosure - Summary of Significant Accounting Policies", "role": "http://biopowercorp.com/role/SummaryOfSignificantAccountingPolicies", "shortName": "Summary of Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-12-01to2022-05-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-12-01to2022-05-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000009 - Disclosure - Notes Payable and Convertible Debt", "role": "http://biopowercorp.com/role/NotesPayableAndConvertibleDebt", "shortName": "Notes Payable and Convertible Debt", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2021-12-01to2022-05-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 60, "tag": { "BOPO_BaruchHalpernMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Baruch Halpern [Member]", "label": "Baruch Halpern [Member]" } } }, "localname": "BaruchHalpernMember", "nsuri": "http://biopowercorp.com/20220531", "presentation": [ "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "BOPO_BioPowerCorporationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Bio power corporation [Member]", "label": "BioPower Corporation [Member]" } } }, "localname": "BioPowerCorporationMember", "nsuri": "http://biopowercorp.com/20220531", "presentation": [ "http://biopowercorp.com/role/OrganizationDetailsNarrative" ], "xbrltype": "domainItemType" }, "BOPO_BonnieNelsonMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Bonnie Nelson [Member]", "label": "Bonnie Nelson [Member]" } } }, "localname": "BonnieNelsonMember", "nsuri": "http://biopowercorp.com/20220531", "presentation": [ "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "BOPO_CanadianInvestorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Canadian investor [Member]", "label": "Canadian Investor [Member]" } } }, "localname": "CanadianInvestorMember", "nsuri": "http://biopowercorp.com/20220531", "presentation": [ "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "BOPO_ChiefExecutiveOfficerAndDirectorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Chief Executive Officer And Director [Member]", "label": "Chief Executive Officer and Director [Member]" } } }, "localname": "ChiefExecutiveOfficerAndDirectorMember", "nsuri": "http://biopowercorp.com/20220531", "presentation": [ "http://biopowercorp.com/role/OrganizationDetailsNarrative" ], "xbrltype": "domainItemType" }, "BOPO_ChinaEnergyPartnersLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "China Energy Partners LLC [Member]", "label": "China Energy Partners LLC [Member]" } } }, "localname": "ChinaEnergyPartnersLLCMember", "nsuri": "http://biopowercorp.com/20220531", "presentation": [ "http://biopowercorp.com/role/OrganizationDetailsNarrative", "http://biopowercorp.com/role/SeniorPromissoryNoteRelatedPartyDetailsNarrative", "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "BOPO_ChinaEnergyPartnersNoteAmendmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "China Energy Partners Note Amendment [Member]", "label": "China Energy Partners Note Amendment [Member]" } } }, "localname": "ChinaEnergyPartnersNoteAmendmentMember", "nsuri": "http://biopowercorp.com/20220531", "presentation": [ "http://biopowercorp.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "BOPO_ConsultantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Consultant [Member]", "label": "Consultant [Member]" } } }, "localname": "ConsultantMember", "nsuri": "http://biopowercorp.com/20220531", "presentation": [ "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "BOPO_ConvertibleDebtAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible Debt Agreement [Member]", "label": "Convertible Debt Agreement [Member]" } } }, "localname": "ConvertibleDebtAgreementMember", "nsuri": "http://biopowercorp.com/20220531", "presentation": [ "http://biopowercorp.com/role/NotesPayableAndConvertibleDebtDetailsNarrative" ], "xbrltype": "domainItemType" }, "BOPO_ConvertibleDebtRelatedPartiesClassifiedC": { "auth_ref": [], "calculation": { "http://biopowercorp.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Convertible debt related parties classified.", "label": "Convertible debt - related parties," } } }, "localname": "ConvertibleDebtRelatedPartiesClassifiedC", "nsuri": "http://biopowercorp.com/20220531", "presentation": [ "http://biopowercorp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "BOPO_ConvertibleNotesPayableToRelatedPartiesNonCurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Convertible notes payable to related parties non current.", "label": "Convertible notes payable to related parties" } } }, "localname": "ConvertibleNotesPayableToRelatedPartiesNonCurrent", "nsuri": "http://biopowercorp.com/20220531", "presentation": [ "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "BOPO_DebtInstrumentPrepaymentPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt prepayment percentage.", "label": "Prepayment Percentage" } } }, "localname": "DebtInstrumentPrepaymentPercentage", "nsuri": "http://biopowercorp.com/20220531", "presentation": [ "http://biopowercorp.com/role/ScheduleOfAmountOwedOnPrepaymentOfDiagonalLendingNoteDetails" ], "xbrltype": "percentItemType" }, "BOPO_DebtTransferAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Debt transfer amount.", "label": "Debt transfer amount" } } }, "localname": "DebtTransferAmount", "nsuri": "http://biopowercorp.com/20220531", "presentation": [ "http://biopowercorp.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "BOPO_DemandLoanAgreementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Demand Loan Agreements [Member]", "label": "Demand Loan Agreements [Member]" } } }, "localname": "DemandLoanAgreementsMember", "nsuri": "http://biopowercorp.com/20220531", "presentation": [ "http://biopowercorp.com/role/NotesPayableAndConvertibleDebtDetailsNarrative" ], "xbrltype": "domainItemType" }, "BOPO_DemandLoansMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Demand Loans [Member]", "label": "Demand Loans [Member]" } } }, "localname": "DemandLoansMember", "nsuri": "http://biopowercorp.com/20220531", "presentation": [ "http://biopowercorp.com/role/ScheduleOfNotesPayableDetails" ], "xbrltype": "domainItemType" }, "BOPO_DigitalArtMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Digital art [Member]", "label": "Digital Art [Member]" } } }, "localname": "DigitalArtMember", "nsuri": "http://biopowercorp.com/20220531", "presentation": [ "http://biopowercorp.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "BOPO_DirectorOfBusinessStrategyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Director Of Business Strategy [Member]", "label": "Director Of Business Strategy [Member]" } } }, "localname": "DirectorOfBusinessStrategyMember", "nsuri": "http://biopowercorp.com/20220531", "presentation": [ "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "BOPO_DisclosureSeniorPromissoryNoteRelatedPartyAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Senior Promissory Note Related Party" } } }, "localname": "DisclosureSeniorPromissoryNoteRelatedPartyAbstract", "nsuri": "http://biopowercorp.com/20220531", "xbrltype": "stringItemType" }, "BOPO_ExclusiveLicenseOptionsYearFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exclusive License Options Year Five [Member]", "label": "Exclusive License Options Year Five [Member]" } } }, "localname": "ExclusiveLicenseOptionsYearFiveMember", "nsuri": "http://biopowercorp.com/20220531", "presentation": [ "http://biopowercorp.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "BOPO_ExclusiveLicenseOptionsYearOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exclusive License Options Year One [Member]", "label": "Exclusive License Options Year One [Member]" } } }, "localname": "ExclusiveLicenseOptionsYearOneMember", "nsuri": "http://biopowercorp.com/20220531", "presentation": [ "http://biopowercorp.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "BOPO_FTZExchangeLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "FTZ Exchange LLC [Member]", "label": "FTZ Exchange LLC [Member]" } } }, "localname": "FTZExchangeLLCMember", "nsuri": "http://biopowercorp.com/20220531", "presentation": [ "http://biopowercorp.com/role/OrganizationDetailsNarrative" ], "xbrltype": "domainItemType" }, "BOPO_FiveCustomerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Five Customer [Member]", "label": "Five Customer [Member]" } } }, "localname": "FiveCustomerMember", "nsuri": "http://biopowercorp.com/20220531", "presentation": [ "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "BOPO_GoingConcernPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Going concern [PolicyTextBlock]", "label": "Going Concern" } } }, "localname": "GoingConcernPolicyTextBlock", "nsuri": "http://biopowercorp.com/20220531", "presentation": [ "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "BOPO_GrossSalesCustomaryPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Gross sales customary percentage.", "label": "Gross sales percentage" } } }, "localname": "GrossSalesCustomaryPercentage", "nsuri": "http://biopowercorp.com/20220531", "presentation": [ "http://biopowercorp.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "pureItemType" }, "BOPO_HyFiMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "HyFi [Member]", "label": "HyFi [Member]" } } }, "localname": "HyFiMember", "nsuri": "http://biopowercorp.com/20220531", "presentation": [ "http://biopowercorp.com/role/OrganizationDetailsNarrative" ], "xbrltype": "domainItemType" }, "BOPO_HyFiTokensMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "HyFi Tokens [Member]", "label": "HyFi Tokens [Member]" } } }, "localname": "HyFiTokensMember", "nsuri": "http://biopowercorp.com/20220531", "presentation": [ "http://biopowercorp.com/role/OrganizationDetailsNarrative", "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative", "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative", "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "BOPO_IncreaseDecreaseInLongTermDebt": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase decrease in long term debt.", "label": "Increase decrease in long term debt" } } }, "localname": "IncreaseDecreaseInLongTermDebt", "nsuri": "http://biopowercorp.com/20220531", "presentation": [ "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "BOPO_LenderMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lender [Member]", "label": "Lender [Member]" } } }, "localname": "LenderMember", "nsuri": "http://biopowercorp.com/20220531", "presentation": [ "http://biopowercorp.com/role/NotesPayableAndConvertibleDebtDetailsNarrative" ], "xbrltype": "domainItemType" }, "BOPO_NFTsReceivedFromAcquisition": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "NFTs received from acquisition.", "label": "NFTs received from acquisition" } } }, "localname": "NFTsReceivedFromAcquisition", "nsuri": "http://biopowercorp.com/20220531", "presentation": [ "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative", "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "integerItemType" }, "BOPO_NotesPayableAndConvertibleDebtMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Notes Payable and Convertible Debt [Member]", "label": "Notes Payable and Convertible Debt [Member]" } } }, "localname": "NotesPayableAndConvertibleDebtMember", "nsuri": "http://biopowercorp.com/20220531", "presentation": [ "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "BOPO_NotesPayableSeniorSecuredRelatedParty": { "auth_ref": [], "calculation": { "http://biopowercorp.com/role/BalanceSheets": { "order": 6.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Notes payable senior secured related party.", "label": "Notes payable Senior secured - related party" } } }, "localname": "NotesPayableSeniorSecuredRelatedParty", "nsuri": "http://biopowercorp.com/20220531", "presentation": [ "http://biopowercorp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "BOPO_NumberOfAssets": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of assets.", "label": "Number of assets" } } }, "localname": "NumberOfAssets", "nsuri": "http://biopowercorp.com/20220531", "presentation": [ "http://biopowercorp.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "integerItemType" }, "BOPO_NumberOfTokensIssuedToPurchaseAssets": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of tokens issued to purchase assets.", "label": "number of tokens issued to purchase assets" } } }, "localname": "NumberOfTokensIssuedToPurchaseAssets", "nsuri": "http://biopowercorp.com/20220531", "presentation": [ "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "integerItemType" }, "BOPO_PIPAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "PIP agreement [Member]", "label": "PIP Agreement [Member]" } } }, "localname": "PIPAgreementMember", "nsuri": "http://biopowercorp.com/20220531", "presentation": [ "http://biopowercorp.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "BOPO_PrepaymentPeriodOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "May 31, 2022 to July 30, 2022 [Member]", "label": "May 31, 2022 to July 30, 2022 [Member]" } } }, "localname": "PrepaymentPeriodOneMember", "nsuri": "http://biopowercorp.com/20220531", "presentation": [ "http://biopowercorp.com/role/ScheduleOfAmountOwedOnPrepaymentOfDiagonalLendingNoteDetails" ], "xbrltype": "domainItemType" }, "BOPO_PrepaymentPeriodThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "October 29, 2022 to November 27, 2022 [Member]", "label": "October 29, 2022 to November 27, 2022 [Member]" } } }, "localname": "PrepaymentPeriodThreeMember", "nsuri": "http://biopowercorp.com/20220531", "presentation": [ "http://biopowercorp.com/role/ScheduleOfAmountOwedOnPrepaymentOfDiagonalLendingNoteDetails" ], "xbrltype": "domainItemType" }, "BOPO_PrepaymentPeriodTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "July 31, 2022 to October 28, 2022 [Member]", "label": "July 31, 2022 to October 28, 2022 [Member]" } } }, "localname": "PrepaymentPeriodTwoMember", "nsuri": "http://biopowercorp.com/20220531", "presentation": [ "http://biopowercorp.com/role/ScheduleOfAmountOwedOnPrepaymentOfDiagonalLendingNoteDetails" ], "xbrltype": "domainItemType" }, "BOPO_PurchaseOfVaultsDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Purchase of vaults description.", "label": "Purchase of vaults, description" } } }, "localname": "PurchaseOfVaultsDescription", "nsuri": "http://biopowercorp.com/20220531", "presentation": [ "http://biopowercorp.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "BOPO_ReclassificationOfAccruedCompensationToNotesPayableMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reclassification Of Accrued Compensation To Notes Payable [Member]", "label": "Reclassification of Accrued Compensation To Notes Payable [Member]" } } }, "localname": "ReclassificationOfAccruedCompensationToNotesPayableMember", "nsuri": "http://biopowercorp.com/20220531", "presentation": [ "http://biopowercorp.com/role/ScheduleOfNotesPayableDetails" ], "xbrltype": "domainItemType" }, "BOPO_RedemptionAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Redemption Agreement [Member]", "label": "Redemption Agreement [Member]" } } }, "localname": "RedemptionAgreementMember", "nsuri": "http://biopowercorp.com/20220531", "presentation": [ "http://biopowercorp.com/role/OrganizationDetailsNarrative", "http://biopowercorp.com/role/SeniorPromissoryNoteRelatedPartyDetailsNarrative", "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "BOPO_ReductionInLiabilityShareIssurance": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Reduction in liability share issurance.", "label": "Reduction in liability insurance" } } }, "localname": "ReductionInLiabilityShareIssurance", "nsuri": "http://biopowercorp.com/20220531", "presentation": [ "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "BOPO_RelatedPartiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related Parties [Member]", "label": "Related Parties [Member]" } } }, "localname": "RelatedPartiesMember", "nsuri": "http://biopowercorp.com/20220531", "presentation": [ "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "BOPO_RestrictedCommonStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Restricted common stock [Member]", "label": "Restricted Common Stock [Member]" } } }, "localname": "RestrictedCommonStockMember", "nsuri": "http://biopowercorp.com/20220531", "presentation": [ "http://biopowercorp.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "BOPO_RobertKohnMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Robert Kohn [Member]", "label": "Robert Kohn [Member]" } } }, "localname": "RobertKohnMember", "nsuri": "http://biopowercorp.com/20220531", "presentation": [ "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative", "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "BOPO_SaleOfTokensMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of tokens [Member]", "label": "Sale of Tokens [Member]" } } }, "localname": "SaleOfTokensMember", "nsuri": "http://biopowercorp.com/20220531", "presentation": [ "http://biopowercorp.com/role/StatementsOfOperations" ], "xbrltype": "domainItemType" }, "BOPO_SaleOfTokensRelatedPartyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of Tokens - Related Party [Member]", "label": "Sale of Tokens - Related Party [Member]" } } }, "localname": "SaleOfTokensRelatedPartyMember", "nsuri": "http://biopowercorp.com/20220531", "presentation": [ "http://biopowercorp.com/role/StatementsOfOperations" ], "xbrltype": "domainItemType" }, "BOPO_SanctumAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sanctum agreement [Member]", "label": "Sanctum Agreement [Member]" } } }, "localname": "SanctumAgreementMember", "nsuri": "http://biopowercorp.com/20220531", "presentation": [ "http://biopowercorp.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "BOPO_ScheduleOfAmountOwedOnPrepaymentOfDiagonalLendingNoteTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of amount owed on prepayment of diagonal lending note [Table Text Block]", "label": "Schedule of Amount Owed on Prepayment of Diagonal Lending Note" } } }, "localname": "ScheduleOfAmountOwedOnPrepaymentOfDiagonalLendingNoteTableTextBlock", "nsuri": "http://biopowercorp.com/20220531", "presentation": [ "http://biopowercorp.com/role/SubsequentEventsTables" ], "xbrltype": "textBlockItemType" }, "BOPO_SecuritiesPurchaseAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Securities Purchase Agreement [Member]", "label": "Securities Purchase Agreement [Member]" } } }, "localname": "SecuritiesPurchaseAgreementMember", "nsuri": "http://biopowercorp.com/20220531", "presentation": [ "http://biopowercorp.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "BOPO_SeniorPromissoryNoteRelatedPartyDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Senior Promissory Note Related Party Disclosure [Text Block]", "label": "Senior Promissory Note \u2013 related party" } } }, "localname": "SeniorPromissoryNoteRelatedPartyDisclosureTextBlock", "nsuri": "http://biopowercorp.com/20220531", "presentation": [ "http://biopowercorp.com/role/SeniorPromissoryNoteRelatedParty" ], "xbrltype": "textBlockItemType" }, "BOPO_StockPurchaseAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock Purchase Agreement [Member]", "label": "Stock Purchase Agreement [Member]" } } }, "localname": "StockPurchaseAgreementMember", "nsuri": "http://biopowercorp.com/20220531", "presentation": [ "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "BOPO_TechnologyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Technology [Member]", "label": "Technology [Member]" } } }, "localname": "TechnologyMember", "nsuri": "http://biopowercorp.com/20220531", "presentation": [ "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "BOPO_ThirdPartiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Third Parties [Member]", "label": "Third Parties [Member]" } } }, "localname": "ThirdPartiesMember", "nsuri": "http://biopowercorp.com/20220531", "presentation": [ "http://biopowercorp.com/role/NotesPayableAndConvertibleDebtDetailsNarrative" ], "xbrltype": "domainItemType" }, "BOPO_ThirdPartyInvestorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Third Party Investor [Member]", "label": "Third Party Investor [Member]" } } }, "localname": "ThirdPartyInvestorMember", "nsuri": "http://biopowercorp.com/20220531", "presentation": [ "http://biopowercorp.com/role/NotesPayableAndConvertibleDebtDetailsNarrative", "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "BOPO_ThirdPartyInvestorOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Third Party Investor One [Member]", "label": "Third Party Investor One [Member]" } } }, "localname": "ThirdPartyInvestorOneMember", "nsuri": "http://biopowercorp.com/20220531", "presentation": [ "http://biopowercorp.com/role/NotesPayableAndConvertibleDebtDetailsNarrative" ], "xbrltype": "domainItemType" }, "BOPO_ThirdPartyInvestorTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Third Party Investor Two [Member]", "label": "Third Party Investor Two [Member]" } } }, "localname": "ThirdPartyInvestorTwoMember", "nsuri": "http://biopowercorp.com/20220531", "presentation": [ "http://biopowercorp.com/role/NotesPayableAndConvertibleDebtDetailsNarrative" ], "xbrltype": "domainItemType" }, "BOPO_ThreeNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Three Notes [Member]", "label": "Three Notes [Member]" } } }, "localname": "ThreeNotesMember", "nsuri": "http://biopowercorp.com/20220531", "presentation": [ "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "BOPO_TokenPrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Token price", "label": "[custom:TokenPrice-0]" } } }, "localname": "TokenPrice", "nsuri": "http://biopowercorp.com/20220531", "presentation": [ "http://biopowercorp.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "BOPO_TokensIssuedDuringPeriodSharesNewIssues": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tokens issued during period shares new issues", "label": "[custom:TokensIssuedDuringPeriodSharesNewIssues]" } } }, "localname": "TokensIssuedDuringPeriodSharesNewIssues", "nsuri": "http://biopowercorp.com/20220531", "presentation": [ "http://biopowercorp.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "BOPO_TokensIssuedDuringPeriodSharesNewIssuesValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tokens issued during period shares new issues value.", "label": "[custom:TokensIssuedDuringPeriodSharesNewIssuesValue]" } } }, "localname": "TokensIssuedDuringPeriodSharesNewIssuesValue", "nsuri": "http://biopowercorp.com/20220531", "presentation": [ "http://biopowercorp.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "BOPO_TroyMacDonaldMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Troy Mac Donald [Member]", "label": "Troy Mac Donald [Member]" } } }, "localname": "TroyMacDonaldMember", "nsuri": "http://biopowercorp.com/20220531", "presentation": [ "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "BOPO_TwoCustomerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two Customer [Member]", "label": "Two Customer [Member]" } } }, "localname": "TwoCustomerMember", "nsuri": "http://biopowercorp.com/20220531", "presentation": [ "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biopowercorp.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biopowercorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r468" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biopowercorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r468" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biopowercorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biopowercorp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biopowercorp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biopowercorp.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r467" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biopowercorp.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r465", "r467", "r468" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biopowercorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biopowercorp.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biopowercorp.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biopowercorp.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biopowercorp.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r466" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biopowercorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r454" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biopowercorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r467" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biopowercorp.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r467" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biopowercorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r469" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biopowercorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biopowercorp.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r457" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biopowercorp.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biopowercorp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biopowercorp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biopowercorp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biopowercorp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biopowercorp.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biopowercorp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biopowercorp.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r460" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biopowercorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r456" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biopowercorp.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biopowercorp.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biopowercorp.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biopowercorp.com/role/OrganizationDetailsNarrative", "http://biopowercorp.com/role/SeniorPromissoryNoteRelatedPartyDetailsNarrative", "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r456" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biopowercorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r480" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biopowercorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biopowercorp.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r456" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biopowercorp.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biopowercorp.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r477" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biopowercorp.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r468" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biopowercorp.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biopowercorp.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r456" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biopowercorp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r456" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biopowercorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r456" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biopowercorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r456" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biopowercorp.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biopowercorp.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r478" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biopowercorp.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biopowercorp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biopowercorp.com/role/OrganizationDetailsNarrative", "http://biopowercorp.com/role/SeniorPromissoryNoteRelatedPartyDetailsNarrative", "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biopowercorp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biopowercorp.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r467" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biopowercorp.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r461" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biopowercorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r462" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biopowercorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r455" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biopowercorp.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r459" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biopowercorp.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r458" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biopowercorp.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r463" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biopowercorp.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r464" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biopowercorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biopowercorp.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r479" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://biopowercorp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "srt_ChiefExecutiveOfficerMember": { "auth_ref": [ "r131" ], "lang": { "en-us": { "role": { "label": "Chief Executive Officer [Member]" } } }, "localname": "ChiefExecutiveOfficerMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://biopowercorp.com/role/OrganizationDetailsNarrative", "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_ChiefFinancialOfficerMember": { "auth_ref": [ "r131" ], "lang": { "en-us": { "role": { "label": "Chief Financial Officer [Member]" } } }, "localname": "ChiefFinancialOfficerMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_ChiefOperatingOfficerMember": { "auth_ref": [ "r131", "r361" ], "lang": { "en-us": { "role": { "label": "Chief Operating Officer [Member]" } } }, "localname": "ChiefOperatingOfficerMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_EquityMethodInvesteeNameDomain": { "auth_ref": [], "localname": "EquityMethodInvesteeNameDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://biopowercorp.com/role/OrganizationDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [ "r130", "r264", "r266", "r442" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [ "r172", "r173", "r174", "r175", "r193", "r232", "r271", "r273", "r377", "r378", "r379", "r380", "r381", "r382", "r401", "r440", "r443", "r452", "r453" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://biopowercorp.com/role/ScheduleOfNotesPayableDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r172", "r173", "r174", "r175", "r193", "r232", "r271", "r273", "r377", "r378", "r379", "r380", "r381", "r382", "r401", "r440", "r443", "r452", "r453" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://biopowercorp.com/role/ScheduleOfNotesPayableDetails" ], "xbrltype": "domainItemType" }, "srt_NameOfMajorCustomerDomain": { "auth_ref": [ "r130", "r264", "r266", "r442" ], "localname": "NameOfMajorCustomerDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r128", "r173", "r174", "r264", "r265", "r403", "r439", "r441" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://biopowercorp.com/role/StatementsOfOperations", "http://biopowercorp.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r128", "r173", "r174", "r264", "r265", "r403", "r439", "r441" ], "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://biopowercorp.com/role/StatementsOfOperations", "http://biopowercorp.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r168", "r172", "r173", "r174", "r175", "r193", "r232", "r268", "r271", "r273", "r302", "r303", "r304", "r377", "r378", "r379", "r380", "r381", "r382", "r401", "r440", "r443", "r452", "r453" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://biopowercorp.com/role/ScheduleOfNotesPayableDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r168", "r172", "r173", "r174", "r175", "r193", "r232", "r268", "r271", "r273", "r302", "r303", "r304", "r377", "r378", "r379", "r380", "r381", "r382", "r401", "r440", "r443", "r452", "r453" ], "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://biopowercorp.com/role/ScheduleOfNotesPayableDetails" ], "xbrltype": "domainItemType" }, "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": { "auth_ref": [ "r146" ], "lang": { "en-us": { "role": { "label": "Investment, Name [Axis]" } } }, "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://biopowercorp.com/role/OrganizationDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r131", "r361" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://biopowercorp.com/role/OrganizationDetailsNarrative", "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative", "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://biopowercorp.com/role/OrganizationDetailsNarrative", "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative", "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": { "auth_ref": [ "r28" ], "calculation": { "http://biopowercorp.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.", "label": "Accounts payable and accrued expenses" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableRelatedPartiesCurrent": { "auth_ref": [ "r26", "r72", "r360", "r362" ], "calculation": { "http://biopowercorp.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount for accounts payable to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts payable and accrued expenses - related party" } } }, "localname": "AccountsPayableRelatedPartiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r132", "r133" ], "calculation": { "http://biopowercorp.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts receivable" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedSalariesCurrentAndNoncurrent": { "auth_ref": [ "r420", "r435" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided.", "label": "Accrued salary" } } }, "localname": "AccruedSalariesCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r17", "r367" ], "calculation": { "http://biopowercorp.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r75", "r76", "r77", "r307", "r308", "r309", "r337" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/StatementsOfChangesInStockholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net loss to net" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r306" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Accrued compensation" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "localname": "ArrangementsAndNonarrangementTransactionsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://biopowercorp.com/role/NotesPayableAndConvertibleDebtDetailsNarrative", "http://biopowercorp.com/role/OrganizationDetailsNarrative", "http://biopowercorp.com/role/SeniorPromissoryNoteRelatedPartyDetailsNarrative", "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative", "http://biopowercorp.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r9", "r71", "r118", "r121", "r126", "r147", "r178", "r179", "r180", "r181", "r182", "r183", "r184", "r185", "r186", "r187", "r188", "r329", "r332", "r343", "r365", "r367", "r416", "r429" ], "calculation": { "http://biopowercorp.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets [Default Label]", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current assets" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r277", "r278", "r279", "r281", "r282", "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r301", "r302", "r303", "r304", "r305" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/ScheduleOfAmountOwedOnPrepaymentOfDiagonalLendingNoteDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r270", "r272", "r324" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree." } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/OrganizationDetailsNarrative", "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative", "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r270", "r272", "r322", "r323", "r324" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/OrganizationDetailsNarrative", "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative", "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity": { "auth_ref": [ "r321" ], "lang": { "en-us": { "role": { "documentation": "With respect to a business combination completed during the period, this element provides a description of the business, other than the name, which may include the industry, size, products and other important information.", "label": "Business combination description" } } }, "localname": "BusinessAcquisitionDescriptionOfAcquiredEntity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/OrganizationDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "auth_ref": [ "r325", "r326", "r327" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.", "label": "Cash consideration, acquisition" } } }, "localname": "BusinessCombinationConsiderationTransferred1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/OrganizationDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAcquiredFromAcquisition": { "auth_ref": [ "r47" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).", "label": "Proceeds from acquisition" } } }, "localname": "CashAcquiredFromAcquisition", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative", "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r3", "r8", "r56" ], "calculation": { "http://biopowercorp.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and cash equivalents", "verboseLabel": "Cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/BalanceSheets", "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r57" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "verboseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "auth_ref": [ "r51", "r56", "r62" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations", "periodEndLabel": "Cash and cash equivalents at end of period", "periodStartLabel": "Cash and cash equivalents at beginning of period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r51", "r344" ], "calculation": { "http://biopowercorp.com/role/StatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net increase in cash and cash equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r13", "r14", "r15", "r68", "r71", "r89", "r90", "r91", "r93", "r95", "r102", "r103", "r104", "r147", "r178", "r182", "r183", "r184", "r187", "r188", "r230", "r231", "r235", "r239", "r246", "r343", "r470" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/BalanceSheets", "http://biopowercorp.com/role/BalanceSheetsParenthetical", "http://biopowercorp.com/role/OrganizationDetailsNarrative", "http://biopowercorp.com/role/SeniorPromissoryNoteRelatedPartyDetailsNarrative", "http://biopowercorp.com/role/StatementsOfChangesInStockholdersDeficit", "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative", "http://biopowercorp.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Stock [Line Items]" } } }, "localname": "ClassOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]" } } }, "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/NotesPayableAndConvertibleDebtDetailsNarrative", "http://biopowercorp.com/role/OrganizationDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r34", "r421", "r434" ], "calculation": { "http://biopowercorp.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies (Note 9)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r169", "r170", "r171", "r176", "r451" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/CommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r75", "r76", "r337" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/StatementsOfChangesInStockholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common stock, par value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/BalanceSheetsParenthetical", "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/BalanceSheetsParenthetical", "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative", "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common stock, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/BalanceSheetsParenthetical", "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative", "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r15", "r246" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common stock, shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/BalanceSheetsParenthetical", "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative", "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r15", "r367" ], "calculation": { "http://biopowercorp.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common stock, $.0001 par value: 500,000,000 authorized; 45,625,000 and 45,000,000 issued and outstanding on May 31, 2022 and November 30, 2021, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r111", "r112", "r130", "r341", "r342", "r450" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r111", "r112", "r130", "r341", "r342", "r449", "r450" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r111", "r112", "r130", "r341", "r342", "r449", "r450" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskCreditRisk": { "auth_ref": [ "r107", "r426" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for credit risk.", "label": "Concentration" } } }, "localname": "ConcentrationRiskCreditRisk", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r111", "r112", "r130", "r341", "r342" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration risk, percentage" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r111", "r112", "r130", "r341", "r342", "r450" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r64", "r331" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "Principles of Consolidation" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConversionOfStockDescription": { "auth_ref": [ "r59", "r60", "r61" ], "lang": { "en-us": { "role": { "documentation": "A unique description of a noncash or part noncash stock conversion. The description would be expected to include sufficient information to provide an understanding of the nature and purpose of the conversion. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Conversion of stock, description" } } }, "localname": "ConversionOfStockDescription", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConversionOfStockSharesConverted1": { "auth_ref": [ "r59", "r60", "r61" ], "lang": { "en-us": { "role": { "documentation": "The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Stock conversion, shares" } } }, "localname": "ConversionOfStockSharesConverted1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/OrganizationDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ConversionOfStockSharesIssued1": { "auth_ref": [ "r59", "r60", "r61" ], "lang": { "en-us": { "role": { "documentation": "The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Stock conversion, issued shares", "verboseLabel": "Conversion of stock shares issued" } } }, "localname": "ConversionOfStockSharesIssued1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/OrganizationDetailsNarrative", "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ConvertibleDebt": { "auth_ref": [ "r12", "r418", "r430" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company.", "label": "Convertible Debt", "verboseLabel": "Convertible debt" } } }, "localname": "ConvertibleDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/NotesPayableAndConvertibleDebtDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleDebtCurrent": { "auth_ref": [ "r10" ], "calculation": { "http://biopowercorp.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.", "label": "Convertible debt" } } }, "localname": "ConvertibleDebtCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleDebtMember": { "auth_ref": [ "r189", "r190", "r191", "r193", "r203", "r204", "r205", "r209", "r210", "r211", "r212", "r213", "r221", "r222", "r223", "r224" ], "lang": { "en-us": { "role": { "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.", "label": "Convertible Debt [Member]" } } }, "localname": "ConvertibleDebtMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_CustomerConcentrationRiskMember": { "auth_ref": [ "r110", "r130" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.", "label": "Customer Concentration Risk [Member]" } } }, "localname": "CustomerConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r67", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r207", "r214", "r215", "r217", "r225" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Notes Payable and Convertible Debt" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/NotesPayableAndConvertibleDebt" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAnnualPrincipalPayment": { "auth_ref": [ "r12" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the total principal payments made during the annual reporting period.", "label": "Debt payment amount" } } }, "localname": "DebtInstrumentAnnualPrincipalPayment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r10", "r11", "r12", "r70", "r73", "r190", "r191", "r192", "r193", "r194", "r195", "r197", "r203", "r204", "r205", "r206", "r208", "r209", "r210", "r211", "r212", "r213", "r221", "r222", "r223", "r224", "r353", "r417", "r418", "r428" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative", "http://biopowercorp.com/role/ScheduleOfNotesPayableDetails", "http://biopowercorp.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentConvertibleConversionPrice1": { "auth_ref": [ "r192", "r218" ], "lang": { "en-us": { "role": { "documentation": "The price per share of the conversion feature embedded in the debt instrument.", "label": "Conversion price per share", "verboseLabel": "Debt instrument, convertible, conversion price" } } }, "localname": "DebtInstrumentConvertibleConversionPrice1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/NotesPayableAndConvertibleDebtDetailsNarrative", "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.", "label": "Debt instrument, conversion percentage" } } }, "localname": "DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentDescription": { "auth_ref": [ "r10", "r12", "r247", "r417", "r418", "r425", "r428" ], "lang": { "en-us": { "role": { "documentation": "Identification of the lender and information about a contractual promise to repay a short-term or long-term obligation, which includes borrowings under lines of credit, notes payable, commercial paper, bonds payable, debentures, and other contractual obligations for payment. This may include rationale for entering into the arrangement, significant terms of the arrangement, which may include amount, repayment terms, priority, collateral required, debt covenants, borrowing capacity, call features, participation rights, conversion provisions, sinking-fund requirements, voting rights, basis for conversion if convertible and remarketing provisions. The description may be provided for individual debt instruments, rational groupings of debt instruments, or by debt in total.", "label": "Debt instrument, description", "verboseLabel": "Debt description" } } }, "localname": "DebtInstrumentDescription", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative", "http://biopowercorp.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r190", "r221", "r222", "r352", "r353", "r354" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt instrument, principal value", "terseLabel": "Principal amount", "verboseLabel": "Debt instrument, face amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/OrganizationDetailsNarrative", "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative", "http://biopowercorp.com/role/SeniorPromissoryNoteRelatedPartyDetailsNarrative", "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative", "http://biopowercorp.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateDuringPeriod": { "auth_ref": [ "r31", "r210", "r352" ], "lang": { "en-us": { "role": { "documentation": "The average effective interest rate during the reporting period.", "label": "Debt principal interest rate" } } }, "localname": "DebtInstrumentInterestRateDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentInterestRateEffectivePercentage": { "auth_ref": [ "r31", "r219", "r352", "r353" ], "lang": { "en-us": { "role": { "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.", "label": "Debt instrument, original percentage", "terseLabel": "Debt instrument, interest rate", "verboseLabel": "Debt instrument, interest rate, effective percentage" } } }, "localname": "DebtInstrumentInterestRateEffectivePercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/NotesPayableAndConvertibleDebtDetailsNarrative", "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative", "http://biopowercorp.com/role/SeniorPromissoryNoteRelatedPartyDetailsNarrative", "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r31", "r191" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Interest rate", "terseLabel": "Debt instrument, interest rate, stated percentage", "verboseLabel": "Debt instrument, interest" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/NotesPayableAndConvertibleDebtDetailsNarrative", "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative", "http://biopowercorp.com/role/ScheduleOfNotesPayableDetails", "http://biopowercorp.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentMaturityDate": { "auth_ref": [ "r32", "r193", "r340" ], "lang": { "en-us": { "role": { "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.", "label": "Debt instrument maturity date", "terseLabel": "Debt maturity date", "verboseLabel": "Debt instrument, maturity date" } } }, "localname": "DebtInstrumentMaturityDate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/NotesPayableAndConvertibleDebtDetailsNarrative", "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative", "http://biopowercorp.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "dateItemType" }, "us-gaap_DebtInstrumentMaturityDateDescription": { "auth_ref": [ "r32" ], "lang": { "en-us": { "role": { "documentation": "Description of the maturity date of the debt instrument including whether the debt matures serially and, if so, a brief description of the serial maturities.", "label": "Maturity date" } } }, "localname": "DebtInstrumentMaturityDateDescription", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/ScheduleOfNotesPayableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r33", "r70", "r73", "r190", "r191", "r192", "r193", "r194", "r195", "r197", "r203", "r204", "r205", "r206", "r208", "r209", "r210", "r211", "r212", "r213", "r221", "r222", "r223", "r224", "r353" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative", "http://biopowercorp.com/role/ScheduleOfNotesPayableDetails", "http://biopowercorp.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r43", "r80", "r81", "r82", "r83", "r84", "r88", "r89", "r93", "r94", "r95", "r98", "r99", "r338", "r339", "r423", "r438" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Net loss per common share: basic and diluted" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/StatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r96", "r97" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Net Loss per Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r0", "r39", "r40", "r41", "r75", "r76", "r77", "r79", "r85", "r87", "r101", "r148", "r246", "r253", "r307", "r308", "r309", "r319", "r320", "r337", "r345", "r346", "r347", "r348", "r349", "r350", "r355", "r444", "r445", "r446" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/StatementsOfChangesInStockholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "auth_ref": [ "r146" ], "lang": { "en-us": { "role": { "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.", "label": "Ownership percentage" } } }, "localname": "EquityMethodInvestmentOwnershipPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/OrganizationDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_FinancialInstrumentAxis": { "auth_ref": [ "r141", "r142", "r143", "r144", "r145", "r149", "r150", "r151", "r152", "r153", "r154", "r155", "r156", "r157", "r216", "r244", "r335", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r470", "r471", "r472", "r473", "r474", "r475", "r476" ], "lang": { "en-us": { "role": { "documentation": "Information by type of financial instrument.", "label": "Financial Instrument [Axis]" } } }, "localname": "FinancialInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r38", "r313", "r314", "r315", "r316", "r317", "r318" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [ "r58" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.", "label": "Cash paid for income taxes" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r54" ], "calculation": { "http://biopowercorp.com/role/StatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "verboseLabel": "Accounts payable and accrued expenses" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties": { "auth_ref": [ "r54" ], "calculation": { "http://biopowercorp.com/role/StatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the obligations due for goods and services provided by the following types of related parties: a parent company and its subsidiaries, subsidiaries of a common parent, an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management, an entity and its principal owners, management, or member of their immediate families, affiliates, or other parties with the ability to exert significant influence.", "label": "Increase (Decrease) in Accounts Payable, Related Parties", "verboseLabel": "Accounts payable and accrued expenses - related party" } } }, "localname": "IncreaseDecreaseInAccountsPayableRelatedParties", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r54" ], "calculation": { "http://biopowercorp.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Increase in accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedSalaries": { "auth_ref": [ "r54" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the period in accrued salaries.", "label": "Decrease in accrued salaries" } } }, "localname": "IncreaseDecreaseInAccruedSalaries", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r54" ], "calculation": { "http://biopowercorp.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "increase in inventory" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Changes in operating assets and liabilities" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInPrepaidExpense": { "auth_ref": [ "r54" ], "calculation": { "http://biopowercorp.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.", "label": "Increase (Decrease) in Prepaid Expense", "negatedLabel": "Increase in prepaid expenses" } } }, "localname": "IncreaseDecreaseInPrepaidExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r163", "r164" ], "lang": { "en-us": { "role": { "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.", "label": "Indefinite-Lived Intangible Assets [Axis]" } } }, "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Indefinite-Lived Intangible Assets [Line Items]" } } }, "localname": "IndefiniteLivedIntangibleAssetsByMajorClassLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r163", "r164" ], "lang": { "en-us": { "role": { "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company." } } }, "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_IndefiniteLivedLicenseAgreements": { "auth_ref": [ "r164" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount (original costs adjusted for previously recognized amortization and impairment) as of the balance sheet date for the capitalized costs to acquire rights under a license arrangement (for example, to sell specified products in a specified territory) having an indefinite period of benefit.", "label": "Exclusive license Amount" } } }, "localname": "IndefiniteLivedLicenseAgreements", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseDebt": { "auth_ref": [ "r45", "r211", "r220", "r223", "r224" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.", "label": "Interest expense" } } }, "localname": "InterestExpenseDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/NotesPayableAndConvertibleDebtDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseOther": { "auth_ref": [], "calculation": { "http://biopowercorp.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OtherNonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of interest expense classified as other.", "label": "Interest Expense, Other", "negatedLabel": "Interest expense", "verboseLabel": "Interest expense" } } }, "localname": "InterestExpenseOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/SeniorPromissoryNoteRelatedPartyDetailsNarrative", "http://biopowercorp.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseRelatedParty": { "auth_ref": [], "calculation": { "http://biopowercorp.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OtherNonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of interest expense incurred on a debt or other obligation to related party.", "label": "Interest expense related party", "negatedLabel": "Interest expense -related party" } } }, "localname": "InterestExpenseRelatedParty", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative", "http://biopowercorp.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r50", "r52", "r58" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Cash paid for interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPayableCurrent": { "auth_ref": [ "r29" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Interest Payable, Current", "verboseLabel": "Accrued interest" } } }, "localname": "InterestPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative", "http://biopowercorp.com/role/SeniorPromissoryNoteRelatedPartyDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPayableCurrentAndNoncurrent": { "auth_ref": [ "r420", "r435" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of interest payable on debt, including, but not limited to, trade payables.", "label": "Accrued interest" } } }, "localname": "InterestPayableCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/NotesPayableAndConvertibleDebtDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestReceivable": { "auth_ref": [ "r16" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of interest earned but not received. Also called accrued interest or accrued interest receivable.", "label": "Accurued interest" } } }, "localname": "InterestReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r4", "r23", "r367" ], "calculation": { "http://biopowercorp.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/BalanceSheets", "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryPolicyTextBlock": { "auth_ref": [ "r7", "r22", "r65", "r100", "r158", "r159", "r160", "r402" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.", "label": "Inventory, Policy [Policy Text Block]", "verboseLabel": "Inventory" } } }, "localname": "InventoryPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestorMember": { "auth_ref": [ "r358", "r359" ], "lang": { "en-us": { "role": { "documentation": "Business entity or individual that puts money, by purchase or expenditure, in something offering potential profitable returns, such as interest income or appreciation in value.", "label": "Investor [Member]" } } }, "localname": "InvestorMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r21", "r71", "r147", "r343", "r367", "r419", "r432" ], "calculation": { "http://biopowercorp.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and stockholders\u2019 deficit" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Stockholders\u2019 Deficit" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r6", "r30", "r71", "r147", "r178", "r179", "r180", "r182", "r183", "r184", "r185", "r186", "r187", "r188", "r330", "r332", "r333", "r343", "r365", "r366", "r367" ], "calculation": { "http://biopowercorp.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current liabilities" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LoansPayable": { "auth_ref": [ "r12", "r418", "r427" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Including the current and noncurrent portions, aggregate carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer).", "label": "Loans Payable" } } }, "localname": "LoansPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r33" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-Term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r33", "r177" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r51" ], "calculation": { "http://biopowercorp.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flow from financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r51", "r53", "r55" ], "calculation": { "http://biopowercorp.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r1", "r36", "r37", "r41", "r42", "r55", "r71", "r78", "r80", "r81", "r82", "r83", "r86", "r87", "r92", "r118", "r120", "r122", "r125", "r127", "r147", "r178", "r179", "r180", "r182", "r183", "r184", "r185", "r186", "r187", "r188", "r339", "r343", "r422", "r437" ], "calculation": { "http://biopowercorp.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://biopowercorp.com/role/StatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net loss", "totalLabel": "Net loss", "verboseLabel": "Net loss, for six months ended May 31, 2022" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/StatementsOfCashFlows", "http://biopowercorp.com/role/StatementsOfChangesInStockholdersDeficit", "http://biopowercorp.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "Recent Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NotesPayable": { "auth_ref": [ "r12", "r418", "r430" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.", "label": "Balance", "verboseLabel": "Notes Payable" } } }, "localname": "NotesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/NotesPayableAndConvertibleDebtDetailsNarrative", "http://biopowercorp.com/role/ScheduleOfNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesPayableCurrent": { "auth_ref": [ "r28" ], "calculation": { "http://biopowercorp.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.", "label": "Notes payable" } } }, "localname": "NotesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesPayableRelatedPartiesClassifiedCurrent": { "auth_ref": [ "r25", "r72", "r360" ], "calculation": { "http://biopowercorp.com/role/BalanceSheets": { "order": 8.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount for notes payable (written promise to pay), due to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Notes payable - related parties" } } }, "localname": "NotesPayableRelatedPartiesClassifiedCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent": { "auth_ref": [ "r72", "r359", "r436" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount for notes payable (written promise to pay), due to related parties.", "label": "Notes payable to related parties" } } }, "localname": "NotesPayableRelatedPartiesCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://biopowercorp.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "totalLabel": "Total operating expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating expenses" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r118", "r120", "r122", "r125", "r127" ], "calculation": { "http://biopowercorp.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Income / (Loss) from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r2", "r334" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "Organization" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/Organization" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r46" ], "calculation": { "http://biopowercorp.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "Other Nonoperating Income (Expense)", "totalLabel": "Total other expenses" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other expenses" } } }, "localname": "OtherNonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OtherNotesPayable": { "auth_ref": [ "r12", "r418", "r430" ], "calculation": { "http://biopowercorp.com/role/BalanceSheets": { "order": 7.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term notes payable classified as other.", "label": "Other Notes Payable", "verboseLabel": "Notes payable" } } }, "localname": "OtherNotesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireIntangibleAssets": { "auth_ref": [ "r48" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.", "label": "Payment for asset" } } }, "localname": "PaymentsToAcquireIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.", "label": "Preferred Stock [Member]" } } }, "localname": "PreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/StatementsOfChangesInStockholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r14", "r230" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred stock, par value" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/BalanceSheetsParenthetical", "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative", "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred stock, shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/BalanceSheetsParenthetical", "http://biopowercorp.com/role/OrganizationDetailsNarrative", "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative", "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r14", "r230" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred stock, shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/BalanceSheetsParenthetical", "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative", "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred stock, shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/BalanceSheetsParenthetical", "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative", "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r14", "r367" ], "calculation": { "http://biopowercorp.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred stock, value" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockVotingRights": { "auth_ref": [ "r14", "r247" ], "lang": { "en-us": { "role": { "documentation": "Description of voting rights of nonredeemable preferred stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights.", "label": "Number of preferred stock voting rights" } } }, "localname": "PreferredStockVotingRights", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/OrganizationDetailsNarrative", "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_PrepaidExpenseCurrent": { "auth_ref": [ "r5", "r24", "r161", "r162" ], "calculation": { "http://biopowercorp.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid expenses" } } }, "localname": "PrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "auth_ref": [ "r49" ], "calculation": { "http://biopowercorp.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the additional capital contribution to the entity.", "label": "Proceeds from issuance of common stock" } } }, "localname": "ProceedsFromIssuanceOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Product Information [Line Items]" } } }, "localname": "ProductInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r167" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r167", "r367", "r424", "r433" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Value of purchased assets" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r166" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r269", "r358", "r359" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/NotesPayableAndConvertibleDebtDetailsNarrative", "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative", "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Related Party Transaction [Line Items]" } } }, "localname": "RelatedPartyTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Identify the stated interest rate per the agreement, for example, leasing and debt arrangements between related parties.", "label": "Related party transaction, rate" } } }, "localname": "RelatedPartyTransactionRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r269", "r358", "r362", "r404", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/NotesPayableAndConvertibleDebtDetailsNarrative", "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative", "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r356", "r357", "r359", "r363", "r364" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/RelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r18", "r253", "r367", "r431", "r447", "r448" ], "calculation": { "http://biopowercorp.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated deficit", "negatedLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/BalanceSheets", "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r0", "r75", "r76", "r77", "r79", "r85", "r87", "r148", "r307", "r308", "r309", "r319", "r320", "r337", "r444", "r446" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/StatementsOfChangesInStockholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r116", "r117", "r119", "r123", "r124", "r128", "r129", "r130", "r263", "r264", "r403" ], "calculation": { "http://biopowercorp.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Total Revenue" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": { "auth_ref": [ "r66", "r255", "r256", "r257", "r258", "r259", "r260", "r261", "r262", "r267" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue from contract with customer.", "label": "Revenue Recognition" } } }, "localname": "RevenueFromContractWithCustomerPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenuesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenue:" } } }, "localname": "RevenuesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cash received on stock transaction after deduction of issuance costs.", "label": "Purchase price" } } }, "localname": "SaleOfStockConsiderationReceivedOnTransaction", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.", "label": "Sale of Stock, Number of Shares Issued in Transaction", "verboseLabel": "Number of shares issued" } } }, "localname": "SaleOfStockNumberOfSharesIssuedInTransaction", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_SalesRevenueNetMember": { "auth_ref": [ "r111", "r130" ], "lang": { "en-us": { "role": { "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.", "label": "Revenue Benchmark [Member]" } } }, "localname": "SalesRevenueNetMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": { "auth_ref": [ "r328" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]" } } }, "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/NotesPayableAndConvertibleDebtDetailsNarrative", "http://biopowercorp.com/role/OrganizationDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfDebtTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.", "label": "Schedule of Notes Payable" } } }, "localname": "ScheduleOfDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/NotesPayableAndConvertibleDebtTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable": { "auth_ref": [ "r164", "r165" ], "lang": { "en-us": { "role": { "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity.", "label": "Schedule of Indefinite-Lived Intangible Assets [Table]" } } }, "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfProductInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line.", "label": "Schedule of Product Information [Table]" } } }, "localname": "ScheduleOfProductInformationTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "auth_ref": [ "r360", "r362" ], "lang": { "en-us": { "role": { "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Schedule of Related Party Transactions, by Related Party [Table]" } } }, "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r275", "r276", "r277", "r278", "r279", "r281", "r282", "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r301", "r302", "r303", "r304", "r305" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/ScheduleOfAmountOwedOnPrepaymentOfDiagonalLendingNoteDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShortTermDebtTable": { "auth_ref": [ "r27" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to borrowings under which repayment was required in less than twelve months (or normal operating cycle, if longer) after its issuance. It may include: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date and measures of the maximum and average amount outstanding during the period; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.", "label": "Schedule of Short-Term Debt [Table]" } } }, "localname": "ScheduleOfShortTermDebtTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/ScheduleOfNotesPayableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfStockByClassTable": { "auth_ref": [ "r13", "r14", "r15", "r68", "r102", "r103", "r226", "r227", "r229", "r230", "r231", "r232", "r233", "r235", "r239", "r244", "r246", "r247", "r248", "r249", "r250", "r251", "r252", "r253" ], "lang": { "en-us": { "role": { "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.", "label": "Schedule of Stock by Class [Table]" } } }, "localname": "ScheduleOfStockByClassTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r44" ], "calculation": { "http://biopowercorp.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling, general and administrative expenses" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_SeriesAPreferredStockMember": { "auth_ref": [ "r13", "r14", "r246" ], "lang": { "en-us": { "role": { "documentation": "Series A preferred stock.", "label": "Series A Preferred Stock [Member]" } } }, "localname": "SeriesAPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/BalanceSheets", "http://biopowercorp.com/role/BalanceSheetsParenthetical", "http://biopowercorp.com/role/OrganizationDetailsNarrative", "http://biopowercorp.com/role/SeniorPromissoryNoteRelatedPartyDetailsNarrative", "http://biopowercorp.com/role/StatementsOfChangesInStockholdersDeficit", "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SeriesCPreferredStockMember": { "auth_ref": [ "r13", "r14", "r246" ], "lang": { "en-us": { "role": { "documentation": "Series C preferred stock.", "label": "Series C Preferred Stock [Member]" } } }, "localname": "SeriesCPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/BalanceSheets", "http://biopowercorp.com/role/BalanceSheetsParenthetical", "http://biopowercorp.com/role/OrganizationDetailsNarrative", "http://biopowercorp.com/role/StatementsOfChangesInStockholdersDeficit", "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/ScheduleOfAmountOwedOnPrepaymentOfDiagonalLendingNoteDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": { "auth_ref": [ "r285" ], "lang": { "en-us": { "role": { "documentation": "Net number of share options (or share units) granted during the period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures", "verboseLabel": "Number of shares issued" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Maximum number of shares that may be issued in accordance with the plan as a proportion of outstanding capital stock.", "label": "Percentage of outstanding shares" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/OrganizationDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r277", "r278", "r279", "r281", "r282", "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r301", "r302", "r303", "r304", "r305" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement." } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/ScheduleOfAmountOwedOnPrepaymentOfDiagonalLendingNoteDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "auth_ref": [ "r280", "r299", "r300", "r301", "r302", "r305", "r310", "r312" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.", "label": "Stock-based Compensation" } } }, "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks of a company.", "label": "Share price" } } }, "localname": "SharePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative", "http://biopowercorp.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesIssuedPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share or per unit amount of equity securities issued.", "label": "Share issued price per share", "verboseLabel": "Issue price per share" } } }, "localname": "SharesIssuedPricePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative", "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Ending balance, shares", "periodStartLabel": "Beginning balance, shares" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/StatementsOfChangesInStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_ShortTermDebtLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Short-Term Debt [Line Items]" } } }, "localname": "ShortTermDebtLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/ScheduleOfNotesPayableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r63", "r74" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Summary of Significant Accounting Policies" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/SummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r13", "r14", "r15", "r68", "r71", "r89", "r90", "r91", "r93", "r95", "r102", "r103", "r104", "r147", "r178", "r182", "r183", "r184", "r187", "r188", "r230", "r231", "r235", "r239", "r246", "r343", "r470" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/BalanceSheets", "http://biopowercorp.com/role/BalanceSheetsParenthetical", "http://biopowercorp.com/role/OrganizationDetailsNarrative", "http://biopowercorp.com/role/SeniorPromissoryNoteRelatedPartyDetailsNarrative", "http://biopowercorp.com/role/StatementsOfChangesInStockholdersDeficit", "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative", "http://biopowercorp.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r0", "r35", "r39", "r40", "r41", "r75", "r76", "r77", "r79", "r85", "r87", "r101", "r148", "r246", "r253", "r307", "r308", "r309", "r319", "r320", "r337", "r345", "r346", "r347", "r348", "r349", "r350", "r355", "r444", "r445", "r446" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/StatementsOfChangesInStockholdersDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/BalanceSheets", "http://biopowercorp.com/role/BalanceSheetsParenthetical", "http://biopowercorp.com/role/SeniorPromissoryNoteRelatedPartyDetailsNarrative", "http://biopowercorp.com/role/StatementsOfChangesInStockholdersDeficit", "http://biopowercorp.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r75", "r76", "r77", "r101", "r403" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/BalanceSheets", "http://biopowercorp.com/role/BalanceSheetsParenthetical", "http://biopowercorp.com/role/SeniorPromissoryNoteRelatedPartyDetailsNarrative", "http://biopowercorp.com/role/StatementsOfChangesInStockholdersDeficit", "http://biopowercorp.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation": { "auth_ref": [ "r274", "r311" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, after forfeiture, of shares granted under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Shares Granted, Value, Share-Based Payment Arrangement, after Forfeiture", "verboseLabel": "Value of shares issued" } } }, "localname": "StockGrantedDuringPeriodValueSharebasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssued1": { "auth_ref": [ "r59", "r60", "r61" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The fair value of stock issued in noncash financing activities.", "label": "Stock issued" } } }, "localname": "StockIssued1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": { "auth_ref": [ "r14", "r15", "r253" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.", "label": "Number of consideration shares" } } }, "localname": "StockIssuedDuringPeriodSharesAcquisitions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/OrganizationDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.", "label": "Number of shares issued" } } }, "localname": "StockIssuedDuringPeriodSharesIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r14", "r15", "r246", "r253" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Sale of common stock, Shares", "verboseLabel": "Shares issued, shares" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/StatementsOfChangesInStockholdersDeficit", "http://biopowercorp.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": { "auth_ref": [ "r14", "r15", "r246", "r253" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.", "label": "Number of restricted stock issued" } } }, "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.", "label": "Value of shares issued" } } }, "localname": "StockIssuedDuringPeriodValueIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r14", "r15", "r246", "r253" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Sale of common stock", "verboseLabel": "Value of shares issued" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/StatementsOfChangesInStockholdersDeficit", "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures": { "auth_ref": [ "r246", "r253" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.", "label": "Value of restricted stock issued" } } }, "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r15", "r19", "r20", "r71", "r139", "r147", "r343", "r367" ], "calculation": { "http://biopowercorp.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "negatedLabel": "Stockholders equity deficit", "periodEndLabel": "Ending balance, value", "periodStartLabel": "Beginning balance, value", "totalLabel": "Total stockholders\u2019 deficit" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/BalanceSheets", "http://biopowercorp.com/role/StatementsOfChangesInStockholdersDeficit", "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders\u2019 deficit" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r69", "r231", "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r242", "r243", "r245", "r253", "r254", "r336" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "verboseLabel": "Stockholders\u2019 deficit" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/StockholdersDeficit" ], "xbrltype": "textBlockItemType" }, "us-gaap_StockholdersEquityPolicyTextBlock": { "auth_ref": [ "r228" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for its capital stock transactions, including dividends and accumulated other comprehensive income.", "label": "Stockholders\u2019 Equity" } } }, "localname": "StockholdersEquityPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.", "label": "Subsequent Event [Line Items]" } } }, "localname": "SubsequentEventLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r351", "r369" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://biopowercorp.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTable": { "auth_ref": [ "r351", "r369" ], "lang": { "en-us": { "role": { "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.", "label": "Subsequent Event [Table]" } } }, "localname": "SubsequentEventTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r351", "r369" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://biopowercorp.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r351", "r369" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://biopowercorp.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r368", "r370" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowElementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental disclosure of cash flow information:" } } }, "localname": "SupplementalCashFlowElementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_TradeAndOtherAccountsReceivablePolicy": { "auth_ref": [ "r134", "r135", "r136", "r137", "r138", "r140" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for accounts receivable.", "label": "Accounts Receivable" } } }, "localname": "TradeAndOtherAccountsReceivablePolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "auth_ref": [ "r141", "r142", "r143", "r144", "r145", "r216", "r244", "r335", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r470", "r471", "r472", "r473", "r474", "r475", "r476" ], "lang": { "en-us": { "role": { "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms." } } }, "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_TypeOfArrangementAxis": { "auth_ref": [ "r328" ], "lang": { "en-us": { "role": { "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]" } } }, "localname": "TypeOfArrangementAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://biopowercorp.com/role/NotesPayableAndConvertibleDebtDetailsNarrative", "http://biopowercorp.com/role/OrganizationDetailsNarrative", "http://biopowercorp.com/role/SeniorPromissoryNoteRelatedPartyDetailsNarrative", "http://biopowercorp.com/role/StockholdersDeficitDetailsNarrative", "http://biopowercorp.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r105", "r106", "r108", "r109", "r113", "r114", "r115" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r88", "r95" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted average common shares outstanding: basic and diluted" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://biopowercorp.com/role/StatementsOfOperations" ], "xbrltype": "sharesItemType" } }, "unitCount": 5 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "270", "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e543-108305" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e4975-111524" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "11B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5212-111524" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5093-111524" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "https://asc.fasb.org/topic&trid=2126998" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b),(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r171": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org/topic&trid=2144648" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751" }, "r176": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466302&loc=d3e4852-112606" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r2": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "https://asc.fasb.org/topic&trid=2122149" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612" }, "r225": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "https://asc.fasb.org/topic&trid=2208564" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(CFRR 211.02)", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21459-112644" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21553-112644" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21484-112644" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a)(5))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r254": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org/topic&trid=2208762" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130561-203045" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130564-203045" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r267": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "https://asc.fasb.org/topic&trid=49130388" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "30", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128088960&loc=d3e3913-113898" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2.Q6)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "30", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126965701&loc=d3e15009-113911" }, "r312": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "https://asc.fasb.org/topic&trid=2228938" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(2))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6578-128477" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6613-128477" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "808", "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r334": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "https://asc.fasb.org/topic&trid=2197479" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r364": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org/topic&trid=2122745" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580" }, "r370": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org/topic&trid=2122774" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(i)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(ii)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)(i)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(5)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(6)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(7)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(b)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "330", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(5))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "(a)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126941378&loc=d3e61044-112788" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16)(a)(2))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.15(a))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.17)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691" }, "r454": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12" }, "r455": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r456": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r457": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r458": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r459": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r460": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d" }, "r461": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r462": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r463": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d" }, "r464": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r465": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" }, "r466": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r467": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r468": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r469": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585" }, "r470": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402" }, "r471": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(1)" }, "r472": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)" }, "r473": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(3)" }, "r474": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(i)" }, "r475": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(ii)" }, "r476": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(iii)" }, "r477": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r478": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405" }, "r479": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585" }, "r480": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690" }, "r74": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258" } }, "version": "2.1" } ZIP 44 0001493152-22-019396-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-22-019396-xbrl.zip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end